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SUMMARY 
 
Pregnancy-associated malaria (PAM) represents a major health concern worldwide. Current 
knowledge of this form of human malaria is concurred by epidemiological, pathological, 
immunological and parasite biology evidence. Nevertheless, the lack of  animal models to 
study PAM constitute a limitation to in-depth identification of cellular and molecular 
components of PAM pathogenesis and to further understand the susceptibility and protection 
mechanisms underlying PAM. 
The aim of this thesis was firstly to establish an experimental system enabling pregnancy-
associated malaria (PAM) studies in mouse models and secondly to characterize the 
immunological and pathological features in murine pregnancy-associated malaria. 
Using P. berghei-ANKA-GFP parasites and the BALB/c mouse strain the experimental systems 
were developed taking in consideration that human PAM has distinct presentations and 
consequences depending on the previous maternal immunity to malaria (premunition). In one 
scenario, women have not developed an immune protection against malaria before pregnancy 
(low premunition), which is typical of regions with low malaria transmission or unstable 
malaria. To model the low premunition scenario the mouse females contacted with malaria 
parasites for the first time when infected with iRBC during pregnancy (Model of infection 
during pregnancy). On the other hand, in the high-transmission areas women experience 
prolonged exposure to malaria and are relatively well protected against malaria before 
pregnancy (high premunition). To model high premunition before pregnancy, the females were 
immunized by infection with iRBC before pregnancy (Model of pre-exposure).  
These models were scrutinized for pregnancy outcome, placenta pathology and PAM 
protective responses. The experimental model established in non-immune mice showed 
enhanced disease severity, poor pregnancy outcomes and the prominent histological 
alterations. The pathology of mouse placenta infected with P. berghei resembles the acute 
P. falciparum placental malaria in humans allowing us to identify trophoblast thickening and 
vascular space reduction as hallmarks of placenta malaria induced by the P.berghei. In the pre-
exposure (pregnancy-induced malaria recrudescence) model the intensity of parasite 
recrudescence showed to be quantitatively correlated with the placenta pathology while the 
recrudescence incidence and the adverse pregnancy outcomes decreased with parity.  
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P. berghei-GFP adhesion experiments indicate that iRBC express ligands for different receptors 
in the mouse placenta. iRBC from recrudescent females displayed enhanced adhesion to the 
placenta suggesting that P. berghei parasites mediating PAM have increased specificity for 
placenta receptors. Pre-exposed females showed a long-term malaria protection state that is 
abrogated by pregnancy, strongly suggesting that the host mechanisms that confer protection 
against pregnancy–associated P. berghei appear not to protect from non-placental P. berghei. 
The data provided in this thesis demonstrate that the experimental systems based on 
P.berghei-BALB/c mouse are valid models to study the pathogenesis of placenta malaria, the 
adhesion of placental parasites, the parasite-placenta interaction and the mechanisms of PAM 
protection elicited during pregnancy. The experimental systems presented in this thesis could 
prove useful in drawing new hypothesis and testing analogies on the factors and mechanisms 
that are considered relevant for human PAM. 
 
Keywords: malaria, pregnancy, placenta, Plasmodium berghei, pathology, parity, mouse 
models, BALB/c, recrudescence, premunition, immunopathology. 
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RESUMO 
 
Em áreas endémicas de malária, estima-se a ocorrência de mais de 50 milhões de gravidezes 
por ano, aproximadamente metade das quais se verificam na África Sub-Sahariana, onde a 
transmissão de P. falciparum é mais intensa. A Malária Associada à Gravidez é um dos mais 
importantes problemas de saúde pública em África, contribuindo para uma alta carga da 
morbilidade materna e fetal, que pode ser responsável por 100,000 mortes de bebés por ano. 
As mulheres grávidas são mais susceptíveis à malária e podem exibir manifestações clínicas 
mais severas. Para além disso, a malária durante a gravidez está associada a maiores taxas de 
aborto e os recém-nascidos têm maior probabilidade de manifestar restrição de crescimento 
intra-uterino em combinação com um baixo peso à nascença, que constituem factores de risco 
fortemente associados à mortalidade neonatal. 
Nem todos os aspectos da malária na gravidez estão totalmente entendidos, tanto do lado do 
parasita, como do lado do hospedeiro e constituem prioridades para a investigação. A maior 
parte do conhecimento que suporta a base biológica e imunopatológica da Malária Associada à 
Gravidez apenas deriva de estudos realizados em mulheres grávidas que vivem em áreas 
endémicas de malária. Uma vez que, por razões éticas ou logísticas, algumas questões 
importantes não podem ser abordadas em seres humanos, o conjunto de resultados 
apresentado na presente tese demonstra as potencialidades em usar modelos de ratinho para 
estudar a Malária Associada à Gravidez.  
Na primeira parte da tese, apresentam-se os aspectos principais da Malária Associada à 
Gravidez em humanos, sendo abordados os pontos seguintes: (i) a importância da doença, 
realçando-se a epidemiologia e o seu impacto, tanto na mãe, como no feto/recém-nascido; (ii) 
caracterização da placenta e de alguns aspectos da imunologia associada à gravidez, 
realizando-se uma descrição subsequente das modificações conhecidas que são causadas pela 
malária; (iii) descrição da interacção entre os parasitas P. falciparum e o hospedeiro (grávida), 
realçando-se as características do parasita essenciais para a doença, bem como os mediadores 
placentários reconhecidos como intervenientes nesta interacção; e finalmente (iv) 
fundamenta-se a necessidade e as vantagens de usar modelos de ratinho para estudar a 
Malária Associada à Gravidez, salientando-se as semelhanças/diferenças na estrutura e no 
desenvolvimento da placenta entre o ratinho e o ser humano e, por último, refere-se os 
estudos anteriores que se debruçaram sobre a malária na gravidez em ratinho.  
Os sistemas experimentais desenvolvidos tiveram em consideração que a malária na gravidez 
humana tem apresentações e consequências distintas conforme o grau de protecção da mãe. 
Este nível de imunidade materna à malária prévia à gravidez (premunição) está correlacionado 
com a exposição à malária e, portanto, com o nível de endemicidade, ou intensidade da 
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transmissão da malária, podendo considerar-se separadamente uma de duas situações. Na 
primeira, as mulheres não desenvolveram uma protecção contra a malária antes da gravidez 
(premunição baixa), o que é típico de regiões com baixa transmissão de malária ou com 
malária instável. No outro cenário, no qual as mulheres vivem em regiões que facilitam a 
exposição permanente à malária, as futuras mães estão relativamente bem protegidas contra 
a malária antes da gravidez (alta premunição). Consequentemente, decidiu-se pelo 
estabelecimento de dois modelos de ratinho que mimetizassem cada um destes cenários. 
No modelo associado a uma premunição baixa, as fêmeas contactam com o parasita pela 
primeira vez apenas quando infectadas durante a gravidez (Modelo de Infecção Durante a 
Gravidez). No outro modelo, é necessário garantir que as fêmeas tenham uma alta premunição 
antes da gravidez, pelo que as fêmeas são infectadas e imunizadas antes da gravidez (Modelo 
de Pré-Exposição). Ambos os modelos foram estabelecidos usando a estirpe de ratinho BALB/c 
e os parasitas P. berghei-ANKA. Além disso, os modelos foram analisados considerando a 
reprodutibilidade das características principais da doença humana, tais como as modificações 
na placenta, os efeitos na prole e o tipo de interacção entre o parasita e a placenta.  
Estes modelos foram avaliados para o resultado da gravidez, patologia da placenta e respostas 
protectoras à malária associadas à gravidez. O modelo experimental estabelecido em ratinhos 
não imunes mostrou uma maior severidade da doença, efeitos adversos na prole e alterações 
histológicas proeminentes. A patologia da placenta de ratinho infectada com P. berghei 
assemelha-se às manifestações agudas de infecções de P. falciparum em seres humanos. 
Particularmente, é possível observar o espessamento do trofoblasto e a redução dos espaços 
intervilosos, características da malária placentária induzida por P. berghei. No modelo de pré-
exposição (recrudescência induzida pela gravidez) a intensidade da recrudescência, em termos 
de percentagem de parasitas no sangue periférico, mostrou estar quantitativamente 
correlacionada com a patologia da placenta. Por outro lado, a incidência de recrudescência e 
os resultados adversos da gravidez diminuíram com a paridade.  
As experiências de adesão com P. berghei-GFP indicam que os eritrócitos infectados expressam 
ligandos diferentes para os receptores na placenta de ratinho. Os eritrócitos infectados de 
fêmeas recrudescentes manifestam uma maior intensidade de adesão na placenta, o que 
sugere que os parasitas de P. berghei que medeiam a malária na gravidez tenham aumentado 
a sua especificidade para se ligarem a receptores das placentas. As fêmeas pré-expostas à 
malária mostraram um estado de protecção por longos períodos contra a doença, mas este 
estado é alterado pela gravidez, sugerindo que os mecanismos que conferem protecção contra 
 ix 
 
os parasitas P. berghei associados à gravidez não protegem de parasitas P. berghei não 
placentários. 
A descrição das características de ambos os modelos permitiu a sua validação como 
representações congruentes da Malária Associada à Gravidez humana. Consequentemente, 
estes modelos podem ser explorados no sentido de contribuir para o avanço do conhecimento 
da doença, nomeadamente dos aspectos da imunopatologia.  
A investigação que serviu de base a esta tese permitiu a observação e a descrição da doença 
murina e das suas consequências. Para além disso, com este trabalho foi possível perspectivar 
algumas linhas de pesquisa, umas relacionados com a biologia de parasita, como a exploração 
da variação antigénica em P. berghei através do uso de parasitas recrudescentes, e outras 
referentes aos mecanismos da doença, como a imunopatologia. Nesse sentido, estes modelos 
podem contribuir para elucidar várias questões que estão ainda por esclarecer, como os 
factores que provocam a recrudescência de parasitas na ausência de reinfecção, o papel de 
anticorpos assimétricos na Malária Associada à Gravidez, a relação entre pre-eclampsia e 
malária, a activação policlonal e os processos associados à memória imunológica. Finalmente, 
a exploração das futuras potenciais direcções da pesquisa da doença pode fornecer novos 
avanços na compreensão dos mecanismos imunopatológicos, bem como servir de base para 
testes de segurança e eficácia de medicamentos ou mesmo contribuir para encontrar uma 
vacina que confira protecção durante a gravidez. Em suma, os modelos de ratinho parecem ser 
um instrumento promissor para compreender melhor os mecanismos desconhecidos da 
Malária Associada à Gravidez humana, constituindo uma esperança para melhorar a prevenção 
e o controlo da doença. 
 
Palavras-Chave: malária, gravidez, placenta, Plasmodium berghei, patologia, paridade, 
modelos murinos, recrudescência, premunição, BALB/c. 
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INTRODUCTION  
 
Pregnancy-associated malaria (PAM) represents a major health concern worldwide. Current 
knowledge of this form of human malaria is concurred by epidemiological, pathological, 
immunological and parasite biology evidence. In this section we summarize the background 
evidence that supports current hypotheses on PAM pathogenesis and elaborate considerations 
on the potential contribution of animal models to further understand the susceptibility and 
protection mechanisms underlying PAM. 
MALARIA IN HUMAN PREGNANCY 
Global distribution and disease burden 
Pregnant women appear to be more susceptible to malaria than other adults and malaria is 
widely recognized as an infection that can seriously jeopardize the outcome of pregnancy, 
especially in women pregnant for the first time (Bray & Anderson, 1979; Brabin, 1983). Each 
year more than 50 million pregnancies occur in malaria-endemic areas, half of which in Africa 
mostly in areas of relatively stable malaria transmission and less than 5% of pregnant women 
have access to effective proposed interventions (Steketee et al., 2001; WHO, 2004). Malaria 
infection of the placenta and malaria-caused maternal anemia contribute to low birth weight 
(LBW) which is a risk factor for infant mortality and impaired child development.  
The burden of malaria infection during pregnancy is caused chiefly by Plasmodium falciparum 
(P. falciparum) (Figure 1), the most virulent/lethal, and also the most common Plasmodium 
species in Africa (Newbold et al., 1997). The global population at risk of P. falciparum 
transmission in 2007 was estimated in 2.37 billion across 87 countries and included 0.98 billion 
people living in areas with low, unstable transmission risk (Snow et al., 2008). Although P. vivax 
is responsible for infecting an estimated 2.59 billion people annually (Guerra et al., 2006), it is 
commonly considered more benign than P. falciparum and its impact in pregnancy has recently 
started to be assessed (ter Kuile & Rogerson, 2008).  
It is generally acknowledged that during pregnancy there is an increase in prevalence and 
density of P. falciparum malaria (Bray & Anderson, 1979; Brabin, 1983) and the impact of the 
other three human malaria parasites (P. vivax, P. malariae and P. ovale) is less clear in 
pregnancy, but they are not associated with severe disease. P. falciparum is normally present 
in tropical, subtropical and warm temperate regions. P. vivax is instead the most frequent 
parasite found in Asia, Central- and South-America and less common in West Africa as the 
majority of the population is negative for the Duffy blood group antigen that serves as a 
receptor for P. vivax parasites to enter the host red blood cells (RBC). P. malariae is much less 
common, appearing only in few African regions and in Western Pacific. Finally, P. ovale which 
Introduction 
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has the most limited distribution of all the malaria parasites of humans, can occur throughout 
most of sub-Saharan Africa and is known to be endemic only in New Guinea and in Philippines 
(Carter & Mendis, 2002). Acquired infections in humans have been recently reported in East 
Malaysia and Singapore for P. knowlesi, a simian malaria parasite that is generally misidentified 
as P. malariae since the blood stages are morphologically similar on microscopy, needing 
molecular methods of detection for correct diagnosis (Singh et al., 2004; Ng et al., 2008). 
 
Figure 1. Geographical distribution of P. falciparum malaria risk defined by annual parasite incidence, 
temperature and aridity. Populations at risk in areas defined as having stable (dark pink) and unstable 
transmission (light pink). No transmission was assumed where assembled data stated no malaria risk, because 
not a single P. falciparum clinical case had been reported over several years, or where temperature was too low 
for sporogony to complete within the average life span of the local dominant vector species, or conditions were 
too arid for anopheline mosquito survival. In this map unstable malaria was used to deﬁne areas where 
transmission was biologically plausible and/or had been documented but where incidence was likely to be less 
than one case per 10,000 population per annum. Stable malaria areas represent populations at risk of signiﬁcant 
disease burdens, including populations exposed to infrequent malaria infection risks and those subject to 
repeated infections and thus high disease burden risks with great public health needs. From Snow et al.(2008). 
 
Effective interventions recommended by WHO have proved capable of reducing substantially 
the adverse disease outcomes in pregnancy (Steketee et al., 2001). These interventions include 
intermittent preventive malaria treatment in pregnancy (IPTp), insecticide-treated bed nets 
(ITN) and effective case management of malaria illness and anemia, which in turn includes 
nutritional supplementation with iron/vitamin/mineral preparations, screening for anemia and 
monitoring of other diseases such as helminthes or bacterial infections (WHO, 2004). 
Nevertheless the majority of pregnant women still have no access to those measures, some of 
which are expensive and logistically difficult to apply, and efforts are required to accelerate 
implementation of strategies to prevent and control malaria in pregnancy. PAM focused 
research is needed to fulfill gaps of knowledge and thus contribute to disease impact 
reduction. The work in progress towards a better understanding of the disease mechanisms, 
parasite biology and maternal immunopathology, is a critical contribution for a stronger 
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interaction between science and strategic programs developing new control/clinical measures 
including a vaccine specific for PAM. 
Epidemiology 
Malaria exists in many parts of the world but the incidence varies from place to place and the 
same is observed for pregnancy malaria. The term “malaria” is derived from the belief of the 
ancient Romans that the disease was caused by the “bad air” of the marshes surrounding 
Rome, which denotes the past occurrence of the disease in places where any cases are 
currently observed. 
The disease distribution is determined by several factors, including parasite life cycle 
attributes. The completion of Plasmodium spp. life cycle usually needs two obligatory hosts: a 
vertebrate intermediate host (mammals, birds and reptiles) and an invertebrate definitive host 
(hematophagous insect of the genus Anopheles). The life cycle of P. falciparum is outlined in 
Figure 2. 
gamete
ookinete
oocyst
sporozoites
mosquito gut
sporozoites migration to salivary gland
 
Figure 2. Plasmodium falciparum life cycle. Female mosquitoes of the genus Anopheles carrying malaria parasites 
inject sporozoites into the blood stream with the saliva while feeding blood. Within few minutes the sporozoites 
travel to the liver where they transverse several hepatocytes before invade and replicate in one (Mota et al., 
2001). Liver stage infection is asymptomatic. About 10-12 days later each sporozoite develops into thousands of 
merozoites that are released back into the bloodstream and will invade RBC. Inside a RBC, the parasite undergoes 
a new phase of asexual division to form a multinucleated schizont while expressing proteins in the outer RBC 
membrane, some of which have adhesive properties, enabling the mature parasite to bind receptors expressed by 
endothelial cells and in the deep vascular beds of organs such as the brain, lungs and placenta. Every 48 hours the 
parasite multiplies, each iRBC bursts and releases around 20 daughter merozoites, thereby continuing the blood 
stage cycle. Some merozoites follow a different developmental path and, rather than form another schizont, they 
differentiate into the sexual stage, forming either a male or female gametocyte, which, when taken by another 
feeding mosquito, perpetuate the sexual cycle in the insect. In the mosquito stomach the gametocytes develop 
into female and male gametes and after fertilization the diploid ookynetes migrate into the gut wall where they 
mature to form oocysts. Meiosis occurs within the oocysts leading to development of haploid infective 
sporozoites. When oocysts rupture the sporozoites migrate to the salivary glands, ready to be injected during the 
next mosquito blood meal. Adapted from Miller et al. (2002) and Carvalho et al. (2002). Malaria is considered 
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endemic in a region when it occurs at a relatively constant incidence by natural transmission 
over successive years. Endemicity levels can be separated in classes according to the parasite 
prevalence in the population. Following Lysenko’s classification cited by Hay et al. (Hay et al., 
2004), endemicity classes are defined by the parasite rate (PR) in the 2–10-year age cohort as 
follows: hypoendemic < 10% infection prevalence; mesoendemic 11–50% infection prevalence; 
hyperendemic 51–75% infection prevalence. The exception is for the holoendemic class (> 75% 
infection prevalence) where the PR refers to the 1-year age group (Snow et al., 2005). 
Stable malaria transmission is associated with little seasonal or annual fluctuation in the 
disease incidence and leads to a characteristic pattern of immunity whereby older children and 
adults become progressively immune to the worst effects of the disease. In areas of stable 
malaria, the parasite is transmitted by a strongly anthropophilic rather than zoophilic 
Anopheles vector species that is found in the warmer regions of the world where the climatic 
conditions facilitate a rapid parasite development inside the mosquito (Carter & Mendis, 
2002). P. falciparum is commonly the most prevalent parasite in areas with stable malaria 
transmission. Malaria is considered unstable in places where there is no reliable periodic 
transmission and sporadic epidemics may occur after long periods of almost no transmission. 
Unstable malaria is often associated with a short-lived vector or a more zoophilic mosquito, 
with low probability of taking two consecutive meals from a human host. In these areas 
typically temperatures are lower than in areas with stable malaria, sporogony (the nuclear 
divisions that give rise to sporozoites inside the mosquito) is slower and the most prevalent 
pathogen is P. vivax. 
Malaria transmission intensity can be quantified by the Entomological Inoculation Rate (EIR) 
that expresses the average number of infective bites per person per year. Climatic factors, 
including temperature, humidity and precipitation, influence the density and development of 
the parasite inside the vector. For instance, the sporogony does not occur bellow 16oC or 
above 33oC, and open-air water is needed for the oviposition by fertilized females, where the 
eggs develop to adults in 7 to 20 days depending on the temperature. In addition, other 
factors such as mosquito longevity, predilection of the vector to feed on humans 
(anthropophily), mosquito endophily (tendency to preferentially rest inside the houses, in 
opposition to exophily when the mosquitoes likely abandon the house after a blood meal) or 
human factors (density and behavior of the human population), are also critical to shape 
human malaria epidemiology (Forattini et al., 1987; Guerra et al., 2008). Furthermore, the 
knowledge of disease epidemiology and the understanding of mosquitoes preferences and 
habits are very important to the design of preventive measures. For instance, if a parasite 
shows exophilic behavior and uses outside refuges, convincing people to use personal 
protection such as a bed net and eliminating open-air water, instead of indoor residual 
spraying, may be considered as a more effective malaria control measure in those conditions. 
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The outcome of malaria disease is determined by factors besides the transmission intensity, 
which include parasite features (virulence, drug resistance), host factors (age, immunity, 
genetics) and even socio-economic factors (access to treatment, politics, gender, economic 
condition, etc.). Relatively to the last point, it is worth to strengthen that malaria and poverty 
are closely related. Endemic countries are among the ones with lower rates of economic 
growth, making more difficult the access to preventive and curative measures. In addition, low 
socioeconomic status, normally associated with low maternal educational levels, can even 
complicate the consequences of malaria in pregnancy. For instance, low socioeconomic 
conditions are connected with poor nutritional status of the mother and hence poor fetal 
nutrition, limited access to complementary foods/supplements due to their cost and standard 
living conditions that facilitate diseases transmission, including malaria (De Pee et al., 2002). 
On the other way round, malaria can be seen as an obstacle to development and a cause of 
poverty, because it can affect population growth, worker productivity, absenteeism and 
premature mortality (Sachs & Malaney, 2002). Specifically, malaria in pregnancy, as a major 
public health concern in low-income countries, also has a negative impact in the development 
and its resolution is constrained by the lack of resources to implement specific and effective 
interventions. The costs associated to malaria in pregnancy include the expenditures coming 
up from measures directed to pregnant women (for example, ITN and IPTp) but also the 
additional costs arising as a consequence of PAM, namely the long-term costs of treating the 
effects of maternal infection in the infant (Worrall et al., 2007). 
Together, all these epidemiological features of malaria determine the worldwide distribution 
of the disease in pregnancy. Africa bears 90% of the world burden of P. falciparum malaria and 
consequently the greatest problems of malaria in pregnancy are in sub-Saharan Africa, where 
it is one of the leading causes of maternal and perinatal mortality and morbidity (WHO, 2004). 
In Asia and South America there is a different scenario because transmission intensities are 
generally lower, despite the existence of discrete areas of very high transmission (Singh et al., 
2001). In those regions P. vivax is the most prevalent species and thus is the major parasite to 
be aware of.  
It is noteworthy the efforts put in the construction of a map of estimates of P. falciparum 
infection prevalence worldwide (http://www.map.ox.ac.uk). This project appears as a tool to 
the commitment of reducing/eliminating malaria, as part of a global effort to tackle diseases of 
poverty through the Millennium Development Goals (Hay & Snow, 2006). These maps will 
constitute a support to identify intervention needs and may provide tools to evaluate the 
implementation of future strategies on malaria control, including malaria in pregnancy.  
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Factors affecting Pregnancy-Associated Malaria (PAM)  
The consequences of P. falciparum-PAM are determined by a range of factors, including the 
number of previous pregnancies, the existence of co-infections and the level of immunity 
acquired by the woman throughout her life. This level of pre-pregnancy immunity, or 
premunition, depends largely on the epidemiological setting where the woman is living. 
Therefore, the prevalence of malaria infection on pregnant women can range from 10% to 65% 
across the different settings (Steketee et al., 2001). A description of PAM in high and low 
transmission regions is reviewed in detail by Nosten et al. (Nosten et al., 2004). 
• PAM in regions with high malaria transmission 
In areas with high endemicity or with stable malaria transmission, adults usually manifest a 
protective semi-immunity against P. falciparum, which is maintained only by continued 
exposure to malaria and most of the malaria infections are asymptomatic (do not produce 
fever or clinical illness) (Desai et al., 2007). Women with previously reasonable immunity 
appear to lose part of that protection in pregnancy and are more likely to be parasitemic than 
non-pregnant women (WHO, 2000). Parasite prevalence and parasitemia density are maximal 
in the second pregnancy trimester, and this is most evident in first and second pregnancies 
with decreased risk in each successive pregnancy (Singh et al., 2001; Rogerson et al., 2007). In 
fact, in contrast with other infectious diseases that induce complications in pregnant women, 
malaria burden in pregnancy decreases in incidence with successive pregnancies (Duffy & 
Fried, 1999). Despite the higher parasite incidence in pregnancy, severe disease is uncommon, 
infection is frequently asymptomatic in these settings and, consequently, malaria may go 
unsuspected and undetected (Diagne et al., 1997). Nevertheless, immune women can display 
heavy placental infection, despite negative peripheral blood smears, which can result in the 
development of maternal anemia and in babies with LBW (Dorman & Shulman, 2000).  
• PAM in regions with low malaria transmission 
In regions where malaria transmission is unstable, less intense, sporadic or periodic, the state 
of premunition is not attained and people are at greater risk of developing severe and 
symptomatic disease, and even of death, at all ages (Luxemburger et al., 1997; WHO, 2004). In 
this epidemiological context, malaria infection in pregnant women may result in a variety of 
adverse outcomes, including a high risk of developing complicated malaria, with central 
nervous system problems, maternal death (as a direct result of severe malaria or as an indirect 
result of malaria-related severe anemia), spontaneous abortion, neonatal death and LBW 
(Nosten et al., 1991; WHO, 2004). Since in these settings malaria is usually symptomatic, it is 
likely to be detected at early stages and, if treated, might result in the reduction of the harmful 
consequences of malaria in pregnancy, often allowing parasite clearance before placental 
colonization (McGready et al., 2004). 
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Malaria pathogenesis and PAM consequences  
Symptomatic malaria disease begins only after multiplication of blood stage asexual parasites, 
leading to massive destruction of RBC, release of bioactive parasite molecules and toxins, 
eventual iRBC sequestration and stimulation of host innate immune system to produce 
proinflammatory mediators that are the main components of malaria pathogenesis. 
The common symptoms of non-pregnant individuals to all four human malaria parasite species 
are headache and muscle aches, periodic fever and chills. However, some P. falciparum 
infections can progress to severe anemia, metabolic acidosis, hypoglycemia and some organ-
related pathological conditions (Miller et al., 2002). The destruction of iRBC is also part of 
malaria pathogenesis that, collectively with the acute hemolysis of uninfected RBC and 
dyserythropoiesis, leads to anemia, compromising the oxygen delivery in the tissues. Only 
P. falciparum, and not the other three species, causes fatal forms of disease due to its two 
main characteristics, that are its higher levels of parasitemia when compared with the other 
species and its property of being sequestered in the microvascular endothelial surface (Kyes et 
al., 2001). This distinct ability of P. falciparum to sequester favors an extensive accumulation of 
the iRBC in vital organs. In addition, the local and/or systemic action of parasite released 
products, as well as local and/or systemic production of inflammatory cytokines and 
chemokines in response to the infection, and the activation, recruitment and infiltration of 
inflammatory cells, can all together influence the progress to pathology, the clinical 
manifestations and the outcome of the disease (Schofield & Grau, 2005). 
The effect of P. vivax in pregnancy has received little attention but is considered less severe 
than P. falciparum. P. vivax infections in pregnancy are likely to result in febrile illness; infected 
women are more likely to be anemic and to deliver neonates with lower birth weight as 
compared to uninfected women, but less pronouncedly than with P. falciparum cases (Nosten 
et al., 1999; ter Kuile & Rogerson, 2008). 
• Effects of malaria on maternal health 
The effect of the infection on the mother may range from insignificant to severe, depending on 
the previous acquired immunity, parity and on other health conditions such as co-infections, 
being the human immunodeficiency virus (HIV) the most worrying at present (Desai et al., 
2007; Van geertruyden & D'Alessandro, 2007). Pregnant women are also more prone to 
develop hypoglycemia, which may be worsen during P. falciparum infection, and possibly 
contribute for LBW associated with peripheral parasitemia (Menendez, 1995). Anemia is the 
most common consequence of maternal malaria regardless the level of endemicity. WHO 
defines anemia when hemoglobin is lower than 11 g/dl and severe anemia when hemoglobin 
is lower than 5 g/dl (WHO, 2000). Anemia is more common in pregnant women than in non-
pregnant and even asymptomatic infections frequently worsen maternal anemia. In areas with 
stable P. falciparum transmission, PAM can contribute to approximately 2% to 15% of 
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maternal anemia (Steketee et al., 2001). Severe maternal anemia increases the risk of 
maternal death and is estimated to cause 10.000 deaths in Africa per year (Guyatt & Snow, 
2001). Generally, anemia causes are multifactorial and include inadequate nutrition, iron and 
folate deficiency, helminthes infections, hemoglobinopaties and HIV infections. In malaria-
endemic regions, malaria-induced anemia in pregnancy is caused by destruction of parasitized 
and non-parasitized erythrocytes, suppression of hematopoiesis and intense sequestration of 
infected erythrocytes in the placenta (Fleming, 1989; Menendez et al., 2000).  
• Effects of malaria on fetus and infant health 
PAM may affect the fetus/infant by a variety of mechanisms, including severe maternal 
disease, placental damage or even by direct infection. Firstly, maternal infection may lead to a 
systemic illness and, because of the high maternal fever, anemia, respiratory distress or 
systemic reactions to malaria, the fetus can suffer, display Intrauterine Growth Retardation 
(IUGR) and even die in absence of parasite sequestration in the placenta. Secondly, the 
placenta may be directly infected, resulting in placental insufficiency by impaired blood flow 
and reduced placental exchanges. Thirdly, the fetus may be directly infected through the 
placenta (Menendez & Mayor, 2007). Moreover, maternal infection may precipitate preterm 
delivery, when the fetus is still unable to tolerate life outside uterus or with LBW, which in turn 
is a cause of poor infant survival and development (van Geertruyden et al., 2004; Menendez & 
Mayor, 2007).  
Epidemiological data reveal that neonates appear to be relatively well-protected from clinical 
malaria and from severe consequences of malaria infection for the first 3-6 months of life 
(Snow et al., 1998). Several attempts have been described to explain the reduced malaria 
incidence in infants. The relative protection of the infants from infection could be due to 
behavioral practices, such as the constant supervision by the mother who may repel biting 
mosquitoes away from them and because they tend to be kept well covered up (Riley et al., 
2001). Furthermore, there are some physiological mechanisms that may inhibit the replication 
of blood stage parasites in neonates conferring them clinical protection during early infancy. 
For instance, malaria parasites grow much more slowly in RBC containing fetal hemoglobin 
(HbF) than in those with normal adult hemoglobin (Pasvol et al., 1977) and infants diet may 
lack some of the essential nutrients for parasite replication, such as the p-amino-benzoic acid 
(pABA) that is vital for parasites and it is present in low levels in breast milk (Riley et al., 2001) 
Depending on the level of malaria transmission intensity, malaria contributes to an estimated 
8% to 36% of cases of prematurity and 13% to 70% of IUGR. Maternal malaria, especially in 
areas of low or unstable transmission, can result in abortion (delivery of a dead fetus before 28 
weeks of gestational age) or stillbirth (delivery of a dead fetus after 28 weeks), and is 
estimated to account for 3% to 8% of all infant deaths (Steketee et al., 2001).  
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PLACENTAL IMMUNOPATHOLOGY CAUSED BY MALARIA 
The aims of this section are firstly to provide an overview of the main characteristics of the 
placenta and pregnancy immunology, and secondly to depict the major malaria-induced 
modifications in both domains. 
Placenta structure 
The word placenta has Latin origin and means ‘ﬂat cake’ (Cross, 2005). The placenta is an 
organ that develops during pregnancy, deriving at a large extent from embryonic tissue and 
indispensable for pregnancy success (Benirschke, 1998) and performs a multitude of 
nutritional, respiratory, hormonal, excretory and immunological functions. By being attached 
to the uterus wall the by blood vessels, it conveys supplies to the fetus and removes waste 
from the fetus transferring it to the mother.  
The placenta is essential for sustaining the fetus growth during gestation and defects in its 
function result in fetal growth restriction or, if more severe, fetal death. The pathological 
changes are best understood in the context of the placenta structure and anatomy (Figure 3).  
 
 
Figure 3. Schematic representation of the human placenta. The human placenta 
can be described as a disk full of blood where the villous trees (fetal part) are 
bathing. Inset showing a cross-section of terminal villi, the “placenta barrier”. 
From Duffy (2001).  
 
The fetus side (chorion) of the human placenta has a flat form, where the umbilical cord is 
inserted, and the opposite face, bordering the uterus, has a u-shaped surface. The umbilical 
cord is a channel that carryies fetal blood between the fetus and the placenta and normally 
contains two arteries and one vein, surrounded by extensive mesenchymal tissue. The villi, 
consisting of connective tissues (mostly fibroblasts) in which fetal blood vessels are found, 
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extend from the chorion plate into the vascular interior of the placenta and continue to branch 
throughout the pregnancy. The spaces between villi, the intervillous spaces (IVS), are filled 
with maternal blood supplied by spiral arteries in the decidua. Some villi end freely in the 
vascular space while others extend to the opposing decidua anchoring to the pregnant uterus 
in the decidua basalis, contributing to stabilize the mechanical integrity of the placental-
maternal interface. The decidual cells are lining the uterus and result from the differentiation 
of maternal endometrial stromal tissue adjacent to the placenta. Fetal circulation is entirely 
closed, confined to vessels within the chorionic villi, whilst maternal blood flow through the 
placenta is open. The inset of Figure 3 outline a cross-section of terminal villi, known as 
“placenta barrier” that separates maternal blood and fetal blood, across which occur all 
exchanges of gases, nutrients, hormones and wastes. The “placenta barrier” is constituted by 
three cell layers: the outer layer, covering the villi named syncytiotrophoblast (a syncytium 
with many dark-stained nuclei), the trophoblastic basement membrane and the fetal capillary 
endothelium. The villous cytotrophoblastic cells (Langhan’s layer) at early pregnancy form a 
continuous single layer of stem cells over the connective tissue of the chorionic villi that, 
during differentiation, fuse together into the multinucleated syncytiotrophoblast and add the 
cellular components to the syncytium. Later in pregnancy the cytotrophoblast is reduced to a 
few scattered large pale cells. In addition to the regulation of the exchange between the 
mother and the fetus, the syncytiotrophoblast is also responsible for placental hormone and 
enzyme production (Benirschke, 1998). During the latter half of the pregnancy, or under stress 
conditions, the villi might shrink allowing the syncytial epithelium to buckle and leading to the 
production of an excessive number of syncytial knots. Hofbauer cells are the placental 
macrophages, within the villous stroma and chorio-amniotic membranes, which naturally have 
phagocytic activity (Benirschke, 1998).  
Placenta pathology associated to malaria 
Placental malaria is an important component of the deleterious effects of malaria in pregnancy 
and the connection between placental histological changes and pregnancy outcome was 
reviewed in detail by Brabin et al. (Brabin et al., 2004b). The accumulation of P. falciparum 
parasites in the intervillous spaces (IVS) of the placenta is a pathological feature of malaria in 
pregnancy. Other characteristics of placental malaria include malaria pigment (hemozoin) 
accumulation, fibrinoid deposits, thickening of the trophoblastic basement membrane, focal 
necrosis, damage of the syncytiotrophoblastic membrane and mononuclear inflammatory 
infiltration of the IVS (Walter et al., 1982; Crocker et al., 2004).  
The striking alterations caused by placental malaria occur within the IVS, but typical 
pathological features are found both in maternal and fetal parts of the placenta. It is possible 
to evaluate the presence of parasites/pigment in IVS, in erythrocytes and monocytes and in 
polymorphonuclear leucocytes. It is also in the IVS that parasites can be sequestered and 
inflammatory infiltrates accumulated. Fibrin-type fibrinoid deposits (blood-clotting product) 
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can be evident in intervillous/perivillous and in the basal plate. Parasites, hemozoin and 
fibrinoid necrosis can be present in the syncytiotrophoblast. In the trophoblastic basement 
membrane a matrix-type fibrinoid can occur resulting in its thickening. Excessive syncytial 
knots are also observed in infected placentas (Walter et al., 1982; Bulmer et al., 1993; Crocker 
et al., 2004).  
The first classification of human placental infection was introduced by Bulmer et al. (Bulmer et 
al., 1993). The rationale of this histological classification was the assumption of the 
progression of infection and allows distinguishing current and past placental malaria infection. 
Thus, active infections are associated with the presence of parasites and can be either acute, if 
the parasites are present in maternal RBC as well as hemozoin (which can be found in iRBC or 
within macrophages) or chronic, when iRBC are also present but hemozoin is covered by fibrin. 
Past infections involve the presence of hemozoin, usually mixed with fibrin but with the 
absence of parasites, since after clearance of the infection the pigment can persist in fibrin 
(Bulmer et al., 1993).  
The cause of placental pathology associated to malaria is still not clear and could include direct 
effects of malaria infection by iRBC and hemozoin deposition as well as accumulation of 
inflammatory infiltrates in the IVS. For instance, intervillous accumulation of mononuclear cells 
induces an alteration in the cytokine balance and may contribute to pathological changes 
resulting in the damage of the syncytiotrophoblastic membrane (Walter et al., 1982; Crocker et 
al., 2004). When the degree of infiltration is intense it results in a massive chronic 
intervillousitis with a prominent inflammatory infiltrate in the IVS mainly composed by 
monocytes and macrophages, frequently associated with fibrin deposition, syncytial knots and 
malarial pigment (Ordi et al., 1998). 
The consequences of these pathologic changes on maternal disease and poor fetal outcomes 
have been discussed (Duffy, 2001; Brabin et al., 2004b). In sum, several observations invoke 
that the dense accumulation of parasites and inflammatory cells, together with the increased 
fibrinoid deposition and the trophoblast basement membrane thickening, could collectively 
cause an obstacle to gas and nutrients placental exchange, between the mother and the fetus.  
Components of immunological response to pregnancy 
Locally in the placenta a correct balance of cytokines produced by various immune cells (T 
lymphocytes, uterine NK (uNK) cells, macrophages) is essential for the pregnancy success 
(Veenstra van Nieuwenhoven et al., 2003). Many cells within the placenta, including Hofbauer 
cells, decidual cells, cells of the syncytiotrophoblast, uterine epithelial cells, uNK cells, amniotic 
membranes, the fetal tissues and intervillous maternal leucocytes, can produce a wide variety 
of cytokines and chemokines having a determinant role in placental development and 
immunology (Robertson et al., 1994).  
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The uNK cells have a NK cell-like function but they are specific for the uterus as they show a 
different phenotype when compared with peripheral NK cells. It has been suggested that uNK 
cells affect implantation and placentation and, at the same time, they play an important role in 
the protection against infections and in the regulation of immune response. For instance, 
decreased numbers of uNK cells were associated with significantly higher rates of miscarriage 
and low numbers of uNK cells were also found in the decidua of women with a genetically 
abnormal fetus as compared with women pregnant with a normal fetus. One recognized 
function of the uNK cells is the production of cytokines, usually influencing placentation, such 
as granulocyte colony-stimulating factor (G-CSF), granulocyte-macrophage colony-stimulating 
factor (GM-CSF), macrophage colony-stimulating factor (M-CSF) and leukemia inhibitory factor 
(LIF) that stimulate growth of the trophoblast and promote trophoblast cell proliferation and 
differentiation (Veenstra van Nieuwenhoven et al., 2003).  
T lymphocytes are the best studied peripheral immune cells in human pregnancy (Veenstra 
van Nieuwenhoven et al., 2003). There are various types of T-lymphocytes namely the helper T 
lymphocytes (Th) and the cytotoxic T lymphocytes (CTL). The former provide help to other 
immune cells by producing cytokines, whereas CTL lymphocytes can directly kill foreign or 
infected cells. T lymphocytes can also be classified into different functional subsets based on 
their profile of cytokine production. Type 1 T (Th1) cells produce cytokines that promote 
cellular immune responses, whereas the cytokines produced by type 2 T cells (Th2) provide 
optimal help for humoral responses (Raghupathy, 2001). 
Each pattern of cytokines has different roles in immune responses. Th1 cells produce, for 
example, IFN-γ, TNF-α and IL-2, which are soluble mediators of the cellular response by 
activating macrophages and cell-mediated reactions, important in resistance to infection with 
intracellular pathogens. Th2 cells produce IL-4, IL-5, IL-9, IL-10 and IL-13 that encourage 
humoral responses, promoting antibody production which is important in combating infections 
with extracellular agents (Veenstra van Nieuwenhoven et al., 2003). However, Th1 and Th2 are 
not the only types of Th-mediated responses and other cytokine patterns also exist. For 
instance, Th3 cells secrete TGF-β but do not secrete IFN-γ, IL-2, IL-4 or IL-10, and are capable of 
down-regulating Th1 cells (Raghupathy, 2001). Th1 and Th2 cells are reciprocally inhibitory to 
each other. For instance, IL-10, a product of Th2 cells, inhibits the development of Th1 cells by 
acting on antigen-presenting cells, whereas IFN-γ, a product of Th1 cells, prevents the 
activation of Th2 cells. The overall effect is that a given immune response can be dominated by 
either a cell-mediated profile (Th1) or humoral immunity (Th2) (Raghupathy, 2001). 
Typically, pregnancy is considered a Th2 dominant state because during pregnancy it is 
observed a decrease in the ratio between type 1 and type 2 cytokine production by peripheral 
lymphocytes, as compared with non-pregnant women, which is beneficial for pregnancy. 
However, Th1 or Th2 balance might be a dynamic process throughout the course of pregnancy. 
For instance, at pregnancy start a Th1 environment is necessary to promote endometrium 
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invasion and implantation. Later, Th2 dominance is adequate for the maintenance of the 
pregnancy and to tolerate the fetus, since Th1 cytokines are harmful as they inhibit embryonic 
and fetal development. Finally at pregnancy termination, the shift towards Th1 is essential for 
delivery.  
The Th1/Th2 paradigm provides an explanation to understand immune responses in pregnancy 
and how the immune system directs responses to different types of pathogens and stimuli. 
However, there is no consensus to whether the decreased type 1/type 2 cytokine production 
ratio is due to a decreased production of Th1 cytokines or to an increased production of Th2 
cytokines (Veenstra van Nieuwenhoven et al., 2003). This decreased ratio can be explained by 
different mechanisms. Firstly, the increase in pregnancy hormones (e.g. progesterone and 
estrogen) may directly affect lymphocytes by shifting their cytokine production towards type 2. 
Secondly, the placenta may interfere with lymphocyte cytokine production, since trophoblast 
cells also produce cytokines (mainly type 2), which may direct the maternal immune response 
towards a Th2 immune response, and could produce factors that inhibit cytotoxic T-
lymphocyte activity (Veenstra van Nieuwenhoven et al., 2003).  
In sum, successful pregnancy and fetal growth are associated with a predominant Th2 
response in the placenta, accompanied by an adequate hormonal regulation. Thus, production 
of Th2 cytokines locally in the placenta favor the maintenance of pregnancy, whereas any 
stimuli that increase Th1 cytokine production locally or systemically may lead to unsuccessful 
pregnancies, since a Th1 dominance is associated with fetal rejection and miscarriage because 
they cause an inflammatory environment (Veenstra van Nieuwenhoven et al., 2003). 
Immunological tolerance of the fetus 
The description of the known pregnancy immunological mechanisms is essential for 
pregnancy-associated malaria studies, because they establish a pattern of comparison with the 
malaria-induced modifications. For instance, abnormalities of maternal immune tolerance to 
the fetal semi-allograft have been implicated in several common disease processes occurring 
during pregnancy, leading to recurrent early miscarriage, pre-eclampsia and eclampsia 
(Zenclussen et al., 2007). These conditions are characterized by inflammation in the fetal-
maternal interface and/or systemic manifestations, which are common to the malaria disease. 
The fetus is often compared to an allograft because it is genetically different from the host 
(mother) and thus must find strategies to evade immune defenses and avoid “rejection”. The 
embryo in early development divides into two groups of cells that originate the fetus and the 
trophoblast, and the last are the only cells to directly interact with the cells of the maternal 
immune system (Veenstra van Nieuwenhoven et al., 2003). The trophoblast cells encounter a 
systemic immune response in the maternal circulation as well as when they are invading into 
the uterine wall, and several specialized mechanisms have evolved to help the fetus, which 
expresses paternal antigens, to evade maternal immune attack. Indeed, the maternal immune 
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system not only becomes aware of the fetus presence but dynamically tolerates it. Those 
mechanisms of tolerance were recently reviewed and summarized (Zenclussen et al., 2007).  
Trophoblast cells, which include the syncytiotrophoblast, villous cytotrophoblast and non-
villous cytotrophoblast, lack expression of major histocompatibility complex (MHC) class Ia 
molecules and so they cannot be recognized as non-self by maternal T cells. However, invading 
non-villous cytotrophoblasts (the tissue of implantation) in endometrium are at risk of lysis by 
uNK cells, which are present in endometrium and in the decidua in large amounts. 
Nevertheless, they do not attack the semi-allogeneic non-villous cytotrophoblast, because uNK 
express inhibitory receptors that bind to the MHC Ib, the non-classical HLA (HLA-C, HLA-E and 
HLA-G), on cytotrophoblasts (Veenstra van Nieuwenhoven et al., 2003).  
Furthermore, trophoblast cells express apoptosis-inducing ligand (FasL) that may cause 
apoptosis of activated maternal lymphocytes expressing the cognate receptor (Fas). In fact, Fas 
and its ligand (FasL) play an important role in the regulation of immune tolerance. Fas is highly 
expressed in several immune cells including activated T and B lymphocytes, NK cells, 
monocytes and macrophages. FasL is expressed on the surface of fetal cytotrophoblasts as well 
as on maternal decidual cells of the placenta, that is, in cells located at the interface between 
the fetal placenta and maternal endometrium (Veenstra van Nieuwenhoven et al., 2003).  
There are other mechanisms acting locally at the site of fetal antigen exposure which may 
operate in parallel to sustain gestation. Complement activation promotes inflammatory and 
immune responses, by inducing chemotaxis of inflammatory cells, enhancing phagocytosis by 
neutrophils and monocytes, facilitating immune complex clearance and mediating cell lysis by 
the membrane attack complex. Complement can also bind and attack self tissues, especially in 
areas of active inflammation but its deleterious effects can be avoided by complement control 
proteins. In pregnancy, complement regulation is essential for the maintenance of a normal 
pregnancy and complement activation is inhibited by expression of some proteins, such as Crry 
which has been implicated as a negative regulator of complement activation in mice, 
promoting maternal-fetal tolerance and survival (Xu et al., 2000).  
Moreover, in a normal pregnancy there is an increase on the levels of IgG asymmetric 
antibodies that have an effective participation in fetal protection. These antibodies behave as 
univalent for having one of the paratopes blocked with a carbohydrate chain and, 
consequently, they do not form antibody-antigen complexes. Thus, due to their molecular 
asymmetry and functional univalency, these immunoglobulins are unable to generate a 
classical immune response and, therefore, to trigger effector immune responses (Margni & 
Zenclussen, 2001). Asymmetric antibodies are present in humans as well as in mice and are 
synthesized systemically, representing 15% of the total serum antibodies (Zenclussen et al., 
2001). When specific for self-antigens, asymmetric antibodies are beneficial for the host due to 
their blocking functions, namely in allergic manifestations, auto-immune diseases and 
especially in pregnancy. During pregnancy asymmetric antibodies were found in serum and in 
Placental Immunopathology Caused by Malaria 
15 
 
the placenta with speciﬁc activity to paternal antigens. Acting locally in the placenta, they 
block paternal antigens without generating the classical immune response (Malan Borel et al., 
1991). In a normal pregnant woman, IgG asymmetric antibodies are elevated in sera and in the 
placenta, constituting around 50% of the IgG population in that organ and 80% of them have 
anti-paternal activity (Malan Borel et al., 1991), being their synthesis modulated by placental 
secreted factors, such as IL-6. High levels of this cytokine are associated with low levels of 
asymmetric antibodies which can endanger pregnancy success (Margni & Zenclussen, 2001).  
The placenta also grants an effective physical barrier to the immune attack, because it 
provides a separation between the maternal and fetal blood, and the villous 
syncytiotrophoblast (the placental membrane directly exposed to maternal blood) is semi-
permeable acting as a filter for two way transport including diffusion of certain molecules and 
active transport (Myren et al., 2007). 
In addition to locally acting mechanisms, systemic changes are also needed to facilitate fetal 
tolerance. For instance, it was shown a peripheral expansion of regulatory T cells (Treg) during 
pregnancy as a result of continuous alloantigen release from the placenta (Zenclussen et al., 
2007). Treg are known to play a major role in preventing autoimmunity but also in tolerating 
allogeneic organ grafts, acting either by cell-cell contact or by secreting immunomodulatory 
factors such as IL-10 and TGF-β. In pregnancy, Treg play a role in promoting additional 
acceptance of the fetus because in certain pathologic scenarios the recruitment and function 
of Treg appear to be impaired and the proportion of Treg is lower in cases of spontaneous 
abortion, when compared with induced abortions in mice (Aluvihare et al., 2004). Particularly, 
at the maternal-fetal interface, Treg are thought to inhibit maternal effector cells and up-
regulate tolerant molecules such as heme oxygenase 1 (HO-1), LIF, TGF-β and IL-10. LIF is 
essential for implantation success but is involved in tolerance of allografts and also has an 
important role on inducing tolerance at the fetal-maternal interface. HO-1 beneficial effects 
are related to the avoidance of the toxic accumulation of free heme. In fact, free heme, 
originated from senescent RBC for example, can cause cell damage and tissue injury as heme 
catalyses the formation of reactive oxygen intermediates (ROI), resulting in oxidative stress 
(Zenclussen et al., 2007).  
General aspects of the immunity to malaria  
It is generally accepted that repeated malaria exposure will lead to increasing immunity to 
malaria. Since protection increases with exposure, the acquisition of immunity is faster in high 
transmission regions, where the age group more affected by the disease is infants under one 
year, who are at higher risk of death. As both age and exposure increase, the individuals also 
acquire higher ability to limit the consequences of infection, namely they are more protected 
from severe illness and death. However sterile immunity is seldom attained, since many adults 
continue to have circulating parasites in the blood (Langhorne et al., 2008). These 
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observations, together with the fact that adult travelers from non-endemic areas are likely to 
have severe clinical manifestations of the disease, suggest that malaria protection can be 
immune-mediated. Clinical immunity to malaria could therefore be attained when the immune 
responses are regulated to perform parasite clearance while avoiding detrimental effects and 
pathology (Artavanis-Tsakonas et al., 2003). There are immune mechanisms that effectively act 
against each parasite stage, some of which are represented in Figure 4.  
Toxins
Antibodies block 
invasion of hepatocytes
(1)
Cellular immunity
Antibodies
(2)
Antibodies block 
invasion of RBC
(3)
Antibodies blocking cytoadherence
Cell-mediated immunity
ROI and NO                                       (4)
Antibodies to parasite toxins
Antibodies blocking 
fertilization
(5)
 
Figure 4. Possible immune protection mechanisms at various stages of the plasmodium life cycle in 
the mammalian host. (1) Antibodies to sporozoite antigens neutralize sporozoites and/or block 
invasion of hepatocytes. (2) At liver stage cellular immunity is essential: IFN-γ released by CD8
+
 and 
CD4
+
 T cells induces NO production by hepatocytes; CD8
+
 CTL and NK cells exert cytotoxicity and 
induce Fas/FasL-mediated apoptosis; NK cells plus antibodies exert ADCC (antibody dependent 
cellular cytotoxicity); γδ T cells and NKT cells also kill intrahepatic parasites. (3) Antibodies to 
merozoites block invasion of RBC, mediate merozoites opsonization and ADCI (antibody dependent 
cell-mediated inhibition), facilitating merozoite phagocytosis by macrophages. (4) Antibodies to iRBC 
surface proteins opsonize iRBC for phagocytosis and/or block the adhesion of iRBC to endothelium; 
CD4
+
 T cells and monocytes secrete cytokines with parasiticide / parasitostatic effects: TNF-α and 
IFN-γ activate macrophages to phagocytose and/or kill iRBC and merozoites; antibodies can 
neutralize parasite toxins (GPI) and prevent severe clinical disease, though with no effect on parasite 
itself; NO (nitric oxide) and TNF-α, released from activated macrophages and ROI (reactive oxygen 
intermediate), have a parasiticidal effect on merozoites or intra-erythrocytic parasites. (5) Antibody 
and complement taken up in the blood meal mediate the lysis of gametocytes and prevent 
fertilization and further development of the parasite in the mosquito. Figure from Long & Hofman 
(2002) and adapted with Bolad & Berzins (2000) and Langhorne et al. (2008).  
 
The relative importance of each of these mechanisms is still debatable (Langhorne et al., 
2008). At the pre-erythrocytic stage, following the sporozoites inoculation into the host, 
antibodies to sporozoites antigens could protect both through opsonization of the sporozoite 
and its clearance before reaching the hepatocyte or by blocking hepatocytes invasion. 
However antibodies to sporozoites are thought of reduced importance (Langhorne et al., 2008) 
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as the intracellular parasite, within a cell expressing MHC classes I and II, is the major target of 
the immune system in the pre - erythrocytic stage. CD8+ T cells, recognizing parasite-derived 
peptides presented by MHC class I have been shown to be important in eliminating 
intracellular parasites that successfully invade and replicate within hepatocytes. This activity is 
mediated essentially by perforin, Fas ligand (FasL) and IFN-γ (Overstreet et al., 2008). The 
process of CD8+ T cells priming by DCs was thought to occur after hepatocytes infection, when 
DCs acquire antigens from apoptotic hepatocytes, migrate to lymph nodes draining the liver 
where they prime T cells, a process called “cross-presentation” (Leiriao et al., 2005). However, 
it was further demonstrated that protective CD8+ T cells are primed primarily in the lymph 
node that drains sporozoite from the skin inoculation site (Chakravarty et al., 2007). The 
parasite antigens are internalized by immature DCs that prime the T cell response specific for 
the parasite through antigen presentation. Thus, CD8+ T cells against malaria are found early in 
the lymphoid tissues linked to the cutaneous infection site. 
As infection progresses to blood stages, the potential targets for an immune response are free 
merozoites or iRBC. Given that RBC do not have MHC I or II, and so, contrary to the infected 
hepatocyte, they cannot be targeted by CD8+ T cells, the humoral responses are usually 
assumed as having a key role in the blood-stage immunity. Antibodies can be effective in 
protection by several mechanisms. Anti-merozoite antibodies may mediate blockade of RBC 
invasion, lead to opsonization of merozoites for uptake through Fc receptors and/or 
complement receptors on phagocytes. Antibodies against parasite molecules on the RBC 
surface membrane could act by either allowing antibody-dependent cell-mediated inhibition 
(ADCI) mediated by cytophilic antibodies (IgG1 and IgG3 in humans, which are functionally 
similar to IgG2a in mice) or complement-mediated lysis of iRBC or by mediating opsonisation 
of iRBC for phagocytosis. In the case of P. falciparum some of the surface proteins mediate the 
iRBC sequestration to endothelium, and thus, antibodies blocking adhesion to host receptors 
could allow phagocytes to act and avoid severe malaria syndromes, such as cerebral malaria.  
Malaria infection symptoms in non-immune individuals arise as the rupture of schizont-
infected erythrocytes triggers a cascade of inflammatory responses, owing to molecules 
released at that moment by the synchronic parasites, which, if not controlled, can lead to 
death. This wave of toxaemia and cytokines release from cells of both the innate and adaptive 
immune systems trigger the classical symptoms of fever and chills, but also contribute to 
control parasite replication, maintaining densities at levels compatible with host survival. 
Glycolipids have been identified as the major candidates to trigger toxins release, having a 
potent capacity of stimulate TNF-α production by macrophages (Schofield & Hackett, 1993). 
Thus, the antibodies that neutralize malaria toxins can contribute to reduce disease severity. 
For instance, antibodies to malarial glycosylphosphatidylinositol (GPI) and other glycolipids 
block induction of TNF-α from macrophages thereby down-regulating the inﬂammatory 
cascade and preventing immunopathology (Artavanis-Tsakonas et al., 2003). 
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Antibody-independent cellular-mediated immunity might also play a role in natural immunity 
against the erythrocytic stage. CD4+ cells of the Th2 type have a role in humoral immunity as 
helper cells for B cells (Perlmann & Troye-Blomberg, 2000). CD4+ T cells of the Th1 type 
activate macrophages and other cells to produce TNF, nitric oxide (NO), reactive oxygen 
intermediates (ROI) and other mediators, through the release of cytokines, such as IFN-γ 
(Good et al., 2004). These inflammatory molecules and released products have been shown 
capable of killing parasites, which probably occurs in the spleen, where blood flow slows in 
marginal sinuses, allowing iRBC to be removed by marginal zone macrophages and DCs. 
The spleen has several crucial functions to control malaria infection including the removal of 
damaged iRBC and the restitution of blood cells, since it is a major site for erythropoiesis, and 
it is a place where pathogen-specific T and B cells are generated (Engwerda et al., 2005). In 
Figure 5, it is represented an accepted model by which cell-mediated immunity clears the 
parasite in the spleen. Parasite-specific CD4+ T cells can be activated specifically by parasite 
epitopes expressed on APCs, but parasites are killed by non-specific mechanisms. 
 
 
 
 
 
 
Figure 5. Schematic representation of the 
possible mechanism by which cell-mediated 
immunity clears malaria parasites. Immature 
dendritic cells (DC) are “sentinels” that 
endocytose and process parasites in their 
immediate environment, which leads to its 
activation and presentation to CD4
+
 T cells (and 
also to CD8
+
 T cells), together with activation 
signals (IL-12) to initiate immune response. 
Activation of CD4
+
 T cells lead to macrophage 
activation, phagocytosis of parasitized RBC and 
production of cytokines and inflammatory 
molecules, such as NO and ROI. From Wykes & 
Good (2008).  
 
Innate immune cells have an important role in controlling the primary wave of blood-stage 
parasitemia. Monocyte-derived macrophages, polymorphonuclear leukocytes, NK cells and γδ 
T cells are able to kill mature stages of parasitized iRBC in the absence of antibodies, which 
may be due to the expression of proteins (such as PfEMP1) on the iRBC surface containing 
binding sites for CD36 or ICAM-1, promoting binding of leukocytes and phagocytosis (Bolad & 
Berzins, 2000). Moreover NK cells and γδ T cells can have an important role in controlling the 
disease by producing IFN-γ. Additionally, iRBC or parasite products can interact with various 
Toll-like receptors (TLR) present in immune cells. GPI anchors from certain protozoans have 
been shown to bind TLR2-TLR1 complex on human DC, macrophages and B cells, and hemozoin 
(or more likely contaminating DNA) activates DC through TLR9, inducing potent 
immunostimulatory properties and pro-inflammatory cytokines (Langhorne et al., 2008).  
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In the murine malaria model using P. chabaudi chabaudi AS both cell-mediated immunity and 
humoral immunity act sequentially to clear the infection. The predominant response during 
the first/acute phase of the infection is of a Th1-type cell, producing IL-2 and IFN-γ, while the 
control of the parasites at later phases, after the clearance of the first phase, also involves a 
specific response where Th2 cells provide B cell help by producing IL-4, which generate specific 
IgG antibodies important effectors in controlling the disease in these phases (Langhorne et al., 
1989). 
It is noteworthy to remark that in malaria endemic regions the majority of malaria-infected 
individuals are also concomitantly infected with a range of other pathogens, such as other 
protozoan, helminthes, bacteria and viruses. The immune response to intracellular 
microorganisms, such as protozoan, bacteria, viruses, is often characterized by cellular 
cytolytic activity and the production of inflammatory cytokines, such as IFN-γ and TNF-α. 
Conversely, the immune protection to extracellular pathogens, helminthes for example, 
depends on humoral responses and on specific Igs generated to neutralize the foreign agent 
(Constant & Bottomly, 1997). Thus, individuals with co-infections can display different abilities 
in mounting an effective immune response to malaria. For instance, an individual with 
helminthes may bias the immune response towards Th2-type, which may reduce the levels of 
IFN-γ necessary in early response to malaria infection. 
Immune memory in malaria 
It is often observed that immunity to malaria wane quickly when immune adults leave malaria-
endemic regions, proposing that continued exposure to malaria antigens is necessary not only 
for the generation of effector and memory cells but also for their persistence (Langhorne et al., 
2008). It has been difficult to identify the several immune players involved in immunological 
memory, as these cells are ill-defined by available methods, both in humans and in mouse 
models (Langhorne et al., 2008). It is established that the formation of both central and 
effector CD8+ memory T cells in the liver stage requires priming by DC in the draining lymph 
nodes (Chakravarty et al., 2007) and are long-lived (up to 6 months). Immune responses to 
blood-stages malaria antigens have also memory cells associated. However, the normal 
immune response and memory establishment can be hampered by a chronic plasmodium 
infection (Figure 6) (Urban & Roberts, 2002; Langhorne et al., 2008). In fact the parasite seems 
to be able to manipulate the host immune system during infection and to interfere with B and 
T cell activation, impairing the generation of immunological memory, which might result in a 
short-lived memory.  
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Figure 6. Possible mechanisms interfering with B 
and T cells activation and with the generation of 
immunological memory induced by malaria 
parasites. Red vertical bars indicate points in the B 
and T cell response at which parasites could 
interfere (inhibit, suppress or change the immune 
response). Numbers indicate possible mechanisms 
of interference: 1, interaction between iRBC–
parasite and DC can inhibit DC maturation and 
reduce its capacity to stimulate T cells; 2, hemozoin 
can inhibit macrophage (Mφ)–monocyte function; 
3, shift of IL-12 to IL-10 secretion by parasite-
modulated DC and macrophages may inhibit CD4
+
 T 
cell (CD4T) activation; 4, CD4
+
 T cells produce IL-10 
and TGF-β, which inhibits the generation of central 
and memory-effector (m-e) cells; 5, iRBC induce 
apoptosis and/or depletion of memory B cells 
(Bmem); 6, limiting specificities repertoire of 
plasma cells; 7, the P. falciparum genome encodes a 
large number of predicted proteins and most 
induced responses to many polymorphic targets 
may not be protective and act as a ‘smoke-screen’. 
Hypergamma-globulinemia, a common feature of 
P. falciparum infection, may accelerate the 
catabolism of immunoglobulin molecules. 8, 
antigenic variation of proteins on the iRBCs may be 
an effective mechanism for immune escape; 9, 
circulating immune complexes and low-affinity 
immunoglobulin molecules can trigger apoptosis of 
long-lived plasma cells (PC) through FcγRIIB. From 
Langhorne et al. (2008)  
 
 
 
Polyclonal B cell activation and hypergammaglobulinemia are prominent features of human 
malaria (Achtman et al., 2005), which are caused by parasite molecules that can directly induce 
the proliferation and differentiation of antibody-secreting cells from different B cell, regardless 
of their antigen specificity. Particularly, malarial chronic infections lead to severe deregulation 
of the immune system and B cells are overactivated resulting in hypergammaglobulinemia, the 
secretion of an array of autoantibodies and the frequent occurrence of B-cell tumors (Burkitt’s 
lymphoma) (Donati et al., 2004). The antibodies secreted by B cells stimulated with polyclonal 
activators are nonspecific and normally recognize antigens such as actin, myoglobin, myosin 
and DNA (Montes et al., 2007). The antigens and mechanisms that lead to polyclonal activation 
are poorly understood. Polyclonal activators can be components of cell membranes, the 
cytosol or excretion/secreted products. For instance, it was identified the exact region of the 
PfEMP1 (the CIRD1α domain) that induces the polyclonal activation in malaria (Donati et al., 
2004). Polyclonal activators have the capacity of inducing the proliferation of multiple B cell 
clones and the up-regulation of MHC class II, CD69, CD25 and costimulatory receptor 
molecules such as CD80 and CD86 (Montes et al., 2007). It has been debated whether 
polyclonal activation produces detrimental or beneficial effects in the host (Achtman et al., 
2005; Montes et al., 2007). Polyclonal activation can be seen as a strategy of the infectious 
agents to avoid the host-specific immune response. Conversely, two potential beneficial 
effects of polyclonal activation were described. First, by enhancing natural antibodies 
production, recognizing a conserved range of antigens in many pathogens that can activate the 
innate immune system via the classical pathways of complement activation. Thus natural 
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antibodies represent a first line of defense while the adaptive response is not mounted 
(Montes et al., 2007). Second, the polyclonal stimuli can be responsible for memory B cells 
maintenance. In this sense, it was demonstrated that in contrast to naïve B cells, memory B 
cells proliferate and differentiate into antibody-secreting cells after in vitro stimulation with 
polyclonal stimuli. This continuous stimulation and differentiation of memory B cells has been 
proposed as a plausible mechanism for the sustainment of “a long term serological memory” 
in the absence of a specific antigen. Contrarily, a “short term serological memory” is antigen-
dependent and lasts for few months (Bernasconi et al., 2002). In respect to malaria, it has been 
debated how malaria antibodies can persist for long periods after termination of the infection 
and the role of polyclonal activation in malaria, namely whether it gives rise to long-lived 
plasma cells (Achtman et al., 2005). 
Immunological response to malaria in pregnancy 
Malaria in pregnancy might be the overall result of combining humoral immunity and cellular 
immunity mechanisms to the modifications associated to pregnancy, which include alterations 
in hormones balance and the development of the placenta. 
Human PAM antibodies are directed to antigens specific of P. falciparum selected for their 
affinity to placental receptors, namely chondroitin sulfate A (CSA) (Staalsoe et al., 2004). 
Through exposure to CSA-binding parasite variants over successive pregnancies women might 
acquire specific immunity to this parasite subpopulation. This notion is supported by several 
studies showing that primigravida women do not have antibodies that block binding of 
parasites to CSA. By contrast, multigravida possess serum IgG that inhibit iRBC adhesion to CSA 
(Ricke et al., 2000). Moreover, women with high levels of anti-CSA-binding antibodies have 
reduced anemia and deliver babies with increased birth weight (Staalsoe et al., 2004). 
Decreased cellular immunity can also be a reason for increased malaria susceptibility, since 
several reports showed reduced responses to malaria antigens in pregnancy (Rasheed et al., 
1993; Fievet et al., 2002). Placental infections are frequently characterized by the presence of 
inflammatory cells that are not usually present in sites of peripheral circulation. These 
recruited cells are predominantly monocytes that can be activated by parasites or parasite-
derived products, such as hemozoin (Pichyangkul et al., 1994) and GPI (Nebl et al., 2005). 
Activated macrophages release potent anti-microbial molecules to aid parasite elimination, 
such as ROI, NO and TNF-α, contributing to an altered Th1 cytokine milieu in the placenta.  
Changes in cytokines levels during malaria in pregnancy and associated to parity have also 
been documented. PAM typically induces a Th1/Th2 disequilibrium favoring the Th1-type 
pathway, leading to increased levels of inflammatory cytokines in the placenta and maternal 
peripheral blood. This event is associated with poor outcomes principally in primigravida and 
the role of inflammatory cytokines, such as IFN-γ and TNF-α, on PAM pathogenesis has been 
intensively investigated. Conversely, it has been observed a counter-regulatory effect in 
response to the inflammation, possibly to compensate immune-mediated damage in the 
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placenta. Th2 cytokines concentrations have also modified concentrations among pregnant 
infected women in comparison with non-infected. For example, in a study from Kenya (Fried et 
al., 1998a) malaria-infected women had abundant levels of pro-inflammatory cytokines in 
concert with increased levels of the regulatory cytokine TGF-β. In fact, this cytokine is 
recognized by its immunosuppressive role, for example by reducing macrophages activation. In 
the placenta the main sources of TGF-β are the decidual and trophoblast cells (Robertson et 
al., 1994) and it is known that it plays an important role in pregnancy by inhibiting strong 
proliferative cellular responses and that low levels of this cytokine are associated with 
spontaneous abortions (Raghupathy, 2001).  
Increased levels of TNF-α has been associated with adverse birth outcomes (Fried et al., 1998a; 
Fievet et al., 2001; Rogerson et al., 2003a). Besides having a role in protection, this cytokine 
has also been implicated in the pathogenesis of malarial disease, in particular in the malarial 
fever (Schofield & Hackett, 1993). Despite its potent cytotoxic effects, TNF-α also plays a role 
in normal fetal development and parturition and is produced in normal placentas by 
trophoblast cells and by resident macrophages (Hofbauer cells) (Robertson et al., 1994). 
Overproduction of TNF-α and other pro-inflammatory cytokines in the placenta were observed 
in women that experienced spontaneous abortion (Raghupathy, 2001) and pre-eclampsia 
(Azizieh et al., 2005). Higher levels of TNF-α were observed in malaria-exposed pregnant 
women and associated with LBW in a study realized in Kenya (Fried et al., 1998a), and also in 
another report on placental malaria from Malawi (Rogerson et al., 2003a), suggesting that this 
cytokine has also an immunopathologic role. TNF also primes neutrophils, regulates 
macrophage IL-12 production and is a co-factor for IL-12-induced IFN-γ production by T cells, 
and can even up-regulate the expression of ICAM-1 on endothelial cells (Robertson et al., 
1994). 
IFN-γ is extremely potent in mediating host defense and is released from NK cells, T-
lymphocytes and γδ T cells, upon stimulation by other T-cell or macrophage immune-
mediators such as IL-12, TNF-α and hydrogen peroxide. In turn, high levels of IFN-γ may 
activate mononuclear cell production of TNF-α. In the placenta IFN-γ can be produced by 
cytotrophoblasts and by villous syncytiotrophoblast (Robertson et al., 1994). Although 
elevated levels of TNF-α associated to LBW in PAM have been a consistent finding, the effect 
of IFN-γ has been controversial. In the study from Malawi mentioned above, IFN-γ levels are 
higher in plasma of women with placental malaria and in malaria-infected placentas than in 
uninfected placentas but were not associated with LBW (Rogerson et al., 2003a). In the Kenyan 
study, placental plasma showed higher levels of IFN-γ associated with LBW especially in 
aparasitemic exposed primigravida, meaning that even after resolving infection IFN-γ might 
have harmful effects (Fried et al., 1998a). In a different report from Kenya, IFN-γ response, 
elicited by placental leucocytes in response to malaria antigen stimulation, correlates with 
protection against placental malaria and in fact multigravida produce higher levels of this 
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cytokine. In particular, parasitemic multigravida cells were low IFN-γ responders, producing 60-
fold less IFN-γ than cells from uninfected multigravida (Moore et al., 1999). 
IL-10, as a Th2 cytokine induces B cell proliferation, plasma cell differentiation and 
immunoglobin production. However, IL-10 has other tasks than the stimulation of humoral 
activity and the development and maturation of antimalarial antibodies. It also has a role on 
the decrease of anti-inflammatory responses, by reducing the production of IL-6, TNF-α, IFN-γ 
and IL-12, which make it also a regulatory cytokine. Trophoblast cells and maternal leucocytes 
are the main source of placental IL-10 (Robertson et al., 1994; Fievet et al., 2001). The effective 
role of IL-10 in protecting the placenta and the fetus by preventing the termination of the 
pregnancy has been demonstrated in several studies (Moore et al., 1999; Fievet et al., 2001; 
Suguitan et al., 2003b), even though the elevated levels of IL-10 may suppress anti-parasite 
inflammatory responses resulting in high placental parasitemias and anemia (Suguitan et al., 
2003a).  
Nevertheless, the relationship between peripheral and placental cytokine levels in the same 
individual has not been established. In human studies only peripheral parameters are available 
and it is not possible to access the concentrations in the placenta in order to infer their role in 
pathogenesis. A correlation between peripheral and placental concentrations of TNF-α, IFN-γ 
and IL-4 has been reported at delivery, suggesting that placental responses might determine 
the systemic profile of some cytokines (Fried et al., 1998a). Since placentas are only available 
at delivery, these evaluations are limited and it is not possible to perform kinetics of this 
correlation. 
The balance between pro- and anti-inflammatory cytokines is required for adequate protection 
and influences the pathology, namely the degree of anemia, clinical severity and disease 
outcome (Stevenson & Riley, 2004). Th1 cytokines are important in controlling early 
parasitemia, but they need to be counterbalanced later in the infection by a Th2 response 
leading to antibody production. In fact, cytokines such as IFN-γ appear to play a role in 
protecting against placental parasitemia whilst IL-10, for example, appears to avert 
inflammation, having a regulatory role in avoiding the detrimental effects of IFN-γ and TNF-α. 
Cytokines may be determinants of malaria severity and disease outcome and, once their 
effects are better understood, are potential targets for therapeutic interventions or even for 
placental malaria diagnosis. In conclusion, unraveling the cytokines interplay in the context of 
placental malaria should be helpful in scrutinizing the PAM pathogenesis mechanisms and 
define possible correlations of altered levels of cytokines with poor pregnancy outcomes. 
Vertical transmission of disease and protection 
There is no clear agreement on the definition of congenital malaria. Vertical transmission of 
parasites, from mother to child, may occur during pregnancy or perinatally during labour. 
Some authors stated that only the former should be considered true congenital malaria 
(Menendez, 1995), although more recently they do not discriminate both courses of 
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transmission (Menendez & Mayor, 2007). The overall incidence of congenital malaria is 
unknown and difficult to estimate owing also to its unclear definition. It is thought that 
congenital transmission is an uncommon event due mainly to the effectiveness of the placenta 
as a barrier to parasites. However, some reports have described cord blood infections in 35% 
of babies born to women with placental malaria infection (Redd et al., 1996), or up to 10-32% 
of all newborns independently of the placental infection using sensitive diagnostic molecular 
methods, suggesting that cord malaria parasites were acquired antenatally and that they could 
cross the placenta with higher frequency than what was previously expected (Brabin, 2007; 
Menendez & Mayor, 2007). Indeed, placental malaria may be accompanied by damage of the 
syncytiotrophoblastic membrane, which may compromise the integrity of the placenta, 
allowing the parasites to enter the fetal circulation, establishing a route for malaria 
transmission (Crocker et al., 2004). Moreover, some immunological evidence also points to 
fetal lymphocyte exposure to malaria antigens in uterus (Menendez & Mayor, 2007).  
Whatever the course of parasite transmission to fetus/newborn is, the exposure to malaria 
parasites or to malaria antigens is likely to have important implications in their development. 
Certainly this exposure has immunological effects by priming the immune response or by 
inducing immune tolerance in the fetus, conferring reduced or increased malaria susceptibility, 
respectively (Menendez & Mayor, 2007). Thus, infection during pregnancy may be either 
harmful or beneficial for the infant, and the outcome will depend mainly on the time of 
pregnancy at which the first infection has occurred (Menendez, 1995).  
Transfer of maternal antibodies occurs in utero across the placenta and vertical transmission of 
malaria maternal antibodies has been observed (Hviid & Staalsoe, 2004). The Ig transplacental 
transfer is restricted to the IgG isotype and the mechanism of transplacental transfer of 
maternal IgG was reviewed few years ago (Kristoffersen, 2000). Briefly, the transfer of IgG 
across the placental barrier (Figure 7) is an active process involving Fc receptor (FcR) 
molecules. The maternal IgG must pass two cellular barriers: the syncytiotrophoblast and the 
fetal endothelial cells.  
Passive transfer of antibodies continues after birth via breast feeding, since anti-malaria 
antibodies have been detected in human breast milk (Leke et al., 1992). However these 
antibodies are believed to act only within the gut to protect the infant from enteric pathogens, 
as the majority of the immunoglobulins are degraded in the intestine and very little if any Ig 
isotype is absorbed in an active form into circulation (Riley et al., 2001).  
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Figure 7. Steps in the IgG transport through the 
placental barrier. Maternal IgG (A) enters the 
syncytiotrophoblast (STB) by an active receptor-
mediated process, or by liquid fluid phase endocytosis 
(not established). Once internalized (B), by either mode, 
vesicles fuse and molecules are sorted. Transport within 
the endocytotic compartment involves IgG binding to 
the high-affinity FcRn of the early endosome and 
transcytosis (the complex is internalized and carried 
through the cytoplasm of the syncytiotrophoblast in a 
transport vesicle to its luminal surface), whereas 
unbound molecules will enter the lysosomal pathway 
(C) and are degraded. Once brought to the basal side 
(D), the FcRn/IgG complex is exocytosed and IgG 
dissociated from FcRn. The FcRn is then probably 
recycled (E). IgG then diffuse through the villous stroma 
(VS) and is transferred to the fetal vessels (FV) through 
the endothelial cells in caveolae by an unknown 
mechanism (F). From Kristoffersen (2000).  
Placental pathologic changes caused by malaria may inhibit the transfer of maternal proteins 
generically and reduce the transfer of antibodies, even those associated to other diseases 
(Riley et al., 2001). Systemic antibody transfer to the infant decays abruptly at birth and IgG 
concentrations decline as it is catabolized and thus the persistence of antibody titers in the 
infant depends on the starting concentration of antibody at birth (Riley et al., 2001). 
Furthermore, it has been observed that maternal antibodies do not protect infants against 
malaria as it could be expected. In a longitudinal study with 143 children in Ghana there was 
no association between levels of maternal antibodies and protection against malaria over the 
first 20 weeks of age, but in the contrary infection risk was higher in children with higher 
maternally derived antibody levels (Riley et al., 2000). This increased susceptibility to infection 
in presence of maternal infection, rather than an expected protection, might be due to 
immunologic tolerance induced by in utero exposure to parasite antigens (Lammie et al., 
1991). Later, a study conducted in Cameroon evaluated the levels of antibodies specific for 
PAM and for non PAM parasites in cord blood of 79 neonates, who were followed up to 2 
years until the first appearance of P. falciparum parasites (Cot et al., 2003). They concluded 
that maternally transmitted anti-PAM antibodies, but not antibodies to any other specificity, 
were negatively related to the length of time until the first appearance of parasites in 
peripheral blood and positively related to the mean parasite density during the first 2 years of 
life. In fact, these results show that such antibodies have affinity to P. falciparum that 
cytoadhere in the placenta and this parasite population is only present in pregnant women and 
not in non-pregnant hosts like children. Therefore the presence of anti-PAM antibodies in cord 
blood only reflects the past occurrence of a maternal infection and is non-protective in 
children. 
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PARASITE-HOST INTERACTIONS IN PREGNANCY-ASSOCIATED MALARIA 
P. falciparum infected red blood cells (iRBC) do not generally remain in the peripheral 
circulation but instead adhere to molecules expressed on the vascular endothelium surface of 
the capillaries of specific organs of the host. Hence, the parasites find a proper environment 
for their relatively safe maturation and multiplication, avoiding to be taken by macrophages in 
the spleen. As a result there is an extensive accumulation of parasites in vital organs and, 
consequently, high concentration of parasite toxic metabolites and other factors inducing pro-
inflammatory responses in the host, leading to vascular damage and organ dysfunction (Miller 
et al., 2002). The adhesion is mediated by the recognition of parasite proteins expressed on 
the outer membrane of infected erythrocytes by receptors on the host endothelial cells. 
Parasite features determinant for disease establishment 
Malaria parasites and disease have several peculiar features and the understanding of how 
they are achieved is crucial to the knowledge of disease-related mechanisms and for the 
design of interventions aimed to reduce or eliminate infection. The parasite biology itself 
presents certain characteristics that appear strategic for immune evasion, ranging from the 
fact of being an intracellular parasite, to antigenic diversity and antigenic variation, and even 
to the capacity of being sequestered. Many aspects of PAM epidemiology are explained on the 
light of some of these parasite features. 
Malaria parasites rely on a mosquito vector for a part of their life cycle, which is dependent of 
suitable moist conditions for its breeding. In areas of highly seasonal transmission with a long 
dry season, malaria episodes are concentrated in a short period of the year following the rainy 
season and parasites have to maintain long infections in order to survive. This was imperative 
to ensure their transmission, since they must survive for 9 or 10 months in their mammalian 
hosts in order to be transmitted to mosquitoes in the following wet season (Kyes et al., 2001). 
Another characteristic of malaria parasites, functioning as a strategy of immune evasion, is 
evident at RBC invasion by merozoites that evolved a ‘just-in-time’ mode of invasion (Kats et 
al., 2008). Merozoites have a polarized morphology and several organelles characteristic of the 
Phylum Apycomplexa, namely an apicoplast (a plastid-like organelle) and an apical complex 
constituted by three other organelles (rhoptries, micronemes and dense granules), 
concentrated on the apical end of the parasite that are involved in cellular invasion (Cowman 
& Crabb, 2006). The apicoplast possibly arose in an ancestor of the apicoplexan parasites that 
engulfed a eukaryotic alga retaining its plastid. Its genome encodes for 30 proteins and is 
essential for parasite survival, having a function in the anabolic synthesis of fatty acids, 
isoprenoids and heme (Gardner et al., 2002). The initial interaction between the merozoite 
and the RBC appears to occur at any point on the surface of the merozoite, followed by its 
reorientation in order to juxtapose the apical end of the merozoite with the erythrocyte 
membrane, allowing a subsequent stronger interaction (Figure 8). To invade a RBC the 
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merozoite must engage RBC receptors and undergoes apical reorientation. Afterwards, the 
invasion process is facilitated by released proteins contained within the apical organelles. The 
fact that these secreted factors are inside an organelle might protect the parasite from 
recognition, as they are secreted only shortly prior to or at the time of merozoite attachment. 
This allows the parasite to protect essential ligands from antibody-mediated neutralization by 
minimizing their exposure to the host immune system. Moreover, the parasite can 
compartmentalize proteins according to function and deliver them in a temporally-regulated 
manner. For instance, proteins that are involved in reorientation and tight junction formation 
are secreted first, followed by proteins necessary for alteration of the host RBC cytoskeleton 
and parasitophorous vacuole (PV) formation, as the parasite invades the host cell, and finally 
proteins required for long-term maintenance of the PV are released. Within this PV, derived 
from the RBC plasma membrane, the parasite creates a frontier to seal itself from the host cell 
cytoplasm (Kats et al., 2008). 
 
 
Figure 8. Invasion of a RBC by a 
P. falciparum merozoite. Invasion is 
a sequence of processes. Initial 
attachment can occur with the 
merozoite in any orientation and 
involves low-affinity interactions 
between merozoite surface proteins 
and receptors on the target cell 
(glycophorin A in P. falciparum). 
Subsequent interactions are 
facilitated by proteins that are 
initially hidden within the apical 
organelles and are secreted only 
shortly prior to or at the time of 
attachment. From Kats et al. (2008).  
Malaria parasites seem to have chosen an immune-privileged site by infecting RBC, which have 
no surface MHC molecules and no mechanism for antigen presentation. However, the parasite 
is not invisible to the host immune system, since on the iRBC surface novel proteins appear 
produced by the parasites. Some of these proteins correspond to highly polymorphic antigens, 
and can enable the iRBC to cytoadhere to host receptors. In fact, a controlled parasite 
proliferation may be attained by exposing iRBC to the immune system even without leading to 
its total elimination. Otherwise, if parasites remained unchecked, proliferation would be 
unconstrained and the host would be killed before an efficient transmission to a mosquito 
(Scherf et al., 2008).  
Once infection is established in the blood, it continues until either the host dies or the parasite 
is controlled by drugs or by the immune response. In an untreated individual the typical 
pattern for parasitemia is to rise to a high level, producing severe clinical symptoms, and then 
fall, with the symptoms either disappearing or becoming milder. At some later point, 
parasitemia rises again and clinical symptoms return (Scherf et al., 2008). The clinical pattern 
of relapses reflects the “strategy” used by the parasite to contour the host immune response 
Rhoptry
Dense granules
Microneme 
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by an antigen switching mechanism. In principle, parasite strains with inherently high switching 
rates (allowing rapid sequential expression of novel antigens) would be able to cause repeated 
infections in the same patient and to establish a chronic infection (Kyes et al., 2001).  
A further property of some P. falciparum isolates is the ability of iRBC to bind to uninfected 
RBC, leading to the formation of erythrocyte rosettes and this event is associated with an 
increased risk of severe disease (Udomsangpetch et al., 1989). Parasite sequestration and 
rosetting are mechanisms that maintain the parasite shielded from destruction by the immune 
system, favoring its growth and multiplication, but with likely problematic consequences for 
the host, such as capillary occlusion, organ dysfunction and severe malaria syndromes like 
cerebral malaria. 
Additionally, most immune responses directed to many of these polymorphic antigens may not 
have any protective function and may confound the immune system. It is noteworthy to 
remark that P. falciparum genome encodes for 5,268 predicted proteins, 31% (1,631) have one 
or more transmembrane domains, many of which are highly polymorphic (Gardner et al., 
2002).  
The surface of infected erythrocytes 
A normal RBC presents a discoid shape and a diameter of about 7 µm, having a central bi-
concave form, enabling it to entry the smallest blood vessels and capillaries. Upon infection of 
RBC by merozoites, the parasites modify the RBC membrane to enable their survival and 
proliferation. After RBC invasion, the parasite starts to increase in size and to digest 
hemoglobin taken from the RBC cytoplasm, depositing the undigested heme residue in a 
polymerized pigment, the hemozoin (Cooke et al., 2004). Maturation of the parasites causes 
structural and morphologic changes in the iRBC, which include alterations in cells deformability 
(loss of the normal discoid shape and acquisition of a spherical appearance), permeability, and 
perturbations in the mechanical and adhesive characteristics, accomplished essentially by the 
trafficking of proteins and proteins export to the RBC membrane. Some exported proteins are 
conserved across plasmodial species and are essential for parasite survival. The parasite 
develops inside the RBC through the ring, trophozoite and schizont stages and at the 
termination of this asexual cycle the iRBC needs to be lysed to release merozoites for invading 
new RBC. This lysis is completed in two steps, firstly the lysis of the internal membrane that 
surrounds the parasite, the PV membrane, allowing the parasite to enter the RBC cytoplasm, 
and secondly the lysis of the RBC membrane (Cooke et al., 2004).  
The iRBC surface (in trophozoites and schizonts stages) appears punctuated by up to 10.000 
distinct knob-like protrusions (with ~100 nm in diameter) (Figure 9) that resulted from the co-
localization of parasite proteins and might be associated with altered cellular adhesive 
properties of the cell (Cooke et al., 2004; Maier et al., 2009). Although knobs are considered 
necessary for adhesion, some studies show that the presence of knobs does not necessarily 
lead to sequestration. For example P. malariae iRBC show knobs and do not sequester 
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(Sherman et al., 1995), whereas the rodent parasite P. chabaudi iRBC lack knobs and can 
sequester (Cox et al., 1987) as well as a knobless line of P. falciparum (Biggs et al., 1990). Thus, 
the presence or absence of knobs is not as decisive for cytoadhesion, as the presence of 
certain parasite proteins on the RBC surface. 
 
Figure 9. The variant PfEMP1 mediates adhesion of the infected RBC to host receptors. PfEMP1 is 
expressed by the malaria parasite P. falciparum on the knobs formed on the surface of iRBC. The 
variable extracellular regions of the protein (DBLs and CIDR) mediate adhesion through binding to 
several tissue receptors such as CD36, ICAM1 and CSA. PfEMP1 also mediates adhesion to 
uninfected erythrocytes forming rosettes. (PV, parasitophorous vacuole; MC, Maurer’s cleft). From 
Pasternak & Dzikowski (2009).  
Antigenic diversity and antigenic variation in P. falciparum 
Different populations of P. falciparum show antigenic differences, which confer them distinct 
properties. Antigenic diversity, which reflects polymorphisms in allelic gene products, can be 
distinguished from antigenic variation, which is a result of the expression of alternative genes 
in multicopy family genes. This process of antigenic variation prevents the parasite of being 
attacked by continuously changing some iRBC surface proteins, allowing the extension of the 
infection period. Antigenic variation in P. falciparum has been intensively studied but many 
underlying molecular mechanisms remain unknown. Significant work in recent years has 
contributed to the understanding of antigenic variation process and the “state of the art” has 
been reviewed and summarized by diverse authors (Kyes et al., 2001; Ralph & Scherf, 2005; 
Kyes et al., 2007; Scherf et al., 2008; Dzikowski & Deitsch, 2009). The process of antigenic 
variation results from switches in expression between members of a specific gene family, thus 
altering the form of the surface exposed protein (variant surface antigen or VSA). Four 
multicopy gene families might be involved in antigenic variation of P. falciparum: var, rifin, 
stevor and Pfmc-2TM. The best characterized is the var family, which encodes the Plasmodium 
falciparum Erythrocyte Membrane Protein 1 (PfEMP1), a protein responsible for iRBC 
sequestration, recognized as the major target of antibodies and clustered on the iRBC knobs 
(Figure 9). Similarly to the var genes, the other gene families also undergo clonal variation, but 
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the proteins they encode have unknown biological functions (Kyes et al., 2001; Scherf et al., 
2008).  
The multigene family var has approximately 60 genes distributed across all P. falciparum 
genome, each one displaying a distinct repertoire of surface variants for PfEMP1. The 
switching in transcription from one var gene to another appears to rely only in epigenetic 
changes in the gene locus (Ralph & Scherf, 2005). Each individual parasite expresses a single 
var gene at a time (coding for the dominant neoantigen), maintaining all the other members of 
the family in a transcriptionally silent state. Therefore, there is a mutually exclusive expression 
of a single var gene member orchestrated by different epigenetic factors that do not require 
programmed DNA rearrangements. A switch in expression must be coordinated so that 
activation of one gene coincides with simultaneous silencing of the previously active copy with 
modifications in chromatin structure clearly playing an important role in determining which 
var gene is active in any given parasite. However, a mechanism of “memory” must exist to 
maintain the transcription state through subsequent parasite generations, so that the 
epigenetic marks, namely that the chromatin structure is kept across cell divisions. At present 
this process is not completely understood. Several other aspects remain to be elucidated, 
namely the switching sequence process and the clarification on how to maintain an antigen 
switching rate that allows emergence of a new protein variant without exhausting all the 
possibilities, and whether the switching follows an order or is a random process.  
Studies to clarify those unknown mechanisms are impracticable in humans. For instance, the 
order and rate at which parasites switch expression from one var gene to another is difficult to 
measure in patients. iRBC VSA switch rates of P. falciparum were firstly evaluated in a study 
where the authors showed that parasites cultured in vitro, in absence of immune pressure, 
switched spontaneously at a rate of 2%, leading to parasites with different antigenic and 
cytoadherence phenotypes (Roberts et al., 1992). Nevertheless, there is evidence that 
switching rates in vivo are higher (~18%) although the predictions are based in few 
experiments and on mathematical models founded on assumptions of hypothetical var 
switching mechanisms (Gatton et al., 2003).  
Host receptors for malaria parasites 
The P. falciparum adhesion process, in which most parasites first tether and then roll before 
becoming firmly secure, is comparable to leukocyte adhesion. Only two receptors, CD36 and 
chondroitin sulphate A (CSA), have been shown to provide stable stationary iRBC adhesion 
(Miller et al., 2002). Cooperation between host receptors is known to enhance adhesion of 
iRBC, which may need to be preceded by tethering and rolling before stabilizing. The type of 
affinity between iRBC and the host receptors might modulate the final interaction, namely 
adhesion and/or rosetting properties. Binding studies using recombinant PfEMP1 domains 
have shown interactions with various host receptors, which include: CD36, the most abundant 
adhesion receptor and a mediator for most of the clinical isolates and laboratory lines of 
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P. falciparum; is found in the surface of platelets, monocytes, dendritic cells and microvascular 
endothelial cells; ICAM-1, expressed in the endothelium, has an important role in the 
leucocytes adhesion to the endothelium during inflammation and was shown to support rolling 
of iRBC; thrombospondin, a molecule with anticoagulant properties, that appears on 
extracellular matrix of the endothelium and syncytiotrophoblast; platelet-endothelial cell 
adhesion molecule (PECAM); vascular cell adhesion molecule-1 (VCAM1) and the endothelial-
cell selectin (E-selectin). The last two receptors are not expressed on resting endothelium but 
their expression is induced by inflammatory cytokines, such as TNF-α (Sherman et al., 1995; 
Baruch et al., 2002; Schofield & Grau, 2005).  
Rosettes, or aggregates of infected and uninfected RBC, are observed in some P. falciparum 
isolates and appear to involve several RBC surface molecules. Rosetting mediators can include 
the sulfated glycoconjugates heparin or heparan sulfate, blood groups antigens A and B and 
the complement receptor (CR1) expressed on uninfected RBC, and also IgM in serum (Kyes et 
al., 2001). The formation of these aggregates, between parasitized and non-parasitized RBC, 
might also lead to the obstruction of capillaries in patients with cerebral malaria 
(Udomsangpetch et al., 1989).  
Other host receptors were also found to have affinity to iRBC surface proteins. In 1995, 
Rogerson et al. found that P. falciparum laboratory strains can adhere to Chinese hamster 
ovary (CHO) cells and that the binding is mediated by CSA (Rogerson et al., 1995). In their 
experiments, CHO cell-adherent iRBC were unable to bind CHO cell mutants lacking CSA 
expression. Moreover, iRBC binding to CHO cells was inhibited by CSA but not by other 
glycosaminoglycans and treatment of CHO cells with chondroitinase ABC but not with other 
enzymes led to a reduction in iRBC binding. Thus CSA was identified as a potential receptor 
involved in parasite sequestration, a result confirmed a year later by Fried and Duffy. In fact, 
these authors discovered the biological importance of iRBC adhesion to CSA, by demonstrating 
that iRBC obtained from human infected placentas binds to uninfected placentas in a CSA-
dependent manner (Fried & Duffy, 1996). 
Receptors for parasites on human placentas 
In human pregnancy-malaria pathogenesis the receptors that are reportedly involved in 
placental parasite sequestration are glycosaminoglycans (GAG), such as the low-sulphated CSA 
(Fried & Duffy, 1996; Achur et al., 2000) and possibly the hyaluronic acid (HA) (Beeson et al., 
2000; Beeson et al., 2002b; Rasti et al., 2006). Within the placenta, CSA is shown to be 
distributed throughout the intervillous spaces and at low but significant levels on the 
syncytiotrophoblast lining (Muthusamy et al., 2004). Studies of placental CSA expression 
kinetics show that CSA is present in placentas and available for iRBC adhesion during the 
second and third trimesters of pregnancy (Gowda, 2006). CSA is a GAG composed of repeats of 
disaccharide units of D-glucuronic acid (GlcA or GlcUA) linked to N-acetyl-D-galactosamine 
(GalNAc) with a sulfate group at position C4 of GalNAc. CSA molecules from different sources 
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differ in sulfation patterns, and this property may influence their ability to support iRBC 
binding in the placenta (Fried et al., 2000). Highly sulfated forms can fail to support adhesion, 
whereas low-sulfated forms are optimal for binding (Alkhalil et al., 2000). 
HA is a controversial candidate as iRBC placental receptor, since it is not present in the 
intervillous spaces (Achur et al., 2000; Muthusamy et al., 2007) and it is claimed that its 
presence in the placenta is due to contamination from the umbilical cord where it is abundant 
(Fried et al., 2006). Previously reported binding to HA could be due to the CSA contaminations 
in HA preparations. Additionally, since the level of HA is less than 1-2% as compared to other 
GAG, if it can be a placental receptor, it should not be a main one (Valiyaveettil et al., 2001). 
Few years ago it was also suggested that non-immune immunoglobulins (of the IgG isotype) 
can be adsorbed to iRBC surface and this prompted the hypothesis that IgG may act as a bridge 
for iRBC to bind Fc receptors on the syncytiotrophoblast (Flick et al., 2001; Rasti et al., 2006). 
Nevertheless, the presence of HA and Fc receptors either in the intervillous space or in the 
syncytiotrophoblast lining of placentas is still unclear and more data is needed to resolve these 
controversies.  
CSA and other GAG on the intervillous spaces and on the syncytiotrophoblast appear to have 
several functions. They may play a structural role (similarly to other organs subjected to 
mechanical deformation like the joints cartilage) in maintaining the shape of the IVS to 
facilitate maternal blood flow. Additionally, they might constitute chemical barriers in masking 
fetal antigens from the maternal immune system and they may be involved in adsorbing 
essential components including metal ions, growth factors, and nutrients from maternal blood 
and in assembling them in the IVS for effective uptake by fetal villi. The low sulfation of the 
GAGs is associated with a low charge density of GAG chains that may facilitate the effective 
transfer of the adsorbed materials by a relatively weak interaction, which would be stronger if 
the GAGs were to be highly sulfated (Achur et al., 2000). In sum, the accumulation of these 
molecules with low sulfated GAG chains in the IVS suggests that they play a fundamental role 
in the placenta, and P. falciparum takes advantage of it to sequester and thus survive.  
Variant surface antigens associated to PAM 
CSA is expressed in large amounts in the placental IVS and on syncytiotrophoblast and, in fact, 
placental parasite isolates preferentially adhere to CSA in vitro, whereas parasites from men 
and non-pregnant women usually do not (Fried & Duffy, 1996; Beeson et al., 1999). Thus, the 
conclusion of several experimental observations is that placental parasites are antigenically 
distinct from those of non pregnancy origin.  
PfEMP1 proteins are involved in several malaria disease syndromes, but its role is best 
understood for PAM (Rogerson et al., 2007). Through switching expression of the different var 
genes, PfEMP1 undergoes antigenic variation and expresses specific VSAs that mediate 
adhesion to CSA, allowing the parasite to evade former host immune responses (Smith et al., 
1995). The gene var2csa is transcriptionally upregulated in both placental isolates and 
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laboratory parasites selected to bind CSA (Salanti et al., 2003), and disruption of var2csa 
causes infected erythrocytes to lose their ability to bind CSA (Viebig et al., 2005; Duffy et al., 
2006). In fact, in iRBC with non-CSA-binding abilities the gene var2csa is silent and different 
members of the var gene family are transcribed during chronic infection.  
During the first pregnancy, women who have previously developed malaria immunity are 
susceptible to placenta infection. After one or two pregnancies they develop protection to the 
placental form of the disease and generate antibodies recognizing placental parasites (Fried et 
al., 1998b; Duffy & Fried, 2003; Staalsoe et al., 2004), suggesting that surface molecules 
expressed by placental infected erythrocytes may have unique and conserved features. 
Additionally, Salanti et al. show that high levels of anti-VAR2CSA antibodies correlated with a 
lower risk of delivering LBW neonates (Salanti et al., 2004) and in a different study CSA-binding 
placental isolates were also significantly associated with LBW children (Tuikue Ndam et al., 
2004). 
VAR2CSA-PfEMP1 plays a major role in PAM, displaying an extensive polymorphism, but only a 
limited portion of the variable domain is actively seen by the host immune system (Bockhorst 
et al., 2007). Thus, placenta-associated parasites have adhesive and antigenic differences 
between isolates that correspond to var2csa polymorphisms, hence stimulating different host 
responses (Beeson et al., 2006; Trimnell et al., 2006; Kyes et al., 2007). Women exposed to 
malaria acquire and expand the repertoire of variant-specific antibodies, some of which cross-
react with different placental isolates and the extent of reactivity appears to be greater among 
women who experienced more exposures in pregnancies (Beeson et al., 2006). 
Overall, a woman is highly susceptible to placental infection when pregnant for the first time, 
even if her pre-existing acquired immunity can control non-placental parasitemia. 
Nevertheless, an interesting question remains: how does a var gene that is apparently silent in 
a woman appear to be the major var gene expressed during pregnancy? Nunes and Scherf 
reviewed this issue recently and considered that there are two hypothetical mechanisms that 
could lead to var2csa activation during pregnancy malaria (Nunes & Scherf, 2007). The first is a 
selective process by the placenta, which is based on the fact that the placenta expresses a 
range of new receptors, providing a niche for parasites expressing variant CSA-binding 
phenotypes (that are circulating in very small numbers in the peripheral blood of the 
primigravida) to survive and selectively accumulate. The second is an induction mechanism 
promoted by specific host factors. Pregnancy triggers physiological changes, including serum-
speciﬁc factors (hormones/cytokines) and locally-released mediators by the 
syncytiotrophoblast, which may promote the transcription of var2csa. 
Parasite recrudescence in human PAM  
Parasite recrudescence has been observed in course of pregnancy in different situations but is 
generally difficult to identify. Many P. falciparum genes show extensive genetic polymorphism, 
which can be detected by molecular genotyping studies. Because of this ample polymorphism, 
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it is highly unlikely for individuals in areas of intense transmission to become newly infected 
with a parasite having an identical genotype during a disease follow up (this probability is the 
product of individual allele frequencies of each allele of the total number of genes in study). 
Therefore, by comparing the genotypes of the target loci across disease relapses, parasite 
recrudescence can be distinguished from a new infection (Mugittu et al., 2006). A recent study 
on PAM using a sensitive genotyping method of P. falciparum isolates show PAM recrudescent 
infections in 21% of the women as they had parasite isolates sharing the same antigens 
without evidence of new infections and with a mean time interval between consecutive 
malaria-recrudescence episodes of 58 days (Mayor et al., 2009). A case of recrudescence was 
reported in a pregnant woman who had been absent from endemic regions for a long period 
of time (4 years) (Giobbia et al., 2005).  
It is important to point out that the genotyping of field isolates could be useful in detecting not 
only the multiplicity of infections (number of concurrent infections) but also in studying 
infection dynamics in pregnancy. In fact, WHO states that recurrent parasites should be 
genotyped by polymerase chain reaction (PCR) to distinguish recrudescent from new infections 
and that these tools are very valuable for studies on drug resistance and for other specialized 
epidemiological investigations (WHO, 2006). However these tools are not generally available 
for human PAM studies in malaria endemic areas, where women are continuously exposed to 
new infections. Identification of recrudescent events in pregnant women by parasite molecular 
genotyping may improve the understanding of the pathological mechanisms of PAM, the 
processes of acquired immunity, the evaluation of the placenta-specific parasite antigenic 
variation, transmission conditions, efficacy of treatments and the genetic basis of drug 
resistance in pregnancy. 
Mechanisms attempts to explain PAM epidemiology 
The mechanisms and biological bases of PAM susceptibility and linked recrudescence, as well 
as protection acquired by multigravida, are still not well understood. Several efforts have been 
made to explain the epidemiological finding that, especially in areas of stable transmission, 
malaria is more frequent and severe in first pregnancies with observed reduced susceptibility 
in women who have had several pregnancies exposed to malaria (Fried & Duffy, 1998).  
Some explanatory attempts are based on the higher attractiveness of women for malaria-
carrying mosquitoes during pregnancy (Himeidan et al., 2004), due to both physiological and 
behavioral changes. In fact, pregnant women have a higher production of exhale breath and an 
increased blood flow / hotter skin than their non-pregnant counterparts, raising the release of 
volatile products that allow mosquitoes to perceive them more readily (Lindsay et al., 2000). 
However this can only explain the higher parasite exposure to new infections, which could 
cause the parasitic load to expand, but not the cases of recrudescence. 
Other postulated mechanisms include the hormone-dependent depression of the immune 
system during pregnancy that would allow the exacerbation of malaria. Indeed, there are few 
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examples of hormone fluctuations during pregnancy that can modulate the immune system, 
either by suppressing or stimulating it, and thus modify maternal susceptibility to malaria 
(Rasheed et al., 1993; Bouyou-Akotet et al., 2005; Mavoungou, 2006). The immunosuppression 
is mainly sustained by increased blood levels of cortisol that reduces the NK cytolytic effect on 
P. falciparum iRBC (Bouyou-Akotet et al., 2004). Cortisol concentrations were higher in 
primigravida than in multigravida from the second trimester onwards, and also higher in 
infected than in uninfected primigravida (Vleugels et al., 1989; Bouyou-Akotet et al., 2005), 
whereas susceptibility to malaria is higher in the second trimester and then decreases (Brabin, 
1983). Conversely, the plasma prolactin levels, a stimulator of the immune system, is higher in 
multigravida (Bouyou-Akotet et al., 2005). It was proposed that the hypothalamic-pituitary-
adrenal (HPA) axis might be modulated by repeated pregnancies/lactations events, which 
could “desensitize” stress circuits leading to a reduction of cortisol secretion after multiple 
births (Tu et al., 2006), thus reducing multigravida immunosuppression. 
However these hypotheses do not explain the preferential replication of parasites within the 
placenta. Duffy discussed the immunosuppression hypothesis (Duffy, 2001), stating that 
malaria could confound cortisol studies in pregnancy, since it makes difficult the distinction 
between cortisol levels due to pregnancy, due to malaria disease itself, puzzled with malaria-
related immunosuppression. Interestingly, the connection between malaria in pregnancy and 
immunosuppression was first demonstrated in mouse models, showing that development of 
recrudescent infection leads to increased corticosteroide production, suggesting that cortisol 
played a regulatory role in malaria during pregnancy (van Zon et al., 1982). 
Presently, immunosuppression is not generally acknowledged as an explanation for PAM 
susceptibility and hypotheses that include acquired immunity to neoantigens, resulting from 
parasite antigenic variation, are more accepted because they corroborate the epidemiology of 
the disease. The currently accepted hypothesis emerged after the discovery that P. falciparum 
parasite sub-populations are responsible for maternal malaria (Fried & Duffy, 1996). As specific 
immunity would start developing towards those parasites, infections could be cleared. 
Primigravida generally do not have antibodies to placental-binding iRBC, suggesting that these 
parasites represent novel VSAs to which women have not been previously exposed (Beeson et 
al., 1999; Ricke et al., 2000). Antibodies to surface antigens expressed by placental isolates and 
isolates that adhere to CSA are more prevalent in multigravida after exposure to placental 
malaria (Beeson et al., 1999; Ricke et al., 2000; Beeson et al., 2004) and are associated with a 
reduced risk of malaria during pregnancy and improved pregnancy outcomes (Staalsoe et al., 
2004). This explains why malaria premunition acquired during childhood, by people living in 
endemic areas, does not include antibodies that prevent CSA-iRBC adhesion and immunity 
against CSA-adherent parasites. Indeed a placental-parasite related immunity is crucial to 
control placental malaria and parasite exposure through consecutive pregnancies is required 
for this immunity to develop and be maintained (Hviid & Staalsoe, 2004).  
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CONTRIBUTION OF MOUSE MODELS FOR PREGNANCY-ASSOCIATED 
MALARIA STUDIES 
 
There are still several gaps of knowledge on PAM that constitute priorities of research, both in 
the parasite side and in the host side, some of which are difficult to perform in vivo for several 
reasons, including ethical constraints. Animal models can give a contribution in this area of 
research and some authors mentioned the importance of animal studies in providing new 
scientific hypotheses (Beeson et al., 2002a; Nosten et al., 2004; Greenwood et al., 2007; 
Rogerson & Boeuf, 2007).  
Malaria exposure is a composite of mosquito and parasite factors including numbers of 
infective bites, duration of infection and genetic diversity of the parasite population, which are 
difficult to quantify and to compare. Disease outcomes (duration and density of infection and 
disease severity) are equally difficult to categorize and measure and are influenced by host 
factors other than immunity. Animal models can have an added value in this respect, since 
they allow the tight control of many exposure variables and close monitoring of disease 
development. 
Laboratory animals, such as mice, are suitable models for PAM because of their relatively short 
gestational period that allows a reasonable experimental time frame, and of the availability of 
immunological and genetic tools. It is critical to appreciate the degree of similarity/differences 
of mice and human pregnancy physiology, namely on their immunology, placental structure 
and function. Desowitz summarizes the possible model systems that can be used to study 
malaria in pregnancy (Desowitz, 2001) and concludes that the congruency between the mouse 
and human is enough to allow the use of rodent malaria as a model for human PAM. It is clear 
that placental malaria is associated with several complications in pregnancy, paralleling 
analogous features in human and animal pregnancies, including embryonic lethality, fetal 
growth restriction, pre-eclampsia and the high rates of fetal mortality. 
Comparative histology of the human and mouse placentas 
Recent studies have provided extensive new data on the anatomy and physiology of the 
mouse placenta. Although the gross construction of the human and mouse placentas differ 
somewhat in their details, the overall structures and molecular mechanisms underlying 
placental development are thought to be quite similar (Rossant & Cross, 2001). Placental 
development comparison between mouse and human, as well as studies of molecular biology 
that attempt to localize gene expression patterns, have been described in several other 
reports (Adamson et al., 2002; Cross et al., 2002; Georgiades et al., 2002; Cross et al., 2003; 
Cross, 2005; Watson & Cross, 2005). 
Both rodents and humans have discoid placentas, with a flat part facing the fetus and a convex 
opposite surface adjacent to the uterine wall. During implantation and subsequent trophoblast 
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invasion, fetal trophoblast cells and maternal tissues (endometrium and myometrium in 
humans but only endometrium in mice) come into intimate contact. Both placentas are 
classified as hemochorial, because the uterine epithelium is eroded such that maternal blood 
comes into direct contact with trophoblast villi surface. In a cross-sectional view of both 
placentas it is possible to observe analogous structures (Figure 10) (Georgiades et al., 2002). 
Briefly, the three major placental zones have a correspondence in human and mouse: the 
outer maternal layer (decidua basalis) includes decidua cells of the uterus, as well as the 
maternal vasculature that brings blood to/from the uterine implantation site; a middle region 
which attaches the fetal placenta to the uterus and contains trophoblast cells that invade the 
uterine wall and maternal vessels (known as basal plate in humans and junctional zone in 
mice); and an inner region formed of highly branched villi where exchanges occur (the fetal 
placenta (villous tree) in human or labyrinth zone in mouse placenta).  
 
 
Figure 10. Human and mouse placentas. Schematic representation of the major regions and cell types of the 
human (left) and mouse (right) placentas, during the last trimester and last fifth of gestation respectively. The 
placentas are oriented with their maternal side towards the top and that facing the fetus (ﬂat) at the bottom. The 
plane of sectioning is through the center of the placenta and perpendicular to its ﬂat surface. The major placental 
zones have a correspondence in human and mouse respectively: decidua basalis (db) in both; basal plate (bp) and 
junctional zone (jz); fetal placenta (villous tree) (fp) and labyrinth zone (l). Arrows depict the direction of maternal 
blood ﬂow within the utero-placental circulation. avb, anchoring villous branch; avm, allantoic vasculature and 
mesenchyme; bp, basal plate; bpet, basal plate endovascular trophoblast; bpit, basal plate interstitial trophoblast; 
bpvc, basal plate venous channel; cc, cytotrophoblastic cell column; cma, central maternal artery; cp, chorionic 
plate; cpp, chorionic plate projection; db, decidua basalis; fp, fetal placenta; igc, invading glycogen trophoblast cells; 
ivs, intervillous space; jz, junctional zone; jzgc, junctional zone glycogen trophoblast cells; jzst, junctional zone 
spongiotrophoblasts; jzvc, junctional zone venous channel; l, labyrinth; m, myometrium; mbs, maternal blood 
sinus/spaces; msa, maternal spiral arteries; mv, maternal veins; pbit, placental bed interstitial invasive trophoblast; 
pbet, placental bed endovascular trophoblast; tgc, trophoblast giant cell; tgcz, trophoblast giant cell zone; tv, 
terminal villi; uc, umbilical cord; vt, villous tree; zi, zona intima. From Georgiades et al. (2002). 
 
The decidua basalis is the zone in contact with the uterus and receive the same name in both 
species, although in human placentas the assembly of the decidua basalis and the underlying 
myometrium is known as placental bed (Georgiades et al., 2002).  
Between the murine decidua basalis and the junctional zone, is a zone of trophoblast giant 
cells that appear not to have an analogous zone in human placenta, although a parallel can be 
Human Mouse 
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made between the murine trophoblast giant cells and the earlier extravillous cytotrophoblast 
cells that invade the human decidua basalis (Georgiades et al., 2002). The trophoblast giant 
cells, so named because of their unusually large size, related to the fact that they are 
extensively polyploid, mediate implantation and invasion into the uterus and at later stages 
produce several hormones and cytokines supporting both local and systemic physiological 
adaptations in the mother (Cross, 2005).  
In the junctional zone of the mouse placenta, also known as spongiotrophoblast layer, there 
are two types of cells, the spongiotrophoblasts and the trophoblast glycogen cells. The 
function of the spongiotrophoblast layer is unknown, but some of the spongiotrophoblast cells 
can differentiate into giant cells and are somewhat analogous to the cytotrophoblastic cell 
columns that anchor the villi of the human placenta. The trophoblast glycogen cells appear 
within the spongiotrophoblast layer after gestational day (G) 12.5 and later they invade into 
the uterus in a diffuse interstitial pattern (Cross, 2005). These cells can secrete hormones, 
contain large amounts of glycogen and under histological observation have large vacuoles 
given the appearance of a clear cytoplasm (Georgiades et al., 2002). In the basal plate, 
especially at the begin of gestation, there are also two types of cytotrophoblasts based on the 
degree of vacuolation and glycogen content and showing a morphological gradient, being the 
cells closest to decidua basalis more vacuolated and glycogen-rich (distal cells) and the 
remaining cells (proximal cells) have an eosinophilic cytoplasm and low amounts of glycogen, 
which allow several analogies between human and mouse (Georgiades et al., 2002).  
The labyrinth layer of the mouse is completely analogous in function to the chorionic villi 
(villous tree) of the human placenta and in both the villi are covered by syncytiotrophoblast 
that lie in direct contact with the maternal blood. These structures differ in terms of the 
ramification patterns. In human placentas they are of the villous type, maintaining a tree-like 
pattern with blunt-ended edges. On the contrary, the branches in the murine labyrinth are 
much more interconnected and generate a maze-like pattern. Consequently the human villi 
are well separated and the maternal blood space (the IVS) appears as a large open space, 
whereas in mice the “villi” are found anastomosed together originating tortuous channels in 
which the maternal blood flows (Cross, personal communication).  
All trophoblast cells located outside the placental villi form the extravillous trophoblast (also 
known as extravillous cytotrophoblast or intermediate trophoblasts). In the basal plate the 
extravillous trophoblast form clusters of stem cells named cytotrophoblast cell columns, which 
connect the anchoring villi to the basal plate (Georgiades et al., 2002; Kaufmann et al., 2003).  
The “placenta barrier” which constitutes the interface between maternal and fetal bloods, has 
few differences between both species. Both interfaces include a trophoblastic portion (lining 
the maternal blood spaces), a basement membrane and the fetal capillary endothelial cells 
that directly line the circulating fetal blood. The difference resides in the number of cell layers 
in the syncytiotrophoblast: in humans the trophoblast has a single syncytial layer (monochorial 
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placenta), whereas in mice it has three layers, namely two syncytial layers and a single 
mononuclear cell type (trichorial placenta). The unique continuous layer of syncytium in 
human placenta (Figure 11) is facing the maternal blood and has numerous microvilli to 
enhanced exchange.  
 
Figure 11. Cross section representation of a 
terminal chorionic villus in human placenta. Fetal 
blood enters the placenta by the umbilical cord spiral 
arteries and arbors into branching chorionic villi that 
are immersed in maternal blood (MB). This cross 
section scheme shows the continuous layer of 
multinucleated syncytiotrophoblasts (STB), a few 
underlying cytotrophoblasts (CT), and the villous 
stroma (VS) with fetal vessels (FV) and the 
macrophage-like Hofbauer cells (HC). From 
Kristoffersen (2000).   
 
In mice the trilaminar trophoblastic layer (Figure 12) consists of a first layer formed by 
mononuclear trophoblast cells (layer I), lining the maternal blood sinusoids, which does not 
have microvilli. The middle and third layers (layers II and III) are syncytiotrophoblastic that 
surround the fetal blood vessels endothelium. 
 
 
Figure 12. Schematic representation of the 
trilaminar layer of labyrinth trophoblast cells 
that separates the maternal and fetal 
circulations of the mouse placenta. From 
Watson & Cross (2005). 
Placental development in mice and humans  
At implantation, which occurs at G4.5 in mice and at G7-10 in humans, a precocious and 
intimate apposition between the maternal and fetal tissues is established. However, the 
establishment of a complete maternal circulation only occurs after this point. In fact, according 
to the effective maternal blood circulation in the placenta, the pregnancy can comprise two 
contrasting periods. In the first trimester of human pregnancy there is a little maternal blood 
flow in the placenta, the oxygen tension within the feto-placental unit is low, and the uterine 
glands may provide much of the nutrient supply (histiotrophic nutrition). At the start of the 
second trimester (around the 12th week of gestation) the maternal circulation within the 
intervillous spaces becomes fully established, the oxygen tension rises and the nutrients and 
gases are supplied by the maternal blood flow (haemotrophic nutrition) (Burton et al., 2001). 
This stage, correspondent to the full establishment of utero-placental circulation, is seen by 
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G12.5 in mice. This suggests that the murine definitive placenta becomes functional at or soon 
after mid-gestation, which indicates that temporarily the end of the first trimester in the 
human gestation may be equivalent to the time around mid-gestation in the mouse (De Pee et 
al., 2002; Georgiades et al., 2002).  
The change from histiotrophic to haemotrophic nutrition is an important event to take into 
consideration in the study of diseases such as malaria, whose infectious agent can reach the 
various tissues through blood circulation. Histiotrophic nutrition, and thus the absence of 
effective blood flow in the intervillous space during the first pregnancy period, may serve to 
protect the fetus from excessive high oxygen levels, reducing the damage mediated by free 
radicals during the sensitive period of organogenesis (Burton et al., 2001). During this phase 
the metabolism relies on anaerobic glycolysis, with oxygen consumption increasing towards 
the end of this period. The uterine glands in the endometrium discharge a cocktail of growth 
factors and carbohydrate-rich secretions into the IVS, which are taken up by 
syncytiotrophoblast. Moreover, the yolk sac also plays a role in nourishing the developing fetus 
in the first pregnancy period, by accumulating nutrients and transporting them to the fetus 
(Burton et al., 2001). The second phase of the pregnancy, starting after the completion of 
organogenesis and when the definitive placenta becomes functional and fully irrigated by 
maternal blood, is dominated by fetal growth. The increasing fetal requirements of oxygen 
arising from its growth are now provided by haemotrophic nutrition. Table 1 summarizes the 
main characteristics of human and mouse placentation described above. 
Table 1. Placentation features in human and mouse. Comparative structural and 
physiological aspects of the human and mouse placentas. 
Human Mouse 
38 weeks of gestation 
Histiotrophic nutrition in the first 
pregnancy period (3 months) 
Haemotrophic support in the second 
phase (last 2 trimesters) 
Discoid placenta 
Invasion of endometrium and 
myometrium during implantation 
Monochorial placenta (single 
syncytiotrophoblast layer) 
Haemochorial placenta (direct contact 
between maternal blood and chorionic 
trophoblast) 
Chorionic villi with a tree-like pattern 
3 weeks of gestation 
Histiotrophic nutrition in the first 
pregnancy period (12.5 days) 
Haemotrophic support in the second 
phase (nearly last half) 
Discoid placenta (per embryo) 
Invasion of endometrium during 
implantation 
Trichorial placenta (three 
syncytiotrophoblast layers) 
Haemochorial placenta (direct contact 
between maternal blood and chorionic 
trophoblast) 
Chorionic villi with a labyrinth or maze-
like pattern 
 
 
Introduction 
42 
 
Mouse models in immunopathological PAM studies  
To date the contribution of mouse models to the placental malaria immunopathogenesis 
knowledge has been negligible although the development and the exploitation of mouse 
models for PAM are likely to have a positive impact offering many tools to dissect the 
immunological and pathological components of pregnancy-associated malaria. 
Although differences between mouse and human immunology do exist and have already been 
reviewed (Mestas & Hughes, 2004), mice constitute an important experimental tool for many 
immunological studies. Regarding mouse malaria, the course of infection depends on factors 
inherent both to the host and to the parasite species/clone but is usually acute and results in 
either death or self-cure. Parasitemia is usually more extreme than in humans and anemia 
develops rapidly and can be either of short term or lethal.  
The first reported studies on mouse PAM were conducted by a Dutch group that used 
Plasmodium berghei K173 to infect outbred (Swiss) and inbred (C3H/StZ and B10LP) mice (van 
Zon & Eling, 1980a), followed by a chemotherapic treatment with sulfadiazine. They observed 
peripheral parasitemia recrudescence in about 46% of the pregnant females, but none of the 
non pregnant controls had recrudescent parasites. The authors noticed that recrudescence in 
second pregnancy depended on the presence of parasites in the first pregnancy. Therefore, 
the presence of parasites during pregnancy reinforced immunity, preventing recrudescence in 
a subsequent pregnancy. In a second report (van Zon & Eling, 1980b) these authors also 
observed a lower recrudescence rate in multigravida. Moreover, the authors verified that 
challenges of immunized mice before pregnancy did not reinforce immunity during pregnancy 
and the presence of parasites before G11 did not act as an antigenic signal, contrarily to the 
proliferating parasites after the second half of the pregnancy period (van Zon et al., 1985). In 
these pregnancy-malaria mouse studies, immunosuppression was the most accepted 
hypothesis to explain the higher malaria vulnerability in pregnancy. Other reports by the same 
team showed that mice that had recrudescence during pregnancy had significantly higher 
plasma corticosterone levels and that immune pregnant females without adrenal gland had a 
reduction of recrudescence rate (van Zon et al., 1982; Van Zon et al., 1986).  
Two research groups have used P.berghei NK65 in A/J and ICR mice strains (Oduola et al., 
1982) and in BALB/c mice (Hioki et al., 1990). In the first report, pregnant females were 
infected at gestational days 7, 12 and 14 and this resulted in a more severe disease in pregnant 
females in comparison with non pregnant controls, placenta pathology and reduced birth 
weight of pups. The second research group observed the fate of pregnant females after 
infection at several gestational days. Mice infected at G12 or before died before the pregnancy 
reached term, whereas the other groups (G14 and 16) lived long enough to deliver their litters. 
All the pregnant infected mice died earlier than non-pregnant controls, which also confirm the 
higher disease susceptibility during pregnancy.  
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In other studies, lethal P. yoelli challenge of pre-immunized pregnant females, using either the 
virulent YM or the non-virulent 17X strains, did not cause maternal mortality and led to the 
delivery of healthy newborns (Pavia & Niederbuhl, 1991). P. chabaudi AS was used to evaluate 
the incidence of abortions/fetal loss, maternal parasitemia and anemia in C57Bl/6 pregnant 
females infected at conception day (Poovassery & Moore, 2006).  
Those reports had the seminal role of revealing disease similarities between mouse and 
humans, such as the pregnancy-induced loss of pre-existing immunity to malaria and the 
presence of placental pathologic features. Nevertheless, these observations were not pursued 
and the PAM pathogenesis mechanisms were not investigated. The availability of sophisticated 
techniques of analysis, including molecular and genetic approaches, imaging tools, transgenic 
parasites and mice, and the current knowledge of parasite biology and host immune system, 
prompt the investigation of many pathological and immunological mechanisms underlying 
PAM and that remain to be elucidated.  
Most of the understanding of the biological basis of PAM is coming from studies conducted 
with pregnant women living in malaria endemic areas. Consequently the disease mechanisms, 
including the immunological tools, have been exploited only based in human data and 
samples, which might constitute a limitation for the disease understanding. In addition, some 
important questions cannot be addressed due to ethical constraints. An easily manipulable 
mouse model for malaria in pregnancy could be a precious tool to investigate disease 
mechanisms that, complemented and validated with human data, would constitute a valuable 
contribution to resolve unanswered questions in PAM.  
In the introduction the current state of knowledge of relevant aspects of PAM in humans was 
summarized, including currently proposed mechanisms contributing to adverse pregnancy 
outcomes. In this thesis we set out to establish and characterize immunopathological features 
of murine models of PAM and we conclude that these models can be useful to address specific 
questions relevant for human PAM. 
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AIMS AND PURPOSES 
 
The aim of the work presented in this thesis was firstly to establish an experimental system 
enabling pregnancy-associated malaria (PAM) studies in mouse models and secondly to 
characterize the immunological and pathological features in murine pregnancy-associated 
malaria. 
SPECIFIC PURPOSES: 
1. To develop a PAM mouse model representing pregnant women with a low premunition 
status before pregnancy. 
2. To establish a PAM mouse model that represents pregnant women carrying a high 
premunition status before pregnancy. 
3. To validate both models by evaluating their capacity of reproducing the main 
characteristics of the human disease and their limitations. 
The objectives 1, 2 and 3 were the subject of the publications I (PAM Model for Low 
Premunition) and II (PAM Model for High Premunition). The scope of characterization 
and validation of the developed PAM models is represented in the following scheme: 
 
Infection during Pregnancy 
Model 
Pre-Exposure Model 
Established 
Model 
Women living in regions with 
low malaria transmission 
(low premunition) 
Women living in a region with 
high malaria transmission 
(high premunition) 
Analysis & 
Validation 
Maternal Disease Severity 
Pregnancy Outcome: Low Birth Weight / Intrauterine Growth 
Retardation 
Placenta Pathology: Parasite-Host Interaction / Adhesion 
PAM Immunopathology: Molecular and Cellular Components 
PAM Immunological Protection: Multigravida Protection and 
Humoral Response. 
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METHODOLOGY  
 
Mice and Parasites 
BALB/c mice were bred and maintained in conventional housing and fed with a regular diet. All 
procedures were in accordance with national regulations on animal experimentation and 
welfare, authorized by the Instituto Gulbenkian de Ciência animal welfare committee. 
P. berghei ANKA parasites (P. berghei ANKA-GFP; 259Cl2 clone) used in infection experiments 
constitutively express green fluorescent protein (GFP) (Janse et al., 2006a; Janse et al., 2006b). 
Infected red blood cells (iRBC) were used in experimental infections at the concentration of 106 
iRBC/animal, either from in vivo passage in BALB/c mice, obtained when the percentage of 
iRBC reached approximately 10%, or from frozen stocks. For the Model of Infection During 
Pregnancy, pregnant females were infected with iRBC from in vivo passage, whereas females 
of the Model of Pre-Exposure were infected with iRBC from frozen stocks. Animal infections 
were performed either by intraperitoneal (i.p.) or intravenous (i.v.) injections in accordance 
with the experiment characteristics. Parasitemia was measured in tail blood using flow 
cytometry analysis as described elsewhere (Janse & Van Vianen, 1994). Alternatively, 
parasitemia was evaluated in thin blood films methanol-fixed and Giemsa-stained.  
Gestation timing and pregnancy monitoring 
BALB/c female and male mice (2:1 or 3:1) were caged together for mating during two to three 
days and females examined for the presence of vaginal plug every morning. Detection of the 
vaginal plug and measurement of body weight were jointly used to determine the timing of 
pregnancy, as described elsewhere (Freyre et al., 2006). The day of finding of the vaginal plug 
was considered as gestation day one (G1) and pregnancy progression was monitored every 
other day by weighting the females. Since the presence of vaginal plug was not always 
followed by pregnancy and in some cases not detectable, successful fertilization was 
confirmed between G10 and G13 when the animals had an average body weight increase of 3-
4 g. Females placed without male did not show a weight fluctuation of more than 1 g for a 
period of 20 days. Thus, weight gain was taken as sign of pregnancy and abrupt weight loss as 
indicator of pregnancy disturbance or interruption. 
Pregnant females infection (Model of Infection During Pregnancy) 
Pregnant mice were infected intravenously (i.v.) between G11 and G13 with 106 iRBC from in 
vivo passage in BALB/c mice and parasitemia was recorded every other day. This infection 
period was determined to be the optimal time point as earlier infections did not allow reaching 
pregnancy at term (data not shown). Non-pregnant infected females or non-infected pregnant 
females were used as controls in pregnancy infection experiments as appropriate. Part of the 
pregnant females (both infected and controls) were allowed to deliver and the progenies were 
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followed up to weaning. The other pregnant females were subjected to caesarian section at 
G17-19 for fetal survival evaluation and placenta pathology observation. 
Offspring monitoring (Model of Infection During Pregnancy) 
As P. berghei ANKA-GFP infection is lethal in BALB/c mice, foster mothers were used for 
newborn post-natal follow-up studies. Hence, both newborns from infected mothers and 
newborns from control mothers were also transferred to foster mothers to avoid weight bias 
due to differential maternal nourishment. The newborns were weighted every other day. 
Chemotherapic treatment for immunization (Model of Pre-Exposure) 
BALB/c females were infected i.p. with 106 iRBC obtained from frozen stocks and treated IP 
with 0.7 mg chloroquine/animal/day for 3 days. Typically the treatment started at day 7 post-
infection when parasitemia reaches values of 5 - 10%. Five to ten percent of the female mice 
exposed to this immunization protocol succumbed but the remaining recovered from the 
infection and were used in subsequent pregnancy-induced recrudescence experiments. 
Pregnancy-induced recrudescence monitoring (Model of Pre-Exposure) 
Forty days post-infection, or thereafter, pre-exposed females were put to mate or used as non-
pregnant controls. Pregnancy monitoring was performed as described above. Some of the 
pregnant females were subjected to caesarian section at G19 for placenta pathology studies, 
while the others were allowed to deliver and to follow to subsequent pregnancies. At delivery, 
the weight and the number of live newborns were registered. Newborns weight and 
development was followed up to day 30 after birth. Non-infected pregnant females were used 
as controls. 
Fetal survival evaluation 
Females used for in uterus pregnancy outcome evaluations were killed by CO2 narcosis 
between G17 and G19, the spleens weighted, uterus examined and the number of fetuses and 
resorptions recorded. Resorptions were identified as small implants with no discernible fetus 
and placenta, corresponding to embryos that died before complete placenta vascularization. 
The fetuses were extracted from their amniotic envelop and viability was immediately 
evaluated by prompted movement reaction to touching with pliers. The lack of reactive 
movement indicated that the fetus had recently died and was considered an abortion. 
Macerated pale white fetuses were dead and recorded as abortions. Fetuses and placentas 
were separately weighted. Non-aborted fetuses were killed combining CO2 narcosis and 
hypothermia. 
Tissue preparation and histopathological analysis 
Placentas from infected and non-infected females were treated in a similar way. Placentas 
were separated in two halves, one half was fixed either in 10% formalin or, in case they would 
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follow to immunohistochemistry, in 1.6% paraformaldehyde with 20% sucrose, for further 
processing and the other half was collected for RNA extraction. Paraffin-embedded non-
consecutive placenta sections were stained with hematoxylin-eosin (HE) and examined under a 
light microscope (Leica DM LB2, Leica Microsystems). For histological and morphometric 
analysis, placental sections were examined in a blind fashion. 
Immunohistochemistry 
Fixed placenta samples were washed in PBS with 15% sucrose overnight, soaked in Tissue-Tek® 
(Sakura) and frozen in dry ice. For immunohistochemistry staining, freshly made frozen 
sections (6 μm thick) were rinsed in PBS for 30 minutes and blocked with 1% bovine serum 
albumin (BSA). To enhance parasite GFP signal, we used rabbit polyclonal anti-GFP antibody 
conjugated with Alexa488 (Molecular Probes). To identify macrophages/monocytes we used 
anti-CD11b biotinilated antibodies (BD Biosciences, Pharmingen), followed by incubation with 
Rhodamin-Avidin D (Vector Laboratories). Nuclei were stained with DAPI (Invitrogen) and 
coverslips were mounted with aqueous mounting media (Mowiol 4-88, Calbiochem). Stained 
sections were examined under fluorescence microscopy (Leica DMRA2, Leica Microsystems). 
Morphometric analysis 
HE stained placental sections were analyzed for vascular space quantification. In each section, 
5 randomly selected microscopic fields in the labyrinthine region (magnification x40) were 
acquired at 1280 x 960 resolution, using a color video camera (Evolution TM MP color, Media 
Cybernetics) connected to a light microscope (Leica DM LB2, Leica Microsystems). The images 
were analyzed by a routine implemented in the ImageJ software (ImageJ 1.37v, National 
Institutes of Health). Briefly, after acquisition, the images underwent an automated light 
analysis procedure where noise removal was applied to ensure color and image quality 
standardization across sections and specimens. The images were given a color threshold to 
cover the area corresponding to blood spaces lumen. The coverage percentage was calculated 
as the ratio between the number of pixels covered by the area defined by the threshold and 
the overall number of pixels in the image. The blood vascular area in each placenta was 
estimated from the analysis of two non-consecutive sections. The reported results correspond 
to individual pregnant females and represent the average result for 2-3 placentas. 
Gene Expression  
Total RNA, from individual placentas and viable newborns, was obtained using an RNeasy Mini 
Kit (Qiagen), following the manufacturer’s protocol for animal tissues. One microgram of total 
RNA was converted to cDNA (Transcriptor First Strand cDNA Synthesis Kit, Roche) using 
random hexamer primers. MCP-1 (Ccl2) and MIP-1α (Ccl3) expression was quantified using 
TaqMan Gene Expression Assays from ABI (Mm00441242_m1 and Mm00441258_m1, 
respectively) with TaqMan Universal PCR master mix. T lymphocytes (Cd3e), natural killer cells 
(Klrd1), macrophages (Mgl2), neutrophils (Ncf2), cytokines and hemoxygenase-1 (Hmox-1) 
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expression was amplified using primer sequences previously described (Epiphanio et al., 2008). 
Endothelin-1 (Edn1) and β-actin (Actb) specific primer sequences were, Edn1 -5’-ACG CAC AAC 
CGA GCA CAT TGA CTA C-3’and 5’ TCC TGC CCG TCT GAA CAA GAA ACT G-3’ and Actb - 5’ AGC 
CAT GTA CGT AGC CAT CC-3’ and 5’-CTC TCA GCT GTG GTG GTG AA-3’. These qRT-PCR 
reactions used Applied Biosystems Power SYBR Green PCR Master Mix. The gene expression 
quantification reactions were performed according to the manufacturers’ instructions on an 
ABI Prism 7900HT system. Relative quantification of specific mRNA was normalized for a 
mouse housekeeping gene mRNA. To select an appropriate internal control, the expression of 
the following housekeeping genes: ACTB, GAPDH, TATA box binding protein (TBP), Succcinate 
dehydrogenase complex, subunit A (SDHA) and Tyrosine 3-monooxygenase/tryptophan 5-
monooxygenase activation protein, zeta polypeptide (YWHAZ) was studied. The last three 
genes have been previously validated in human placental malaria (Boeuf et al., 2008). Due to 
uneven gene expression, when comparing non-infected and infected placentas, the 
housekeeping genes TBP, SDHA and YWHAZ were unsuitable for internal controls. Conversely, 
ACTB and GAPDH expression was maintained under infection conditions. 
Synchronization of parasitized erythrocytes 
iRBC were collected from infected animals (non-pregnant and pregnant females with 
recrudescence) with 10-20% parasitemia, by cardiac puncture, suspended in RPMI medium 
containing 25% of foetal bovine serum (FBS). In order to obtain mature blood stage parasite 
forms (trophozoites / schizonts), P. berghei ANKA-GFP infected erythrocytes were 
synchronized as described elsewhere (Janse et al., 2006c). Briefly, parasites were maintained in 
vitro at 370C for one developmental cycle, which takes about 16 hours. During this period the 
ring forms and young trophozoites develop into schizonts containing mature merozoites. The 
schizonts-infected erythrocytes are separated from the uninfected RBC by a Nicodenz-density 
gradient centrifugation (65% (v/v) Nicodenz/PBS solution), resulting in cell-populations that 
yield over 90% infected erythrocytes. After mature forms enrichment, infected erythrocytes 
were suspended in PBS at a concentration of 108 iRBC/ml.  
iRBC binding assays in placental sections 
Placentas from uninfected BALB/c females, obtained at G19, were treated using a previously 
described protocol (Muthusamy et al., 2004). Briefly, the placentas were fixed in 2% formalin 
and 0.5% glutaraldehyde for 10 minutes, heated in a microwave oven before being paraffin-
embedded, and cut into sections of 5 µm onto glass slides. This fixation protocol aims to 
preserve the binding capacity of glycosylaminoglycans (GAG) in the placenta IVS (Muthusamy 
et al., 2004). Tissue sections on the glass slides, after deparaffinized and rehydrated, were 
delimitated with a DAKO pen. For placenta-receptor cleavage experiments, placental sections 
were incubated with 0.5 U/ml chondroitinase ABC (from Proteus vulgaris, Sigma), with 
30 µg/ml hyaluronidase (from bovine tests, Sigma), with heparinase II (from Flavobacterium 
heparinum, Sigma) or with PBS for 2 periods of 2 hours at 37oC. Both enzyme-treated sections 
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and non-treated sections were blocked with 1% BSA in PBS at room temperature for 30 
minutes. Fifty microliters of synchronized iRBC suspension, at the concentration of 108/ ml, 
were overlaid onto each tissue section for 60 minutes at 370C in a humid chamber. After 
washing the unbound cells, the placental sections were incubated with DAPI. For iRBC-ligand 
blocking experiments, synchronized iRBC were pre-incubated with the indicated 
concentrations of chondroitin sulfate A (CSA) from bovine trachea (Sigma), hyaluronic acid 
(HA) potassium salt from human umbilical cord (Sigma) or colominic acid sodium salt (as 
negative control) from E. coli (Sigma), at 370C for 30 minutes with moderate agitation. Of note 
is that according to Sigma certificate of analysis, HA has less than 5% contamination of 
chondroitin sulphate. For iRBC-ligand cleavage assays iRBC were treated with trypsin (Gibco), 
proteinase K (Sigma) or neuraminidase as a negative control (from Clostridium perfringens, 
Sigma). iRBC were pre-incubated with each enzyme at indicated concentrations for 30 minutes 
at 370C. After washing, iRBC were overlaid on placental sections as described above. The slides 
were mounted with Mowiol and examined under fluorescence microscopy (magnification x40). 
The number of iRBC adhering placental sections in each experimental condition was 
determined in a blind fashion, counting 50 fields in each of three independent experiments. 
Hemoglobin determination 
This procedure is based on the oxidation of hemoglobin to methemoglobin in the presence of 
alkaline potassium ferricyanide. Methemoglobin reacts with potassium cyanide to form 
cyanmethemoglobin, which has maximum absorption at 540 nm. The color intensity, 
measured at 540 nm, is proportional to the total hemoglobin concentration and was quantified 
by visible spectrophometry using the Drabkin method (Drabkin, 1949; Singh & Shinton, 1965). 
Briefly, two microliters of tail blood were collected in 500 μl of Drabkin’s Reagent and 
absorbance measured at 540 nm. 
P. berghei antigens preparation 
Recrudescent parasites were expanded in non-pregnant females following in vitro culture for 
parasite synchronization and parasite mature forms enrichment (about 95% of late stages).  A 
crude preparation of blood stage P. berghei components was obtained from the mature forms 
that were freeze-thawed six times, sonicated and ultra-centrifuged. The protein was quantified 
and aliquots stored in liquid nitrogen.  
ELISA  
For the determination of parasite - specific antibodies, 96 well plates (NUNC MaxiSorp) were 
coated with P. berghei-iRBC proteins extract (50 μl/well at the concentration of 5 μg 
protein/ml) and incubated overnight (ON) at 4ºC. The unbound antigen was removed by 
washing with 0.05% Tween-20 in PBS (PBST). Possible residual free sites were saturated by 
treatment with PBS 1% BSA for 1 h at RT and the plates washed five times with PBST. Fifty μl of 
serum serially diluted samples (diluted from 1:27= 1:128 to 1:214= 1:16384) were incubated for 
3 h at 37ºC. The plates were washed five times with PBST and developed using either 
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antibodies AP-conjugated diluted 1:1500 (for the classes IgG, IgM or IgA) (Southern Biotech) or 
antibodies horseradish peroxidase (HRP)-conjugated diluted 1:4000 (for the IgG isotypes IgG1, 
IgG2a or IgG3) (Southern Biotech) and incubated for 1.5 h at 37oC. Plates were revealed to 
detect bound immunocomplexes by adding, to each group, PA buffer/PNPP or TMB buffer 
(BD), respectively. When PA conjugated was used the absorbance was read at 405 nm 
wavelength filter (Bio-Rad plate reader) after 5-15 minutes of development. When using HRP 
conjugated, the enzymatic reaction, developed for 10 minutes, was blocked with sulfuric acid 
(0.1 M, 50 μl per well) and the OD was read at 450 nm. The anti-P. berghei antibody titers were 
expressed as log2 of the reciprocal serum dilution giving an absorbance value of 30% of the 
saturation level, as previously described (de Moraes et al., 2006). 
Visualization of luciferase activity in whole body and dissected organs 
A pregnant female was infected with a Plasmodium berghei line expressing a GFP-Luciferase 
(676m1cl1 clone) fusion protein, under the control of the eef1a-promoter, at G13 and at G18 
the parasites accumulation was observed through the determination of luciferase activity 
previously described (Franke-Fayard et al., 2005). Briefly, luciferase activity was visualized 
through whole-body imaging or dissected organs with an intensified-charge-coupled device (I-
CCD) video camera of the in vivo Imaging System (IVIS 100, Xenogen). The pregnant mouse 
was injected i.p. with d-luciferin dissolved in PBS (100 mg/kg of body weight; Synchem, Kassel, 
Germany). After 10 minutes the female was killed by CO2 narcosis and bioluminescence 
imaging was acquired with a 15-cm FOV, a medium binning factor and exposure times of 10–
60 s. Individual organs and fetuses were obtained by dissection and placed in a Petri dish and 
imaged with a 10-cm FOV, a medium binning factor, and exposure times of 10–60 s.  
Cytokines quantification in serum 
IL-4, IL-6 and IL-10 levels were determined by Cytometric Bead Array (CBA) (Becton Dickinson 
Biosciences, San Diego, CA, USA) assay, according to manufacturer’s recommendations. Briefly, 
50 μl of the mixed capture beads were added to 50 μl plasma diluted 1:4 of each animal from 
the different groups in their respective tubes and mixed. After 1 hour of room temperature 
(RT) incubation, 50 μl mouse-phycoerythrin (PE) (Positive Control Detector) were added, 
followed by another incubation of 1 hour at RT. Standards were ran simultaneously for each 
cytokine, and were mixed with capture beads and detection reagent conjugated with PE. 
Samples were incubated for 1 h at RT once they had been mixed and protected from exposure 
to light. The samples were washed and centrifuged at 200 × g for 5 min to remove unbound 
detection antibody and then analyzed by flow cytometry (FACScan, BD). Cytokine 
concentration (pg/ml) was calculated by a standards regression curve.  
Statistical analysis 
Statistical differences between groups of mice used in this study were evaluated by the 
Student’s t test, Mann-Whitney test or Kruskal-Wallis, and Log Rank test for survival curves. 
Chi-square or Pearson tests were used for association or correlation analysis, respectively. 
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RESULTS  
EXPERIMENTAL SYSTEMS 
This work aimed to establish mouse models for Pregnancy-Associated Malaria studies taking in 
consideration that different mouse strains are differentially susceptible to malaria and 
different parasite species/strains can lead to different disease manifestations in the same 
mouse strain. In this section we describe the preliminary experiments that were performed in 
order to choose suitable experimental systems that would allow investigating PAM 
development and pathological outcomes.  
Parasite species and mouse strain selection 
Several preliminary tests were performed, using Plasmodium berghei ANKA, P. yoelli 17XL and 
P. chabaudi chabaudi, and the C57Bl/6, BALB/c and DBA-2 mouse strains. When pregnant 
females were infected during pregnancy the three parasite species caused pregnancy 
disturbances in all tested mouse strains, both in the mother and in the offspring. However, 
when females were pre-exposed to each parasite species, only P. berghei ANKA parasites 
relapsed during pregnancy. Thus, P. berghei ANKA was the selected parasite to pursue our 
model set-up. It is worth to remark that this choice would take advantage of a P. berghei 
transgenic line expressing the green fluorescent protein (GFP).  
P. berghei ANKA caused severe malaria syndromes causing high lethality soon after infection in 
all the tested mouse strains except in BALB/c mice that showed progression to 
hyperparasitemia and survived for longer periods (20 days in average). As the other strains 
could not survive long enough to evaluate the typical manifestations of malaria in pregnancy, 
the BALB/c strain was chosen as the host model.  
Infection protocol establishment 
Several preliminary pre-exposure protocols were tested aiming to avoid anti-parasite 
chemotherapy, namely the use of irradiated parasites and RBC transfers. 
Blood stage parasites were irradiated in order to abolish their infective capacity while 
maintaining their antigenicity. In order to identify an irradiation dose suitable to trigger 
protective immunity, iRBC were irradiated with 0, 12, 15, 18, 20 and 23 krad and injected in six 
groups of animals. The results show that parasites irradiated with 12 rad kept their viability 
and lethality while parasites irradiated with 15 rad or higher did not have parasitemic infection 
but did not induce protection against a challenging infection. Thus, we did not find an iRBC 
irradiation regimen that would provide the needed protection to infection in non-pregnant 
females (Figure 13). 
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Figure 13. Irradiated P. berghei-iRBC were not inducers of a protective status. Blood stage 
parasites were irradiated according to the irradiation doses indicated (0, 12, 15, 18, 20 and 23 krad) 
and 5 x 10
6
 iRBC were injected i.v. in C57Bl/6 mice at day 0 (5 animals). The mousethat received 
non-irradiated parasites (0 krad) died at day 8. The parasitemia of the group injected with 12 krad 
irradiated - iRBC was delayed by day 21 all the animals were dead. The four remaining animal 
groups, corresponding to higher doses of irradiation, did not revealed parasitemia and were 
challenged with non-irradiated iRBC at day 21. The parasitemia curves show a dosis dependent-
kinetics, but all animals succumbed. Each point represents mean ± s.e.m. 
 
Next, we tried to prolong the course of infection expecting to obtain a protective immune 
response. We replaced the erythrocytes that were destroyed by the infection through 
repeated blood transfusions from non-infected adult females. Several experiments were 
performed with slight modifications in the protocol, but all of them failed to confer protection. 
In one of these experiments, thirty-one BALB/c females were infected with 105 infected red 
blood cells (iRBC) intraperitonealy (i.p.). Seven days after infection each infected female 
started to receive 100 µl of non-infected blood by intravenous injection (i.v.), and this 
treatment was repeated within an interval of two to four days (Figure 14).  
This transfusion regimen reduced parasitemia almost collectively, but the mice were never 
completely cured and the initial weight was never recovered. The mice start dying on day 14 
post-infection and at day 60 post-infection all the mice succumbed. To discard any detrimental 
effect caused by blood transfusion, five non-infected females were also treated on the same 
way and no weight fluctuation was observed (Figure 2, lower graph, black line). This attempt 
did not result in a protective response implying that prolonging the blood stage of infection is 
not enough to generate an immune response that resolves the infection and confers ulterior 
protection.  
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Figure 14. RBC replacement failed to control infection. Blood transfusion treatment of BALB/c 
P. berghei infected females. Parasitemia (upper plot) and weight (lower plot) of thirty one 
females that were infected i.p. at day 0 with 10
5
 P. berghei infected red blood cells (iRBC) and 
treated with exogenous blood in the indicated days (arrows in the lower plot). In each blood 
transfusion treatment every infected female received 100 µl of non-infected blood, starting 
seven days after infection, and repeated with an interval between two and four days. By day 
60 all the treated females were dead. Red line represents a female infected and not treated. 
Black line (lower graph) corresponds to the weight (mean ± s.e.m) of five non-infected BALB/c 
females that also received blood transfusions. 
 
Finally, the pre-exposure protocol chosen was based in treating chemotherapeutically infected 
females to promote their premunition. Chemotherapic treatments have been used with the 
purpose of generating malaria protected mice (Poels et al., 1977). Since P. berghei ANKA GFP is 
not sensitive to drugs such as pyrimethamine (Franke-Fayard et al., 2004), we used 
chloroquine to perform the immunization protocol. Females immunized under this protocol, as 
described in Methodology section (Figure 15), were the players of the pre-exposure model. 
Thus, the immunization was attained using chloroquine therapy that interferes with the 
parasite metabolism inhibiting the enzymatic reaction of hemozoin synthesis. Briefly, the 
malaria parasite takes up hemoglobin from the host RBC and degrades it to heme (toxic for the 
parasite) and aminoacids. A parasite enzyme – heme polymerase – converts the potentially 
harmful heme into hemozoin (non-toxic storage form) in a reaction that can be blocked by 
chloroquine (Hunt & Stocker, 2007). 
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Figure 15. Subpatent infection is acquired with chemotherapy. Parasitemia and weight 
follow-up of eighteen females infected with 10
6
 P. berghei-iRBC at day 0 and treated 
with chloroquine at days 9, 10 and 11. Typically the parasitemia is controlled after the 
treatment, raised around day 20 and reaches a second peak, which the mice likely self-
clean, and thereafter the parasitemia will never come up again. In this experiment three 
females did not resist to the second parasitemia peak (represented by dashed lines) and 
died. Red line corresponds to a female infected and not treated.  
 
The data plotted in Figure 15 correspond to one of the several pre-exposure experiments that 
were performed, but in all of them the patterns of parasitemia and weight were very similar. 
Usually about 5-10% of the treated females died during the second peak but never before, 
suggesting they were not able to mount an immune response capable of controlling the 
infection. Females that survive after controlling the second peak did not experienced 
parasitemia relapses, unless they became pregnant. Thus, following day 40 after infection the 
females acquired a silent infection and had already recovered their physical condition, as 
judged by the weight recovery, and thus were prepared to be used in the pre-exposure PAM 
model.  
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MODEL OF INFECTION DURING PREGNANCY 
This mouse model aims to represent acute malaria in pregnancy, which enables experimental 
evaluation of human PAM when women have no acquired immunity, a characteristic of 
regions with unstable malaria transmission. 
To set up an experimental model that recapitulates the typical pathology features of severe 
malaria in pregnancy, we took in consideration that poor pregnancy outcomes and fetal 
growth impairments are critically dependent of the gestational day (G) chosen for infection. In 
fact, infection at early stages led to premature pregnancy interruption, while infection around 
mid-pregnancy (G13) when blood flow has already full access to the placenta (Figure 16), 
allowed pregnancy to proceed to later stages, and fetal and placenta pathology became 
apparent resembling human PAM.  
G13
Haemotrophic nutrition
 
Figure 16. Schematic representation of mouse development in uterus. The pre- and post-
implantation phases are shown above the time line. Bellow, the critical events and processes 
are indicated. After G12.5 the placenta is already functional and the maternal circulation in 
the placenta is fully established. Adapted from Kispert & Gossler (2004).  
 
Effects of malaria infection on the pregnant females 
Comparison of P. berghei-GFP course of infection in pregnant and non-pregnant females 
confirmed earlier findings that pregnancy in mice confers an increased susceptibility to malaria 
showing that pregnant mice experienced faster increase in parasitemia as compared to non-
pregnant females (Oduola et al., 1982; Hioki et al., 1990; Pathak et al., 1990). Parasitemia in 
pregnant mice was 55.41 ±  5.44 % (mean ± SE) on day 7 post-infection as compared to 33.83 ± 
3.47 % in non-pregnant mice (P-value = 0.007) (Figure 17A). In addition, survival to infection 
was reduced in pregnant mice, with all deaths occurring between day 5 and day 10 post-
infection (Figure 17B). In contrast, the majority of non-pregnant infected females survived until 
day 20 post-infection and by day 30 all had succumbed to infection (data not shown). Average 
survival time for pregnant and non-pregnant infected mice was 7.5 and 20.5 days, respectively. 
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These results suggest that, similarly to humans, pregnant mice show increased susceptibility to 
malaria infection which may affect their progeny or compromise pregnancy. 
 
 
Figure 17. Increased disease susceptibility in 
pregnant BALB/c mice infected with 
P. berghei-GFP. BALB/c pregnant females 
were infected on G13 by IV injection of 10
6
 
iRBC and non-pregnant females were 
simultaneously infected. The plots represent 
cumulative results of three independent 
experiments in a total of 32 pregnant and 16 
non-pregnant females. (A) Parasitemia curves 
where data points represent mean ± s.e.m. 
From day 3 post-infection onwards 
parasitemia was significantly higher in 
pregnant females (P-value < 0.05). (B) Survival 
curves up to 10 days after infection show that 
survival time of pregnant female mice are 
significantly lower than in controls (P–
value < 0.0001). Non-pregnant females died at 
a later stage with hyperparasitemia. 
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Effects of maternal malaria on the progeny 
• Unsuccessful pregnancy and impaired post-natal growth 
We followed-up the pregnancy outcome in 22 infected females and found out that malaria had 
a strong negative effect in pregnancy success (Table 2). Approximately two-thirds of infected 
pregnant females (14 out of 22) did not give rise to viable pups due to maternal death before 
parturition (8 cases) or to preterm delivery/abortions (6 cases). The remaining mothers carried 
out pregnancy to term giving rise to 27 viable newborns. The progeny of 2 infected mothers, 
out of 8 that gave birth, died after birth between day 2 and day 21, indicating that malaria 
during pregnancy increases newborns mortality. 
 
Table 2. Effect of Plasmodium berghei infection during pregnancy on reproductive outcome and fetus 
development 
(a)
 
P. berghei  
exposure 
No. of  
Pregnant 
females 
Gestational 
period (days)(b) 
 Birth   
weight (g)(b) 
Weight    
day10 (g)(b) 
No. 
Successful 
fetus(b) 
No. Unsuccessful 
pregnancies(c) 
Infected 22 19.8 1.3 3.4 5 14(8/6) 
Uninfected 14 20.7 1.4 5.6 6 0 
p- value(d) __ 0.05 0.03 < 0.0001 0.39 __ 
(a) BALB/c mothers were infected on G13 with P.berghei by IV injection of 106 iRBC and were allowed to give birth at term. 
(b) Average values. 
(c) Number of unsuccessful pregnancies (mother dead pregnant / preterm delivery or abortion). 
(d) Student’s t test. 
 
 
 
A 
B 
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Figure 18. Reduced growth rate in progenies of P. berghei-GFP infected mothers. BALB/c pregnant females 
were infected on G13 by IV injection of 10
6
 iRBC. After delivery newborns were transferred to a foster 
mother and their body weight was followed up to weaning (A). Example of body size difference at day 21 of 
age is shown in (B), mouse born from non-infected (left side) and from infected mother (right side).  
 
• Fetal survival and intrauterine growth retardation 
We evaluated the effects of malaria in pregnancy on fetal survival and fetal growth at late 
pregnancy stages (G18) by analyzing fetuses from 28 pregnant females infected at G13 and 
from 9 non-infected pregnant females (Table 3). Uterus collected at G18 from infected 
pregnancies frequently showed macroscopic abnormalities, as compared to controls, 
corresponding to the presence of aborted fetuses (Figure 19A). In fact, infected mothers had 
significantly lower number of viable fetuses as compared to non-infected mothers (p = 0.01) 
and had higher number of aborted fetuses (p = 0.002) (Table 3). 
 
 
 
Figure 19. P. berghei-GFP infection impairs 
pregnancy outcome and fetus development. (A) 
Representative uterus at G18 from BALB/c pregnant 
females uninfected (upper) and infected on G13 with 
P. berghei-GFP by IV injection of 10
6
 iRBC (bottom). 
The arrowheads indicate abortions. (B) Fetus from 
uninfected (left) and from infected mother (right). In 
detail, mouse placenta from an uninfected (C) and 
infected mother (D). Lack of blood circulation is 
noticeable in the placenta, paws and tail in panel (D). 
Scale bar represents 1 cm in A-B and 0.5 cm in C-D. 
We searched for intrauterine signs of fetal impaired development. Fetuses from uninfected 
healthy mothers showed pink coloration, had translucent skin with visible blood flow in the 
blood vessels and the placentas were replenished with blood (Figure 19B left and 19C). In 
contrast, many fetuses from infected mothers appeared abnormal having remarkable reduced 
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size, pale tone with poor blood vessel replenishment and placentas with reduced blood 
content (Figure 19B right and 19D). It is worth to remark (Table 3) that average weight of 
viable fetus at G18 was significantly lower in infected mothers (0.55 ± 0.034 g) as compared to 
non-infected mothers (0.9 ± 0.053 g). Together, these data strongly suggest that fetuses from 
infected mothers suffer IUGR and have decreased viability due to placenta blood flow 
impairment, recapitulating pathological features of severe malaria manifestations typically 
observed in pregnant women from low malaria transmission regions. 
 
Table 3. Pregnancy outcome obtained at caesarean section on G18 after Plasmodium berghei infection 
during pregnancy
 (a)
 
P. berghei-GFP 
exposure 
No. of 
pregnant 
females(b) 
Mother's spleen 
weight (mg)(c) 
Fetus weight 
(g)(c) 
No. 
Abortions(c) 
No. 
Resorptions(c) 
No. 
Successful 
fetus(c) 
Infected 28 521 0.6 2.4 1.7 3.7 
Uninfected 9 102 1.0 0.2 0.7 7.7 
p-value(d) __ 0.02 < 0.0001 0.002 0.11 0.01 
(a) BALB/c mothers were infected G13 with P.berghei by IV injection of 106 iRBC. 
(b) Pregnant females sacrificed at G18. 
(c) Average values. 
(d) Student’s t test. 
 
Placental pathology  
• Placenta is a site of parasite accumulation 
It has been described that P. falciparum iRBC have the capacity of being sequestered in several 
organs, including the placenta (Brabin et al., 2004b). Parasite-placenta interaction studies in 
humans are based on ex-vivo assays (placental tissues) and on in vitro assays (cell cultures and 
immobilized candidate receptors). To date in vivo placental sequestration studies have not 
been performed in animal models and there is no direct evidence of P. berghei-iRBC dynamics 
inside pregnant hosts. Infection of BALB/c pregnant females at G13 with P. berghei luciferase-
GFP allowed the subsequent visualization of the parasite distribution at G18, confirming that 
the placentas are predilection sites of P. berghei parasites accumulation (Figure 20), similarly 
to organs like lungs and spleen. The observed parasite accumulation strongly suggests that 
placentas are indeed a parasite preferential target. An intriguing observation was that 
parasites accumulated asymmetrically within the uterus. 
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Figure 20. Placentas are target destination of P. berghei parasites. One pregnant female was infected with 10
6
 
P. berghei GFP-luciferase-iRBC at G13 and parasites accumulation was revealed by measuring luciferase activity in 
the whole pregnant female at G18 and in dissected organs. Rainbow scale of the total photon counts show the 
relative level of luciferase activity, ranging from low (violet, blue) to high (red). (A) Whole body acquisition, where 
parasite groups can be visualized in several points distributed on the right side (placentas, fat, lungs) and a strong 
parasite accumulation in the left side. This corresponds to the zone of the spleen and to the uterus left horn, as it is 
illustrated in (B) where it is visualized the asymmetric parasite distribution in the uterus. In (C) dissected organs: 
lungs (top), spleen (bellow) and two groups of fetus with the respective placentas. The two placentas of the fetuses 
from the rifgt horn of the uterus show a lower luciferase activity, whereas the four placentas from the left horn of 
the uterus have a higher parasite accumulation. 
• Placental pathology and inflammation 
Placenta represents the interface between mother and fetus, playing a critical role in fetal 
growth and development and thus any modification on its structure or function can have 
consequences for the pregnancy outcome. Placental tissue of infected pregnant females 
revealed a number of abnormalities in comparison to non-infected controls (Figure 21).  
 
Figure 21. Placenta pathology in infected pregnant mice. Histology of infected placentas collected 
at G18. HE stained sections from non-infected mice (panels A and C) and infected (panels B and D) 
are depicted. Different cell types are identified in panel A as (DC) decidual cells, (Cy) 
cytotrophoblastic cells and (La) labyrinth region. Fibrinoid necrosis areas (Ne) are indicated in 
panel B. Arrowhead in D shows tissue thickening. Scale bar represents 100 μm in (A-B), and 10 μm 
in (C-D). 
We repeatedly observed significant thickening and disorganization in the labyrinthine zone, 
distension and disarrangements of perivascular space (Figure 21D), as well as presence of 
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parasitized red blood cells in the maternal blood space (Figure 22A). Hemozoin, the malaria 
pigment, was observed in most of the infected placentas (Figure 22B). Fetal blood circulation 
often contains larger amount of erythroblasts (Figure 22D) but they never presented any sign 
of parasites or hemozoin.  
 
Figure 22. Placental malaria features. HE stained placentas from BALB/c females infected with 
P. berghei and collected at G18. (A) Image from severely infected placenta with high number of 
parasitized maternal erythrocytes. (B) The same field as (A) under polarization microscopy 
revealing hemozoin. (C) Arrow and insert show an infected erythrocyte adhered to the 
syncytiotrophoblast layer. (D) Placental section with infected erythrocytes in the maternal blood 
and fetal erythroblasts (arrow). Scale bar represents 30 μm in (A, B and D) and 20 μm in (C). 
 
Some specimens show focal fibrinoid necrosis in the placenta basal zone (Figure 21B), 
hyperplasia of syncytiotrophoblastic cells (Figure 21D) and accumulation of mononuclear cells 
in the maternal blood space as revealed by immunofluorescence staining (Figure 23A). The 
accumulation of CD11b expressing cells, suggested that the infiltrate was predominantly 
composed by monocytes/macrophages. This result prompted us to measure the expression of 
macrophages attracting chemokines MIP-1α and MCP-1 in the placenta. RNA quantification 
revealed that MIP-1α gene expression was significantly increased in the infected placenta 
(Figure 23B) providing support for the notion that cell and molecular components of the innate 
immune system participate in the host response to the placenta malaria infection. 
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Figure 23. Inflammatory infiltration and macrophage/monocyte attractant chemokine expression 
in malaria infected placenta. (A) Immunohistochemistry analysis of placentas from BALB/c females 
infected on G13 with P. berghei-GFP iRBC and collected at G18 that were stained with anti-GFP 
(green) and anti-CD11b (red) revealing the presence of parasites on vascular walls and 
monocytes/macrophages infiltration, respectively. The (B) panel represents sections of non infected 
placentas. The cell nuclei were stained with DAPI (blue). Scale bar represents 30 μm. (C) RNA 
expression of MIP-1α and MCP-1 genes was quantified in 30 infected and 8 uninfected BALB/c 
placentas collected on G18. Relative quantification was obtained by normalization for GAPDH 
expression. Each bar represents the mean ± s.e.m. of individual values. P-value = 0.0002 is 
represented by ***. 
• Placental vascular space reduction 
The alterations in tissue organization observed in the infected placenta suggested that the 
maternal blood flow could be reduced in pregnancy malaria. Thus, we used a computerized 
morphometric method to quantify cross-sectional areas of blood sinusoids in placental 
labyrinthine region. Morphometric analysis was performed as described in methods section 
and confirmed that the blood sinusoids areas differed significantly between infected and non-
infected placentas. The average blood sinusoid area was 52.0 ± 4.0 (mean ± SD, arbitrary units) 
in the control group and it dropped to 34.7 ± 7.5 in the infected pregnant group (Figure 24). 
The blood sinusoids area was measured in five different regions of the labyrinthine zone and in 
all of them the area decreased in similar degree, indicating that this phenomenon is spread 
across the placenta rather than restricted to specific areas.  
C 
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Figure 24. Reduction of placental vascular space in infected pregnant mice. The available area 
for blood circulation at G18 is reduced in infected placentas (lower photo) in comparison with 
non-infected placentas (upper photo). Scale bar represents 25 µm. The placental area occupied 
by blood sinusoids was quantified in relation to the total placental area (plot) in non-infected 
and infected placentas using an automated morphometric procedure, as described in 
Methodology section (P – value < 0.001). 
 
Together, the data suggest that alterations of pregnancy outcomes observed in mice infected 
with P. berghei-GFP correlate with pathological alterations of the placenta tissue, involving 
inflammation, tissue disorganization, reduction of vascular spaces and consequent reduction in 
blood supply. 
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EXPOSURE PRIOR PREGNANCY  
The aim of this model was to establish and analyze a system recapitulating the specificities of 
PAM protection observed in women with premunition and allowing investigations on the host 
and parasite components of PAM protection. Non-pregnant women living in regions with 
intense malaria transmission typically display a good protection against clinical malaria, but 
when they become pregnant this scenario of resistance likely changes.  
Malaria outcome in multigravida pre-exposed females 
• Pregnancy-induced malaria recrudescence  
In total, more than one hundred female mice, distributed by several experiments, were 
infected with P. berghei-parasitized red blood cells and subsequently treated with chloroquine. 
These mice typically showed a transient parasitemia peak, which eventually resolved (see 
Figure 15). In the absence of pregnancy, parasitemia remained essentially sub-patent and was 
never observed for the rest of lifespan (Figure 25, upper graph). In contrast, parasite 
recrudescence was frequently observed when malaria-treated females become pregnant 
(Figure 25, under graph), more often after gestation day 14 (G14) but never before G12. We 
followed the first pregnancy of eighty-four pre-exposed females and found out that forty-nine 
(58%) showed parasite recrudescence induced by pregnancy. Twenty-nine recrudescent 
females were followed to the end of pregnancy and we observed uncontrolled parasitemia 
leading to severe malaria and eventually to maternal death in nine of those females (31%), 
while the remaining controlled the parasitemia peak and were apparently cured. These results 
confirm the hypothesis that sub-patent P. berghei infection is exacerbated by pregnancy. 
 
 
Figure 25. Malaria susceptibility is increased during pregnancy. Representative parasitemia curves 
of BALB/c females infected with P.berghei (day 0) and treated with chloroquine for 3 days starting at 
day 7. Parasitemias of females maintained without male (non-pregnant) are represented in the 
upper plot. The lower plot shows 5 typical parasitemia curves of recrudescent primigravida.  
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We investigated whether pregnancy related factors such as reticulocytosis, hormonal balance 
and imnunosuppression could per se trigger malaria recrudescence in pregnancy. 
Reticulocytosis is very frequent during pregnancy and it has been described that P. berghei 
preferentially infects reticulocytes (Cromer et al., 2006). To ascertain if reticulocytosis could 
elicit parasite recrudescence, reticulocytes production was stimulated using phenylhydrazine. 
Phenylhydrazine is an oxidant drug that destroys RBC by denaturation of hemoglobin with little 
evidence of toxicity to other tissues. Consequently, the treatment induces a sudden 
erythropenia followed by an increase in erythropoiesis, as evidenced by the increased number 
of reticulocytes into the blood circulation (Flanagan & Lessler, 1970). This treatment is 
commonly used to increase P. berghei parasitemia level in mice due to its preference by 
reticulocytes. We treat seven pre-exposed and two non-infected females with phenylhydrazine 
(2.5 mg/20 g of body weight, i.p. in one single dose) which were monitored during the 
subsequent month. The treatment evoked extensive reticulocytosis that persisted for eight 
days and weight loss was evident in the immediate subsequent days (Figure 26), without a 
single parasite observation in the peripheral blood. Reticulocytes were depicted in Giemsa 
blood smears as showing stained granules. All the mice were able to recover the weight loss.  
 
Figure 26. Effect of phenylhydrazine treatment in pre-
exposed mice. Phenylhydrazine treatment (at day 0) 
provoked reticulocytosis in six pre-exposed females 
treated. Blood smears and weight were monitored to 
identify any detrimental effect of the drug. No parasite 
was found in the blood but an exuberant presence of 
reticulocytes was observed immediately after the drug 
administration. The weight of the treated pre-exposed 
females suffers a decrease on the days following the drug 
administration but it was recovered (dashed line, mean ± 
s.e.m.). Continuous line corresponds to the weight 
fluctuation of a naïve female not treated.  
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The mice treated with phenylhydrazine were challenged three weeks later with P. berghei and 
also more than four months after the treatment, controlling the parasitemia, which reveals 
that protection was still active. However, we cannot guarantee that the phenylhydrazine 
treatment is not toxic for the parasite, since none of the treated females that become 
pregnant revealed pregnancy-associated recrudescence. Collectively, these results cannot 
exclude that reticulocytosis has an effect on eliciting parasite recrudescence during pregnancy. 
On the other hand, hormonal immunoregulation occurring in pregnancy induces a level of 
immunosuppression that was suggested to be implicated in the higher malaria susceptibility 
during pregnancy in humans (Vleugels et al., 1989) and also in animal models (van Zon et al., 
1982). We made use of P. berghei pre-exposed females to test this possibility in two ways. 
First, we mimicked the pregnancy hormonal balance in malaria pre-exposed females through 
inducing pseudo-pregnancy by mating them with vasectomized males during 30 days. We did 
not detect any parasite recrudescence after mating in any of the females that exhibit vaginal 
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plug. However, when the same females became pregnant after mating with normal males, ten 
out of fifteen (60%) showed recrudescence (data not shown). It is possible that the hormonal 
modifications in pseudo-pregnant females, although sufficient to sustain embryonic 
development in embryonic transfers, were inadequate to induce immunosuppression and 
therefore we further tested whether a direct immunosuppressive treatment would evoke 
parasite recrudescence (Alvarez et al., 1991). Thus, a group of pre-exposed females was 
treated with a single dose of cyclophosphamide (200 mg/Kg of body weight, i.p.) and was 
monitored for parasitemia in the following two weeks, but again no recrudescence was 
detected (data not shown). These results do not discard that pregnancy-induced 
immunosuppression could play a role in the breakdown of malaria protection but they strongly 
suggest that other mechanisms are implicated in malaria recrudescence during pregnancy and 
suggest that as the placenta is absent in pseudo-pregnant females it could play a role in 
inducing parasite recrudescence in pregnancy. 
 
• Disease severity and pregnancy-induced recrudescence are reduced in multigravida 
Analysis focused on recrudescent females revealed that maternal mortality associated to 
recrudescence decreases with parity (Figure 27) suggesting a decrease in disease severity. 
Conversely, we noted that among non-recrudescent females, irrespective of parity, about ten 
percent died during pregnancy or shortly after delivery.  
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Figure 27. Exposure to pregnancy-induced 
recrudescent parasites reduces maternal 
mortality in subsequent pregnancies. 
Maternal mortality rate is plotted according to 
parity and recrudescence occurrence.  
 
 
To test whether pregnant females were able to develop PAM protection upon exposure to the 
recrudescent parasite, we followed up the fate of thirty-two primigravida in subsequent 
pregnancies. The pregnancy-induced peripheral parasitemia peak was graded as high 
recrudescence, if higher than 5%, and as patency if between 1% and 5 %. The pregnant 
females with less than 1% of iRBC as detected by FACS analysis were declared non-
recrudescent. We found that the aggregate incidence of high recrudescence and patency 
significantly decays from the first (59%) to the second (41%) and third pregnancy (22%) 
(Figure 28A). The reduced incidence of cases with high pregnancy parasitemia peaks (more 
than 5% of iRBC) was particularly striking and close to a four-fold reduction from the first (44%) 
to the second pregnancy (12%). Accordingly, the level of parasitemia also decreased 
significantly when comparing first (14.5 % ± 19.2 %), second (3.9 % ± 9.4 %) and third 
pregnancy (2.0 % ± 4.1 %) (Figure 28B).  
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Figure 28. Recrudescence incidence and 
peripheral parasitemia are decreased in 
multigravida. (A) Frequency of females with 
high recrudescence (above 5% parasitemia), 
patency (parasitemia between 1% and 5%) and 
no recrudescence (parasitemia < 1%) according 
to parity. Recrudescence incidence is 
significantly associated with parity (P-value = 
0.001, Chi-square test). (B) Box-plots illustrate 
the range of the peripheral parasitemia peak 
according to parity. The parasitemia peak in the 
first pregnancy was significantly different from 
the second (P-value = 0.004) and third 
pregnancies (P-value = 0.006). Box-plots show 
medians (middle line in the box), central 50% of 
data (box), data range (whiskers) and 
0
 and * 
represent outliers and extremes, respectively. 
 
These results indicate that females that are repeatedly exposed to recrudescent parasites 
during pregnancy develop a protective response that tends to control parasite recrudescence 
and placental malaria during subsequent pregnancies.  
PAM protection in multigravida is not attributable to the age of the pregnant females as we 
observed that pregnancy-induced recrudescence incidence in primigravida was not reduced at 
older ages. In particular, females infected under 20 weeks of age presented about 55% of 
recrudescence and in the group of older females, with more than 20 weeks of age, the 
recrudescence was about 65%. Furthermore, pregnancy-induced recrudescence seems to be 
uncorrelated with the period between infection and the first pregnancy, since we were able to 
observe primigravida recrudescence 40 weeks after infection. These data suggest that both the 
age of the mother and the duration of subpatent parasitemia are not determining factors in 
triggering parasite recrudescence or in malaria protection in multigravida. 
• Susceptibility to pregnancy-induced anemia in pre-exposed mice is associated with 
parasite recrudescence  
Malaria-induced anemia in pregnancy is a major concern in endemic regions. Our data support 
the idea that hemoglobin levels are strongly correlated with parasite density in the peripheral 
blood. We observed that hemoglobin levels decrease with parasitemia rise, both in infected or 
challenged mice (Figure 29A and 29B). In the last case, hemoglobin levels recover after 
parasite clearance. Corresponding correlations were observed with respect to levels of 
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parasitemia and hemoglobin concentration (Figure 29C), both in infected or challenged mice. 
Of note is the fact that infecting naïve mice induces faster hemoglobin decay than in 
challenged mice, as indicated by the respective correlation slopes, - 0.253 and - 0.217. Besides, 
we observed that both P. berghei pre-exposure and pregnancy-associated P. berghei 
recrudescence caused a significant reduction in hemoglobin levels (Figure 29D) in comparison 
with non-exposed and non-recrudescent pregnant females (P-value < 0.001).  
Taken together, these results confirm that P. berghei parasitemia adversely affects hemoglobin 
levels and, consequently, maternal anemia is a likely clinical complication of parasite 
recrudescence during pregnancy. Still, maternal acquired and cumulative immunity reduces 
recrudescent parasitemias, thereby partially protecting the pregnant mice from death by 
severe anemia. 
Offspring of multigravida pre-exposed females 
• Poor pregnancy outcome is associated with pregnancy-induced malaria recrudescence 
but convalesces in multigravida  
To evaluate the effect of pregnancy-induced parasite recrudescence in the pregnancy outcome 
we monitored the offspring of recrudescent females. The twenty-nine recrudescent 
primigravida had significantly smaller litter sizes (average of 1.9 newborns/litter) as compared 
to twenty non-infected females (5.9 newborns/litter in average) (Table 4). Likewise, the 
average birth weight of newborns from recrudescent mothers (1.1 g) was significantly lower 
when compared to the newborns from non-infected mothers (1.4 g). These findings indicate 
that recrudescent primigravida females show poor pregnancy outcome that is characterized by 
decreased fetal viability and intra-uterine growth retardation. 
Table 4. Disease severity and pregnancy outcome in P.berghei recrudescent females according to parity 
Parity 
Pregnant 
females 
Average parasitemia 
peak (%) 
Maternal 
mortality (%) 
Litter size a 
Newborns Birth 
weight (g) a 
Primigravida 29 22.7 31 1.9 ± 3.0 (29) 1.1 ± 0.2 (6) 
Second Pregnancy 9 10.7 20 5.6 ± 2.1  (9) 1.3 ± 0.2 (7) 
Third Pregnancy 3 3.4 0 6.7 ± 1.2 (3) 1.3 ± 0.1 (3) 
Non-Infected 20 ___ 0 5.9 ± 2.2 (20) 1.4 ± 0.2 (20) 
a
 Mean ± stdev (number of litters analyzed) 
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Figure 29. Hemoglobinemia is strongly correlated with parasitemia. Peripheral blood hemoglobin and parasitemia 
were followed after infection in eight naïve BALB/c females (A) and after challenge in seven pre-exposed (B). In (C) 
scatter plot of parasitemia versus hemoglobin with adjusted linear curves for each group of mice: naïve infected (r
2
 
= 0.718, P-value < 0.0001, 31 observations) and pre-exposed challenged collected during the parasitemia peak (r
2
 = 
0.418, P-value = 0.0003, 27 observations). Hemoglobinemia is represented in (D) for different groups of females. 
The first three boxes correspond to non-pregnant females: uninfected females (UF), pre-exposed never-pregnant 
(ENP), pre-exposed pregnant-before (EPB); the others correspond to pregnant females: uninfected pregnant 
females (UP), pre-exposed pregnant females with no recrudescence (EPNR), pre-exposed pregnant females with 
recrudescence (EPR). In pregnant mice hemoglobin was measured between G18 and delivery. Box-plots (D) show 
medians (middle line in the box), central 50% of data (box), data range (whiskers) and outliers (dots). The number of 
mice (n) per group is indicated. (***, P-value < 0.001). 
 
• Poor pregnancy outcome is associated with pregnancy-induced malaria recrudescence 
but convalesces in multigravida  
To evaluate the effect of pregnancy-induced parasite recrudescence in the pregnancy outcome 
we monitored the offspring of recrudescent females. The twenty-nine recrudescent 
primigravida had significantly smaller litter sizes (average of 1.9 newborns/litter) as compared 
to twenty non-infected females (5.9 newborns/litter in average) (Table 4). Likewise, the 
average birth weight of newborns from recrudescent mothers (1.1 g) was significantly lower 
when compared to the newborns from non-infected mothers (1.4 g). These findings indicate 
that recrudescent primigravida females show poor pregnancy outcome that is characterized by 
decreased fetal viability and intra-uterine growth retardation. 
 
 
*** 
*** *** 
*** 
Exposure Prior Pregnancy 
71 
 
Table 4. Disease severity and pregnancy outcome in P.berghei recrudescent females according to parity 
Parity 
Pregnant 
females 
Average parasitemia 
peak (%) 
Maternal 
mortality (%) 
Litter size a 
Newborns Birth 
weight (g) a 
Primigravida 29 22.7 31 1.9 ± 3.0 (29) 1.1 ± 0.2 (6) 
Second Pregnancy 9 10.7 20 5.6 ± 2.1  (9) 1.3 ± 0.2 (7) 
Third Pregnancy 3 3.4 0 6.7 ± 1.2 (3) 1.3 ± 0.1 (3) 
Non-Infected 20 ___ 0 5.9 ± 2.2 (20) 1.4 ± 0.2 (20) 
a
 Mean ± stdev (number of litters analyzed) 
The litter size and the newborn birth weight were lower in the first pregnancy but recovered 
and approximated normal levels in subsequent pregnancies (Figure 30). 
  
Figure 30. Reduced adverse pregnancy outcomes in multigravida. Box-plots of the average litter 
size (left) and average newborn birth weight (right) according to parity (first, second and third 
pregnancy). Pregnancy outcome was significantly different in primigravida as compared to 
multigravida and non-infected pregnant females (***, P-value < 0.001; **, P-value < 0.01; *, P-value 
< 0.05). 
 
• Progeny costs in absence of Maternal Recrudescence 
Progeny derived from non-recrudescent pregnant females, irrespective of parity, displayed a 
litter size below normal levels, even though the mean birth weight appears not to be affected 
(Table 5). This data indicate that in absence of peripheral parasitemia, pre-exposed pregnant 
females may display a degree of placental malaria leading to a slight but significant loss of 
fetuses. 
Table 5. Disease severity and pregnancy outcome in non-recrudescent females according to parity 
Parity 
Pregnant 
females 
Maternal mortality (%) Litter size 
a
 
Newborns Birth 
weight (g) 
a
 
Primigravida 22 12 3.2 ± 3.3 (22) 1.4 ± 0.2 (2) 
Second Pregnancy 10 11 3.8 ± 2.4  (10) 1.4 ± 0.3 (4) 
Third Pregnancy 13 8 3.5 ± 0.2 (13) 1.5 ± 0.7 (6) 
Non-Infected 20 0 5.9 ± 2.2 (20)  1.4 ± 0.2 (20) 
a
 Mean ± stdev (number of litters analyzed) 
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Effects of maternal pre-exposure on placental immunopathology 
• Parasitemia recrudescence correlates with placenta pathology 
The poor pregnancy outcome in females infected during pregnancy is associated with a 
placental inflammatory response that leads to marked tissue disorganization, and the presence 
of maternal iRBC at different stages of maturation in the placenta. In recrudescent 
primigravida the intensity of peripheral parasitemia was quantitatively correlated with the 
reduction of the placental vascular spaces (P-value = 0.0012) (Figure 31A).  
 
Figure 31. Peripheral parasitemia correlates with the reduction of placental blood sinusoids area. (A) The 
blood sinusoidal area is plotted against the peripheral parasitemia peak observed in primigravida. The area of 
placental blood sinusoids, expressed as a fraction of the total placental area, was obtained using an automated 
morphometric procedure as described in the Methodology section. In recrudescent females, the degree of 
parasitemia was correlated with sinusoidal area reduction (correlation coefficient for recrudescent females is 
0.45, P-value = 0.0012). Representative photomicrograph of placental sections HE stained from non-infected (B) 
and recrudescent (C-D) mothers. Accumulation of inflammatory cells (C), trophoblast thickening (arrows) and 
presence of iRBC (D) in blood sinusoids (arrowheads) are evidenced in placenta tissue from recrudescent 
mothers. Scale bars represent 15 μm in (B-D). 
 
In particular, recrudescent females with high parasitemia showed an increased reduction of 
vascular spaces. These results strongly suggest that malaria recrudescence correlates with 
placental tissue damage (Figure 31C and 31D) that possibly underlies the observed poor 
pregnancy outcomes. In addition, the expression analysis of cell-type specific genes in 
placentas from females with recrudescence, revealed increased amounts of inflammatory 
cells, particularly natural killer (NK) cells, T cells and macrophages (Figure 32A) and up-
regulation of macrophages attractant chemokines (MCP-1 and MIP-1α) (Figure 32B).  
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We also found that the expression of several molecules related to vascular stress, namely 
hemoxygenase-1 (HO-1) and endothelin-1 (ET-1), was increased in placentas of recrudescent 
females (Figure 32D). TNF-α expression showed a trend to increase in infected placentas and 
the balance of the immuno-modulatory molecules IL-12 and IL-10 expression denoted an anti-
inflammatory response in the course of the placenta malaria pathogenesis (Figure 32C). In fact, 
IL-10 expression was mostly increased in placentas where pathology was more intense (Figure 
32E). 
 
Figure 32. Placenta pathology is associated with altered gene expression of inflammation markers. 
qRT-PCR of placenta tissue was used to detect the expression of cell type–specific genes indicating 
infiltration of inflammatory cells: Klrd1 gene for Natural Killer cells, Cd3e gene for T cells, Ncf2 gene 
for neutrophils and Mgl2 for macrophages (A). Placental gene expression was quantified for relevant 
markers of monocyte/macrophage chemotaxy (B), inflammation mediators (C) and vascular stress 
(D). RNA expression was quantified in 15 placentas from recrudescent primiparous BALB/c females 
and in 8 uninfected placentas, collected on G19. In (E) placental IL10 mRNA expression was 
separately analyzed in 5 placentas showing moderate pathology (+) and 4 placentas showing severe 
(++) pathology. Relative quantification was obtained with normalization by ß-actin for (A), (C), (D) 
and (E) and by GAPDH for (B). In (E) results are plotted as fold change over the respective non-
infected controls. Each bar represents the mean ± s.e.m. (*, P-value < 0.05).  
 
It is worth noting that, regardless the number of previous pregnancies, the placentas from 
recrudescent females typically showed iRBC in the maternal blood spaces, inflammatory 
infiltrates, erythroblast accumulation in the fetal blood, placenta architecture disruption and 
trophoblast basal membrane thickening. Together these data suggest that placental malaria is 
an inflammatory syndrome likely driven by parasite expansion and accumulation in the 
placental blood spaces. 
 
• Modified levels of cytokines in sera  
The type of cytokines response may modulate the effective immune response and can have a 
role in tailoring the pregnancy outcome. Using a Cytokine Beads Array we intended to capture 
in several animal groups, variations in serum levels of IL-6 as well as IL-4 and IL-10 that are 
typically involved in B cell activation and anti-inflammatory responses (Figure 33).  
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Figure 33. Cytokines evaluation. IL-4, IL-6 and IL-10 cytokines levels in various groups of malaria 
infected mice. Using the Cytokine Bead Assay technique the cytokines were measured in sera from 
individual mice either non-pregnant in the indicated conditions or at G18 of pregnancy.  
IL-10 higher levels are consistently associated with the presence of parasites probably as part 
of a response to compensate the exacerbated inflammation elicited by the active infection 
(Figure 33, upper graph). Among the pre-exposed pregnant, the recrudescent with 
unsuccessful pregnancy show higher IL-10 levels, whereas the recrudescent that succeed in 
delivering offspring only manifest a slight increase. These results are concordant with the 
overexpression of IL-10 in the placenta (Figure 32). IL-4 levels have a more heterogeneous 
pattern but a common characteristic is that all the pre-exposed females are more likely to have 
increased levels of this cytokine, independently of the presence of the parasite (Figure 33, 
middle graph). This corroborates with the fact that IL-4 is associated with the control of the 
disease in later phases by providing B cell help on the generation of specific IgG antibodies 
(Malaguarnera & Musumeci, 2002). IL-6 is a cytokine that can have both a pro-inflammatory 
and anti-inflammatory role, and like IL-1 and TNF-α, is involved in the induction of fever and 
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the acute phase response (Robinson et al., 2009). High levels of this cytokine may compromise 
pregnancy success (Margni & Zenclussen, 2001). Interestingly, increased levels of this cytokine 
were observed in unsuccessful cases of pregnancy (Figure 33, lower graph). These results 
suggest that IL-10 and IL-6 in sera of pregnant females with malaria are associated with poor 
pregnancy outcomes.  
• Sporadic placental parasites are associated with pathologic events in non-recrudescent 
mothers and adverse pregnancy outcomes 
The analysis of non-recrudescent placentas in some cases revealed the presence of iRBC and 
tissue lesions resembling the pathology observed in recrudescent females (Figure 34). We 
quantified P. berghei parasites by qRT-PCR in 24 placentas from six non-recrudescent mice, 
and observed very small amount of parasites of about seventeen-fold less in average as 
compared to placentas from recrudescent mice (data not shown). Since it is possible that small 
parasite numbers are circulating in the peripheral blood of non-recrudescent mothers, we 
carried out an isodiagnosis test in a group of non-recrudescent pregnant females, by injecting 
a blood drop diluted in PBS in naïve animals and observing the parasitemia occurrence. Among 
the 14 non-recrudescent pregnant females tested, 7 had positive isodiagnosis, meaning that 
the parasite was present in the blood. These data suggest that albeit at low frequency, 
placental malaria occurs in absence of detectable peripheral parasitemia recrudescence.  
 
 
Figure 34. Occasional placenta pathology in non-recrudescent pregnant females. 
Photomicrographs of HE-stained placental sections of sporadic cases of placental pathology in non-
recrudescent females. The figure shows presence of iRBC adhered to the syncytiotrophoblast layer 
(A, insert) and in blood sinusoids (arrowheads) as well as trophoblast thickening (arrow). Scale bar 
represents 15 µm. 
 
Together, the data suggest that pregnancy-associated malaria evoked by recrudescent 
P. berghei is attributable to parasites, which on one hand are able to trigger an inflammatory 
response of the placental tissue and, on the other hand, induce a cumulative protective 
response in multigravida that had experienced recurrent infection relapses induced by 
pregnancy. 
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PARASITE AND PLACENTA INTERACTION 
iRBC binding to placental sections  
In histological observations it is common to find iRBC attached to syncytiotrophoblast or in the 
labyrinth vascular space of placentas both from pregnant females infected during pregnancy 
and recrudescent females (Figure 35). To characterize the nature of the interaction of the 
P. berghei-iRBC and mouse placenta tissue, we investigated the role of receptors that have 
been suggested to mediate P. falciparum cytoadhesion and sequestration to the human 
placenta. 
 
Figure 35. Placental section of a recrudescent pregnant female. Of 
note, iRBC on syncytiotrophoblast surface and in the IVS (arrows). 
Erythroblasts and tissue thickening are also evident. Pre-exposed 
pregnant female with 29% of recrudescence. 
Parasite molecules that likely mediate the interaction parasite-placental are surface 
membrane proteins expressed by mature iRBC, the trophozoites and schizonts. Thus, for the 
adhesion/inhibition assays, we used P. berghei-iRBC preparations that were enriched for 
mature forms of parasites prepared by selection, after parasite synchronization (Figure 36), as 
described in the Methodology section.  
With the aim of demonstrating that adhesion properties of iRBC were dependent on the 
presence of surface proteins, we pre-treated iRBC with two proteolytic enzymes (trypsin and 
proteinase K) and a non-proteolic enzyme (neuraminidase). Proteolitic depletion of iRBC 
surface proteins showed to reduce adhesion capacity to placental sections in a concentration-
dependent manner (Figure 37). 
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Figure 36. Synchronization of blood stage parasites and schizonts enrichment. Blood stage parasites were 
incubated to develop into mature forms as described in the methodology section. In (A) a thin blood smear Giemsa-
stained from a recrudescent pregnant female with 20% parasitemia. Of note is the presence of 
polymorphonucleated cells and echinocytes (modified RBC with small knob-like surface projections evenly spaced 
and uniform in shape that are poorly deformable and usually impart high viscosity to the blood, interfering with 
capillary blood flow; the mechanisms of echinocytes formation are diverse but include erythrocytes dehydration as 
a result of electrolyte imbalance; these RBC were frequently observed in blood smears from infected animals). After 
16 h of synchronization, blood stage parasites have developed essentially into mature forms, trophozoites and 
schizonts (B). By a gradient selection it is possible to separate the cultured cell essentially in two groups: one group 
(found in the pellet) formed mainly by non infected RBC and free merozoites (C) and the other group (obtained in 
the ring on the gradient), formed mostly by blood stage mature forms (D), usually enriched in more than 90% of 
iRBC. Inset (D) showing a mature schizont with differentiated merozoites.  
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Figure 37. Protein-like molecules have a role in 
iRBC-placenta interaction. Intact iRBC were 
treated with neuraminidase, proteinase K and 
trypsin prior incubation with the placental 
tissue. All data represent the proportion of 
bound iRBC expressed as a percentage of 
control (mean ± s.e.m. for three experiments).  
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Candidate placental receptors modulate iRBC adhesion  
We analyzed the involvement of two placental candidate mediators of iRBC binding, chosen on 
the basis of human trials. The first one is a generally accepted receptor for parasites 
sequestration in human placentas (CSA), whereas the second (HA) is a controversial candidate. 
Our results showed evidence that CSA and HA are involved in specific interactions of 
P. berghei-GFP iRBC of non-placental origin with the placental tissue (Figure 38). In fact, iRBC 
adherence was significantly reduced if parasite mature forms were previously incubated with 
CSA (Figure 38B) or HA (Figure 38C). 
   
Figure 38. Ex vivo adhesion of P. berghei-GFP iRBC to mouse placenta. (A) Typical microscopic 
image of adhesion assays showing iRBC adhered in the intervillous space and to 
syncytiotrophoblast cell layer (A). Representative images of blocking adherence assays where 
iRBC were pre-incubated with 2 mg/ml of CSA (B) or HA (C). 
Adhesion was competitively inhibited in a dose-dependent fashion by both CSA (69% reduction 
at 1mg/ml) and HA (80% reduction at 1mg/ml), but not with colominic acid (Figure 39, upper 
graph). In addition, iRBC adhesion also registered a significant reduction on tissue sections pre-
treated with chondroitinase (66% reduction) or hyaluronidase (74% reduction), but heparinase 
had no effect on the iRBC adhesion (Figure 39, lower graph).  
 
 
Figure39. Adhesion-inhibition assays regarding 
CSA and HA as candidate receptors. IRBC were 
pre-incubated with increasing concentrations of 
HA, CSA and colominic acid and then used in 
binding assays (upper graph) as described in 
Methodology section. Adhesion of iRBC to 
uninfected placental tissue was partially abolished 
by pretreatment of the placental sections with 
chondroitinase and hyaluronidase but not with 
heparinase (lower graph). All data represent the 
proportion of bound iRBC expressed as a 
percentage of control (non-preincubated iRBC or 
non-treated placentas, in upper and lower plots, 
respectively). Points and bars represent mean ± 
s.e.m. for three experiments. (***, P-value < 
0.001). 
These findings strongly suggested that CSA and HA in the mouse placental tissue participate in 
adhesion of iRBC, since P. berghei iRBC adhesion is partially dependent on the presence of CSA 
and HA receptors in the placenta and is inhibited by blocking their putative ligands in 
P. berghei-GFP iRBC or after their cleavage on the placentas.  
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Pregnancy-induced recrudescent P. berghei show enhanced affinity to placenta  
iRBC sequestration appears to be the pathogenic trigger of the placenta pathology observed in 
pregnant women. In the previous section, we have shown that P. berghei iRBC from non-
pregnancy origin has the ability to specifically adhere to the mouse placenta tissue. To 
evaluate the adhesion properties of the recrudescent P. berghei we performed adhesion 
assays on placental sections, that compared the adhesion properties of iRBC collected from 
recrudescent primiparous females with iRBC isolated from infected males and non-pregnant 
females. Strikingly, the amount of iRBC adhering to the placenta sections was four-fold 
increased in the samples from recrudescent primigravida (Figure 40A). The adhesion of the 
recrudescent parasite was also partially inhibited when the placental sections were treated 
with chondroitinase (70%) or hyaluronidase (43%), as well as when the iRBC were pre-
incubated with CSA (56%) or HA (76%) (Figure 40B).  
 
 
 
Figure 40. P. berghei iRBC from recrudescent 
females show enhanced adhesion to placenta. 
(A) iRBC from males, non-pregnant females and 
recrudescent females were incubated on 
uninfected placental sections and the adherent 
parasitized cells were counted as described in 
methodology section. (B, upper plot) Adhesion 
assays were also performed after pre-treatment 
of placental sections with chondroitinase ABC, 
hyaluronidase or heparinase (negative control). 
(B, lower plot) Adhesion inhibition assays were 
carried out by pre-incubating iRBC from 
recrudescent females with 1 mg/ml 
concentrations of HA, CSA or CA (negative 
control). In panel B the proportion of bound iRBC 
is expressed as a percentage of the control (non-
treated placentas or non-preincubated iRBC, in 
upper and lower plots, respectively). Error bars 
represent the mean ± s.e.m. of three independent 
experiments. (***, P-value < 0.001). 
 
These results suggest that the recrudescent P. berghei expanding during pregnancy display 
enhanced specificity to the placenta and consequently may induce a specific host response to 
the pregnancy-associated parasite, namely the triggering of placenta pathology events 
associated to PAM. Additionally, our data on mouse PAM indicate that both CSA and HA might 
be candidate mediators for recrudescent parasite adhesion to the placenta. Further 
methodologies to study binding of recrudescent parasites in vivo would have to be applied to 
certify the candidacy of these receptors. Moreover, research is needed to determine the GAGs 
composition on mouse placenta, namely of the chondroitin family, the presence of HA and 
their distribution within the placenta vascular spaces throughout the course of pregnancy.  
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ACQUIRED IMMUNITY IN PRE-EXPOSED FEMALES  
Anti-P. berghei antibody response in pre-exposed females 
We investigated the involvement of components of the acquired immune system in pre-
exposed pregnant females and the persistence of the anti-P. berghei antibody response. We 
were interested in understanding if there is any association between the higher susceptibility 
to malaria in primigravida and the level of specific immunoglobulins. 
• Adaptive immunity appears crucial for malaria control  
It has been reported that mice lacking adaptive immune system cannot clear the malaria 
infection (Couper et al., 2007; Nunes et al., 2009) and we have confirmed these findings. Thus, 
immunocompetent BALB/c infected with P.  berghei and treated with chloroquine are capable 
of controlling parasitemia while BALB/c RAG2 KO mice, which lack lymphocytes, die with 
hyperparasitemia (Figure 41) and are unable to control the disease even under chloroquine 
treatment. Infected BALB/c RAG2 KO mice respond to chloroquine treatment reducing the 
level of parasitemia but after a short period the parasitemia rises again and this sequence 
continues until the animal eventually dies.  
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Figure 41. Mice lacking B and T cells are unable to control malaria when chloroquine treated. Course of 
infection as measured by parasitemia is represented for BALB/c grouped mice (6 animals per group) and 
individual BALB/c RAG2 KO (7 animals) infected with P. berghei. Solid lines represent treated mice while 
dashed purple lines correspond to untreated animals. BALB/c mice were treated with chloroquine in the days 
indicated by the red arrows. Conversely, BALB/c RAG2 KO mice were treated with chloroquine in the days 
indicated by the blue arrows but all died without controlling the infection. Light blue lines correspond to 
females receiving early chloroquine treatment (indicated by the light blue arrows) while dark blue represents 
animals treated lately. Untreated BALB/c and BALB/c RAG2 KO (dashed purple lines) died with 
hyperparasitemia. Red lines correspond to BALB/c. Arrows indicate chloroquine treatment with colors 
matching animal lines.  
 
These results illustrate the requirement of an adaptive immune response to control P. berghei 
infection. Thus, we analyzed the course of the adaptive immune response in pre-exposed 
females by monitoring anti-parasite antibodies in the serum. The humoral response, as 
measured by anti-P. berghei IgG, starts around 2 weeks after infection (Figure 42). The anti-
P. berghei IgM production appears to start slightly earlier but overall follows the same kinetics 
as IgG.  
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Figure 42. Representative kinetics of anti-P. berghei IgG and IgM antibody production. IgG and IgM 
titers for a BALB/c female, infected on day 0, who further experienced two pregnancies and a 
challenge as indicated. Serum antibodies were measured by class-specific ELISA.  
Pre-exposed aparasitemic mice maintain a long term production of IgG (Figure 43) and can 
maintain IgG titers for their life time. What keeps this long-term response it is not known but it 
could be due to a persistent unapparent infection.  
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Figure 43. Long lasting IgG production in 
pre-exposed females. Anti - P. berghei 
IgG antibody production of BALB/c 
females infected on day 0, followed by 
chloroquine treatment (days 7-10 post 
infection). Antibodies were measured by 
IgG-specific ELISA in serum. 
 
 
 
Different lines of evidence suggest that long term subclinical infections are sustained in pre-
exposed mice. Isodiagnosis using organs of pre-exposed BALB/c allow to verify that the 
parasite can be “hidden” and hence causing a sub-patent infection. Briefly, several organs of 
eight pre-exposed animals were perfused or macerated and the collected material was 
separately injected in naïve animals. The materials originated from liver and lungs led to five 
positive isodiagnosis, the spleen and kidneys to three, the bone marrow to two and the fat and 
lymph nodes to one. Overall, isodiagnosis was positive for six out of eight pre-exposed animals. 
Furthermore, the isodiagnosis of blood from non-recrudescent pregnant females was positive 
for 7 out of 14 of the cases analyzed, with the period after infection ranging from 110 to 450 
days for the positive cases. In line with these findings we have observed that pre-exposed 
pregnant females can have parasite recrudescence a long time after being infected (more than 
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G18 
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30 weeks after infection, data not shown). These results indicate that parasites may persist for 
long periods in different organs of pre-exposed and protected mice, suggesting that these 
parasites provide the antigenic stimulation that sustains the immunological protective 
response. 
Acquired protection in pregnant females 
P. berghei pre-exposed mice that had not experienced pregnancy respond to parasite 
challenge (with 106 iRBC of non-pregnancy origin/animal, i.p.) with a parasitemia peak that 
typically rises up to 2-10% and eventually resolved (Figure 44). Conversely, pre-exposed 
females that have experienced a former pregnancy, with or without recrudescence, are likely 
to develop, upon challenge uncontrolled parasitemia with a high mortality rate (60%), dying 
normally up to two weeks after challenge. This outcome appears to be independent of the age 
and period of sub-patent infection. 
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Figure 44. Effect of pregnancy on the malaria 
protection status of pre-exposed females. Parasite 
challenge was used to test protection conferred by 
pre-exposure in non-pregnant nulliparous females 
(n=12) and non-pregnant females that formerly have 
experienced at least one pregnancy (n=10). Non pre-
exposed females (n= 5) died with hyperparasitemia 
up to day 25 after infection. Parasitemias of females 
after recovering were excluded. Data points and 
error bars represent average values and s.e.m., 
respectively. 
Following challenge of pre-exposed that did not experienced pregnancy, IgG production 
showed a slight increase but later suffered a reduction and maintained a steady state (Figure 
45A). Interestingly, the observed breakage of malaria protection in females that have 
experienced a pregnancy is paradoxically accompanied by a humoral response of anti-parasite 
antibodies that did not differ from the response of protected pre-exposed females (Figure 
45B). Within each group in Figure 45B (those that recovered and those that succumbed after 
challenge) it was not possible to establish a common previous history, since in both groups 
there were females with and without recrudescence and with different duration periods of 
sub-patent infection.   
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Figure 45. Influence of challenge on IgG production. Typical curves of anti-P. berghei IgG production after 
challenge on day 0 of six pre-exposed BALB/c females never pregnant before (A) and of seven females 
previously pregnant (B). On panel B dashed lines correspond to females that have succumbed after re-
infection. Antibodies were measured in serum by IgG-specific ELISA.  
 
Pre-exposed females previously pregnant challenged with non-pregnancy parasite during 
pregnancy showed poor control of parasitemia (Figure 44), and display a high mortality rate, 
regardless the slight increase in IgG production after challenge (data not shown). These data 
strongly suggest that pregnancy abrogates the malaria protection status conferred by pre-
exposure and induces a state of long term susceptibility to non-pregnancy-associated 
P. berghei.  
Anti-P. berghei antibody response in recrudescent females 
We investigated whether the anti-P. berghei antibody response correlated with parasite 
recrudescence during pregnancy. Analysis of P. berghei-specific IgG in multigravida showed 
that the titers of anti-P. berghei IgG antibodies in sera of pregnant females with recrudescence 
were significantly higher than from pregnant females without recrudescence, independently of 
parity (Figure 46). This suggests that emergence of recrudescent parasite during pregnancy 
elicits a strong specific-antibody response to pregnancy-associated parasite. 
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Figure 46. Anti–P. berghei IgG in serum samples from pregnant females grouped according to parity 
and recrudescence occurrence in pregnancy. Data are shown as medians (middle line in the box), 
central 50% of data (box), data range (whiskers) and outliers (ο). The number of mice per group is 
indicated (n). Antigen preparations used in the ELISA was obtained from iRBCs of recrudescent 
females. Significant differences observed between antibody titers of individuals with and without 
recrudescence in each parity (**, P-value < 0.01; *, P-value < 0.05).  
 
We next evaluated whether the immune response to malaria in pregnancy would favor 
particular IgG subclasses. Again, the antibody response was parity independent and was 
enhanced in presence of recrudescent parasite (Figure 47). IgG2a was significantly increased in 
sera from recrudescent pregnant females irrespective of parity, whereas IgG1 and IgG3 
response appeared to be more relevant in recrudescent primigravida. 
Figure 47. Anti-P. berghei IgG isotypes in serum samples from pregnant females grouped according to the parity and 
recrudescence occurrence in pregnancy. Data are shown as medians (middle line in the box), central 50% of data 
(box), data range (whiskers) and outliers (ο). The number of mice per group is indicated (n). Significant differences 
observed between antibody titers are indicated (*, P-value < 0.05).  
 
The IgG1/IgG2a ratios indicated a tendency for a relative increase in IgG2a, and thus towards a 
Th1 response, which appears to be more relevant in second pregnancies with recrudescence 
(Figure 48).   
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Figure 48. IgG1/IgG2a antibody ratios. IgG1/IgG2a ratios for pregnant females 
grouped according to the parity and recrudescence occurrence in pregnancy. Data is 
represented as in Figure 47. 
 
• Serum from P.berghei-immune mice does not confer protection against malaria in naïve 
individuals  
To investigate if malaria-specific antibodies elicited by PAM and non-PAM parasite cross-
protected against blood-stage malaria infection, we transferred immune serum from one 
immune male and one pre-exposed multigravida into naïve mice. As a control, a group of mice 
received non-immunized serum. On the day after, mice that received the serum were injected 
with 105 iRBC using a group of pre-exposed immune mice as a control. No difference was 
observed in the parasitemia curves of the naïve mice receiving serum and disease protection 
was not observed in any of the serum-recipient naïve mice (Figure 49). 
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Figure 49. Passive transfer of immune sera 
to naïve mice is not protective. Serum 
samples were collected either from non-
immune or immune mice (male and 
multigravida). Serum was injected i.p. into 
naïve BALB/c recipients (3 animals per 
group). On the day after passively immunized 
mice and pre-exposed mice were challenged 
with 10
5
 iRBC from an infected male and 
parasitemia was followed as indicated. 
While these results raise the possibility that serum transfer is not protective we cannot 
exclude that the observed lack of protection could be due insufficient antibody transfer. Four 
days after sera transfer, we detected low titers of specific-P. berghei IgG antibodies, in sera of 
three out of six recipient mice (data not shown). Future experiments using higher amounts of 
transferred antibody will be needed to test whether protection conferred by parasites 
recrudescing during pregnancy is specific to PAM or is also effective against blood stage 
infection in naïve mice.  
ο 
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DISCUSSION 
 
The proposed goals of this thesis were focused on mouse models of pregnancy-associated 
malaria (PAM). Firstly, comments will be tailored on both established models and on their 
validation by paralleling them with the human disease. Secondly, the few immunopathological 
contributions attained with those models will be described. Finally, the potential applications 
and future directions of using mouse models to study PAM will be highlighted.  
PAM MURINE MODELS  
The first aim of this work was to establish and validate mouse experimental systems that 
represent congruent models representation of human PAM. According to Desowitz (Desowitz, 
2001), an experimental model that represents malaria in pregnancy should comprise several 
attributes. Firstly, the maternal disease should show higher parasitemia and virulence as 
compared to non pregnant controls and reflect hematological changes, such as anemia. 
Secondly, the pregnancy outcome (offspring) should be affected by fetal abortions, low birth 
weight, impaired postnatal growth and/or reduced litter size. Finally, the placentas should 
manifest inflammatory/ histopathological defects and show reasonable pathogenesis 
congruency to human disease characteristics, including placental sequestration/cytoadherence 
phenomena.  
The mouse models established in this work appear consistent with the main features of the 
PAM disease seen in women and their attributes are discussed in the context of standard 
indicators of detrimental outcomes of malaria in human pregnancy, namely: 
• Mortality - maternal, fetal and infant (reflects the worst effects of malaria) 
• Intrauterine growth retardation, low birth weight (used as a proxy measure of infant 
mortality; epidemiological marker for the impact of malaria in pregnancy) 
• Peripheral parasitemias and placental parasites (used to detect malaria in pregnancy; it 
is recognized that peripheral parasitemias may remain below the level of microscopical 
detection while parasites are harbored in the placenta) 
• Placental histology (histological examination of the placenta provides one of the most 
sensitive indicators of maternal infection especially in women with high premunition) 
• Maternal anemia (important indicator to describe the impact of malaria in pregnancy) 
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 Maternal and Fetal Consequences 
In areas where malaria transmission is low or unstable, the levels of immunization are weak or 
inexistent and PAM clinical outcomes seem to be more severe for both to the mother and the 
fetus. The PAM experimental model here established, by infecting non-immune BALB/c mice 
during pregnancy, displayed enhanced disease severity and led to impaired fetal viability and 
post-natal growth. Thus, pregnant mice were more susceptible to P. berghei infection as they 
experienced faster increase in parasitemia and earlier death by hyperparasitemia as compared 
to non-pregnant mice. A significant proportion of the infected pregnant females most of the 
times abort or even die before parturition, without allowing the progeny observation (Table 2).  
The mechanism by which maternal malaria contributes to IUGR and LBW is not fully 
understood. In human PAM the increased P. falciparum parasite density in the placenta and in 
maternal peripheral blood at delivery, is frequently associated with infant anemia and, 
consequently, child development and survival are at risk (le Cessie et al., 2002; Brabin et al., 
2004a). Our experimental data showed a strong correlatyion between peripheral parasitemia 
and hemoglobin levels, both in pregnancy-induced recrudescence and in infected females. The 
infant risk of having low hemoglobin when birth weight was normal (> 2500 g) was greater in 
anemic mother than in non-anemic mothers. Moreover, infants born to anemic mothers have 
low iron stores, even when they are born at term with normal weight, and are more likely to 
develop anemia (De Pee et al., 2002). In addition, anemia, pathologic disorders may 
complicate oxygen delivery to the fetus by interfering with the intrinsic respiratory capacity of 
the placenta at any given gestational age (Salafia et al., 1995). Therefore, maternal anemia 
lead to insufficient in uterus hemoglobin/iron/oxygen availability, inducing a compensatory 
increase in the number of fetal circulating erythroblasts that we also observed in our 
experimental systems.  
Many common diseases of pregnancy, including recurrent early miscarriage, pre-eclampsia and 
eclampsia, are characterized by inflammation in the fetal-maternal interface and/or systemic 
manifestations. Hypertensive disorders in pregnancy are estimated to cause 10-15% of 
maternal deaths. Pre-eclampsia, a pregnancy-induced hypertension in association with 
significant amounts of protein in the urine (protenuria), is the most frequently reported 
disorder and is more common in primigravida, both in malarious and in non-malarious areas 
(Brabin & Johnson, 2005). The placenta is essential for the pathogenesis of pre-eclampsia and 
it appears that the secretion of inflammatory mediators can activate the placental vascular 
endothelium leading to increased levels of endothelial markers, many of which are 
vasoactivators and procoagulant promoters, resulting in microtrombi formation. This leads to a 
vascularization restriction and high-flow blood flow across placental villi, with consequences 
for the mother and the fetus (Brabin & Johnson, 2005). In placental malaria, the parasites can 
stimulate host inflammatory mediators that directly activate endothelial cells which can lead 
to maternal hypertensive disorders or pre-eclampsia. Reduced placental perfusion and loss of 
endothelial integrity are common features of placental malaria and pre-eclampsia. However an 
Discussion 
89 
 
important distinction between both conditions is the frequent accumulation of maternal 
leucocytes in placental malaria and its absence in exclusively pre-eclampsia. This issue has 
recently received more attention since there are evidences that pre-eclampsia and malaria can 
be associated (Duffy, 2007). In a study from Tanzania, placental malaria was associated with 
hypertension in young first-time mothers who present histological features of disease but not 
in older or multigravida women (Muehlenbachs et al., 2006). More longitudinal studies are 
needed to evaluate the interaction between placental malaria and pre-eclampsia. 
The pre-exposure model, in which the females were immunized before pregnancy, 
corresponds to a mouse model of pregnancy-induced parasite recrudescence that 
recapitulates epidemiological observations of PAM occurring in pre-immune women that live 
in regions with high-endemicity. There is solid epidemiological evidence from high-endemicity 
malaria regions that the incidence of PAM in women is parity-dependent (Rogerson et al., 
2007), since resistance to pregnancy malaria is acquired over successive pregnancies. In the 
pre-exposure PAM model we have found that disease incidence and severity decreased with 
parity. Furthermore, the adverse pregnancy outcomes from recrudescent mothers were also 
reduced with parity, since we observed an increased recovering of both the litter size and birth 
weight. Nevertheless, we did not find a correlation between the intensity of the parasitemia 
peak in the pre-mating period and the occurrence of pregnancy-induced recrudescence in the 
first pregnancy, implying that such previous exposure did not confer PAM protection. 
Remarkable was the observation of parasites in placentas and associated pathology in the 
absence of maternal peripheral parasitemia. This event is especially common in pregnant 
women from high transmission regions (Dorman & Shulman, 2000).  
Our experiments confirmed that PAM in pre-exposed individuals does not require re-infection 
and suggest that malaria recrudescence during pregnancy requires pregnancy-specific factors. 
More specifically, parasite recrudescence was never detected before G12, and most frequently 
parasitemia arose after G14. These observations converge to the notion that the 
vascularization of placenta occurring at G12.5 plays a critical role in murine PAM development, 
possibly having a role on promoting parasite recrudescence.  
All together, our findings appear to parallel human PAM characteristics in terms of pregnancy 
outcome and placental damage and inflammation, which are underlying the clinical 
manifestations observed in humans (Nosten et al., 1991; Rogerson et al., 2003b). Our 
observations also support the hypothesis that PAM protection in the mouse is progressively 
acquired through repeated exposure to malaria in pregnancy which is in line with a recent 
report on cumulative immunity to PAM over several pregnancies (Megnekou et al., 2009). 
Placental Pathology Caused by P. berghei 
In the course of P. falciparum infections, the placenta can harbor a striking density of 
parasites, macrophages, hemozoin and excess of fibrinoid deposits associated to morphologic 
alterations, such as necrosis and trophoblast basement membrane thickening (Walter et al., 
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1982) that would be harmful to the developing fetus, as the placental exchanges of respiratory 
gases and nutrients became difficult and reduced. Monocytic/macrophagic infiltrate has been 
considered a hallmark of Plasmodium-infected placentas (Rogerson et al., 2003b; Diouf et al., 
2004).  
P. berghei infected placentas showed general tissue architecture disorganization with 
prominent thickening of the trophoblast basement membrane and fibrinoid deposits. This may 
result in part from fibrosis which has been proposed to arise from the reparative process 
stimulated by the response to infection (Oduola et al., 1986). However, extensive fibrinoid 
necrosis and fibrinoid deposition are abnormal and typical of malaria infected placentas 
(Davison et al., 2000). It is noteworthy that in mouse placentas we observed low degree of 
massive chronic intervillositis as compared to reported observations in infected human 
placentas (Ordi et al., 1998). Possibly this difference is related to the short pregnancy time 
span that may condition the inflammatory process in the mouse as compared to human 
pregnancy. We hypothesize that accumulation of P. berghei-GFP iRBC in the placenta may 
evoke the inflammatory response that resembles the placental malaria pathology attributed to 
P. falciparum. We firstly demonstrate that these characteristics can be observed in the model 
system using non-immune BALB/c mice. A striking pathological finding in infected placentas 
was the reduction of blood sinusoids space, which is attributable to placental tissue thickening 
that presumably compressed available blood vascular space. Furthermore, in recrudescent 
placentas the reduction of the blood sinusoidal space is highly dependent on the parasitemia 
level, reinforcing the notion that the parasite has a pivotal role in the genesis of the placental 
pathology.  
Interestingly, we found that in some non-recrudescent females the placentas could harbor a 
very low density of iRBC, which nevertheless seemed high enough to trigger placenta 
pathology. We speculate that these pathologic mechanisms would explain the death of 
pregnant females that do not show peripheral parasitemia but exhibit placenta pathology. 
Cytoadherence of P. berghei–infected erythrocytes to receptors expressed on the 
syncytiotrophoblast surface is considered to contribute to the described placental disorders, 
but might not be a sufficient condition for pathogenesis, as well as in cerebral malaria 
syndrome (Schofield, 2007). Placental malaria studies propose that the observed intervillositis 
is mostly an immunopathologic process, due to cytokines and chemokines production, leading 
to the activation of the syncytiotrophoblast (Fievet et al., 2001; Lucchi et al., 2008).  
Although we have found important pathological changes in both basal and labyrinthine zones 
of mouse placenta, parasites and hemozoin were never visualized in the fetal circulation and 
positive parasitemia was never recorded in newborns from infected mothers. The absence of 
evidence for congenital infection, despite the presence of numerous iRBC in the placental 
maternal blood, points to the efficacy of the placental trophoblastic layer to block parasite 
traversing to fetal blood. The mechanism by which the trophoblastic cells prevent fetal 
infection is poorly understood, but several trophoblast defense mechanisms have been 
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described, including its capacity of producing immune cells chemoattractants (Guleria & 
Pollard, 2000) or its selective phagocytic ability allowing the removal of infectious agents from 
the maternal-fetal interface (Amarante-Paffaro et al., 2004).  
The vascular control in the placenta is dependent in large part on locally produced vasoactive 
compounds and the loss of main vasodilator properties can have significant consequences on 
the intraplacental perfusion possibly intensifying local areas of hypoxia (Bainbridge & Smith, 
2005) and on the triggering of pre-eclampsia (Brabin & Johnson, 2005). We could not detect a 
significant increase in Hypoxia-Inducible Factor-1alpha (HIF-1α) gene expression in infected 
placentas (data not shown). It is likely that tissue stress responses induced by the alterations in 
placenta blood circulation could play a role in placental physio-pathology. Placenta 
microcirculation is in part controlled through a fine balance between different vasoconstrictors 
such as ET-1, and vasodilators like HO-1 enzyme (Bourgeois et al., 1997; Bainbridge & Smith, 
2005). Recrudescent placentas showed an increase in both ET-1 and HO-1 mRNA expression, 
suggesting that the placenta vasculature is exposed to an abnormal vasoactive regulation.  
Adhesion of P.berghei–iRBC to Mouse Placenta 
One of the currently proposed roles for the placenta in P. falciparum PAM pathogenesis is to 
provide new ligands that are recognized by the iRBC. The adhesion mechanisms of iRBC in 
P. falciparum infected placentas remains controversial, but the main placental candidate 
receptors and their cognate parasite ligands participating in iRBC adhesion have been 
identified. Our data show that CSA and HA can be important candidate adhesion receptors in 
mouse placentas. Additionally, iRBC collected from recrudescent females displayed a marked 
enhancement of CSA and HA binding properties, and thus we raise the hypothesis that 
P. berghei expanding during PAM is positively selected by the ability to bind placental ligands. 
This hypothesis is highly supported by recent work showing that pregnant mice acquire 
immunity specific to the recrudescent parasite (Megnekou et al., 2009). Overall, the 
experimental data suggest that cytoadherence of P. berghei-GFP in the placenta may involve 
CSA and HA as receptors and raises the hypothesis that human and murine malaria in 
pregnancy have similar pathogenesis basis. 
In human PAM specific P. falciparum parasites expressing variants of the PfEMP1 such as the 
molecule encoded by the var gene var2csa, are probably expanded via the increased 
cytoadherence of the iRBC to the placental receptors, prominently CSA (Duffy et al., 2005). 
Although PfEMP1 orthologues were not yet found in P. berghei, our findings raise the 
interesting possibility that the receptors mediating adhesion in the mouse placenta could have 
in P. berghei-iRBC cognate ligands. Even though antigenic variation had been shown in other 
murine malaria species, such as P. chabaudi AS (Phillips et al., 1997; Janssen et al., 2002), it is 
noteworthy that P. berghei VSAs were not described so far, although an ancient study (Cox, 
1959) show that P. berghei relapsed parasites (relapsing 90 or more days after infection 
followed by chemotherapic treatment) led to an increased virulence when compared to stock 
Experimental Pregnancy-Associated Malaria 
92 
 
parasites. Nevertheless, our data opens the possibility that murine PAM entails an 
overrepresentation of P. berghei - iRBC displaying parasite components that mediate the iRBC-
placenta interactions.  
IMUNOPATHOLOGY IN MOUSE PAM 
The second aim of our investigation was to show that PAM mouse models presented in this 
thesis could contribute to a better understanding of the immunological basis of the 
protection/susceptibility to malaria shown in pregnancy and of the underlying molecular 
mechanisms. 
Placental inflammatory response to infection in pregnancy  
Systemic immunity to malaria in non-pregnant mice has been subject of intense investigation 
and is very well documented. The early response mainly involves the innate system and is 
dominated by Th1-type cytokines, namely IL-12 and IFN-γ. In mice, blood-stage P. berghei XAT 
infection induces IL-12 production, important for the development of host resistance via IFN-γ 
production, which promote anti-parasitic properties, at least in part by generating high levels 
of TNF-α and NO (Yoshimoto et al., 1998). However, during pregnancy there may be a bias 
towards a Th2-type response and the placenta may synthesize anti-inflammatory cytokines to 
antagonize pro-inflammatory responses that could otherwise be harmful to the fetus.  
Our data show that, in mice infected during pregnancy, the malaria infection rapidly becomes 
established in the placenta, as revealed by the placental accumulation of luciferase-expressing 
P. berghei parasites. In the placenta, the parasite could take advantage of a propitious 
environment for its survival, due to the absence of inflammatory mediators and dominated by 
Th2-like microenvironment necessary to the pregnancy success. Nevertheless, the presence of 
parasites in the placenta can activate the trophoblast that has a role in shaping the local 
immunological milieu (Lucchi et al., 2008) and synthesize chemoattractants that recruit 
monocytes/macrophages to this site of infection. Hofbauer cells, the placental resident 
macrophages, can also be stimulated to produce β-chemokines chemotactic for 
monocytes/macrophages. This is in line with our observation that the chemokine MIP-1α is up-
regulated in infected placentas. MIP-1α is produced by monocytes, macrophages, lymphocytes 
and other cells. Such type of inflammatory triggering can explain the observed recruitment of a 
mononuclear infiltrate that predominate in maternal blood spaces of the labyrinthine zone. 
Expression analysis of cell-type specific markers indicates that in the case of placentas from 
recrudescent mice the mononuclear infiltration includes NK cells, T lymphocytes and 
macrophages ad is associated with increased expression of the chemokines MCP-1 and MIP-1α 
(Figure 32A and 32B). Interestingly, in our model, IL-12 expression in the placenta was 
significantly decreased (Figure 32C), while the expression of TNF-α and IL-10 was increased. 
This down-regulation of IL-12 production was suggested to be due to the inhibitory effects of 
hemozoin.  
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We noted that iRBC were in intimate contact with placental tissue components and that 
hemozoin was widely spread in maternal blood spaces of infected placentas. In fact, hemozoin 
can accumulate in tissue and within macrophages, remaining for several months after parasite 
clearance, leading to placental function impairment and having inhibitory effects on tissue 
monocytes and macrophages (Sullivan et al., 2000; Schwarzer et al., 2001). Early events in the 
cell-mediated immune response required for protection against malaria are initiated by the 
release of IL-12 from monocytes/macrophages, dendritic cells and neutrophils. However, it 
was shown that the constitutive production of IL-12 by monocytes is inhibited following 
phagocytosis of small amounts of hemozoin. Ingestion of hemozoin may possibly have 
differential effects on cytokines production, namely by enhancing IL-10 production and 
suppressing IL-12 release (Luty et al., 2000). These observations allow the speculation that the 
strong local inflammatory environment generated by the iRBC adhesion is counteracted by a 
systemic anti-inflammatory response. In fact, we noted that the up-regulation of IL10 
expression was correlated with the severity of placenta pathology (Figure 32E). Coincidently, 
IL-10 levels in the serum were associated with poor pregnancy outcomes and this cytokine has 
been suggested as a biomarker for placenta inflammation in pregnant women (Kabyemela et 
al., 2008). 
It remains to be resolved whether T cell infiltration corresponds to activated effector T cells or 
to T regulatory cells as part of a placenta anti-inflammatory response. IL-12, produced by 
activated macrophages, DCs, B lymphocytes and neutrophils, has an important role in inducing 
NK cells to produce IFN-γ. However, in recrudescent placentas the IL-12 expression decreases 
and IFN-γ levels did not increase substantially, despite the presence of more NK cells and T 
cells. Similarly TNF-α expression was not substantially increased even though the increased 
number of recruited macrophages to the placenta. These overall results may be a consequence 
of induction of regulatory cytokines that act to suppress synthesis of inflammatory cytokines. 
In fact, placental IL-10 expression was substantially increased in placentas with higher parasitic 
load. In sum, P. berghei clearly induces a Th1/Th2 disequilibrium in the placenta favoring 
inflammatory responses; IL-10 is also increased and should remain effective in protecting the 
placenta by controlling the negative effects of Th1-type cytokines. This is of utmost importance 
as it allows the mother to keep nurturing and protecting the fetus. However, at delivery 
numerous placentas remain infected, suggesting that the parasite-induced response is not 
effective enough to clear placental infection. An additional increase in Th1 response could be 
efficient in clearing infection but could endanger the fetus, given the detrimental effects of 
TNF-α and IFN-γ on pregnancy. 
Classically, BALB/c mice show a natural bias towards Th2 responses (Hansen et al., 2003). 
When infected with Leishmania major, also a protozoan, produce low levels of IFN-γ and high 
levels of IL-4 and IL-5 (Scott et al., 1989). Conversely, C57Bl/6 that has a higher Th1 response is 
capable of self-healing the infection, while BALB/c develop a non-healing and fatal infection. 
Therefore, it would be interesting to evaluate if mice with a stronger inflammatory response 
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(characterized by elevated levels of IFN-γ, for example) and showing a more efficient initial 
malaria attack would have less deleterious placental consequences in terms of parasite 
accumulation and pathology. 
Adaptive immune response in mouse pregnancy 
Pregnant women develop antibodies that are pan-reactive towards placental parasites isolates 
from different geographic areas (Fried et al., 1998b; Lekana Douki et al., 2002). This has 
suggested that the antigenicity of the placental parasite drives a humoral specific response 
that contributes to protect mutigravida from severe forms of PAM.  
We observed that pre-exposed aparasitemic mice display long-lasting high titers of anti-
parasite IgG (Figure 43) and we also observed likewise that the parasites may persist for long 
periods in different organs of pre-exposed mice. Such mice are protected of severe disease, as 
they develop a strong response upon parasites challenge that is revealed by a transient 
parasitemia peak that resolves to apparent cure. These observations sustain the interpretation 
that residual and persistent infection supports a continued humoral anti-parasite response 
that would contribute to a long-term malaria protection state. 
We also observed that pre-exposed females that experience pregnancy maintain high titers of 
antibodies against parasites derived from placenta, implying that these mice were 
immunocompetent towards P. berghei. This was particularly visible in recrudescent females 
irrespective of parity (Figure 46), which display higher levels of IgG (and its subclasses) as 
compared to their non-recrudescent counterparts. These results are suggestive that residual 
P. berghei in pre-exposed females elicits further antigenic stimulation during pregnancy 
particularly when the parasite recrudescence is apparent.  
Surprisingly, we found out that pre-exposed females that are pregnant or that experienced 
pregnancy, loose strong malaria protection upon challenge with parasite of non-placental 
origin (see Figure 44). These data strongly suggest that pregnancy abrogates the malaria 
protection status conferred by pre-exposure and induces a state of long term susceptibility to 
non-pregnancy-associated P. berghei.  
This breakage of malaria protection does not correlate with inability to mount an anti-parasite 
humoral response and contrasts with the increased premunition against recrudescent 
P. berghei acquired by pregnancy-experienced females. Thus, the immune response that 
confers protection to pregnancy–associated P. berghei appears not to protect from non-
placental P. berghei. This implies that the immunogenicity of P. berghei involved in PAM differs 
from regular P. berghei. This is line in with a report demonstrating differential specificities in 
the humoral response to P. berghei parasites collected from pregnant females (Megnekou et 
al., 2009) and raises the possibility that antigenic specificities are critical to confer protective 
immune response to the malaria parasites.  
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Notwithstanding, it is intriguing that pre-exposed females that are pregnant or have 
experienced pregnancy not only to gain PAM-specific premunition but sharply loose the 
previous protection against non-placental parasite. This also suggests that recrudescent 
P. berghei in pregnancy drives an immune response that abrogates the protection conferred by 
previous exposures to parasites that possibly show different antigenicity. This abrogation of 
previous immunological protection could be a general mechanism by which malaria parasites 
escape to immunological control in successive infections, as is frequently observed in high-
transmission regions. 
An alternative explanation for the lack of correlation of the high-antibody titers and disease 
protection could be that the humoral response is not a relevant contributor to the 
effectiveness protection against malaria. This hypothesis would explain the failure of 
hyperimmune serum transfers in protecting from infection (Figure 49). In this context it 
remains to be analyzed the possibility that the effectiveness of previous humoral response to 
malaria parasite is compromised as the proportion of asymmetric antibodies raises in the 
pregnant females. Presumably, this could lead to a repertoire that is able to recognize the 
parasite antigens but would not be able to elicit the effector phase of the immune response. 
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CONCLUDING REMARKS 
This thesis describes two PAM mouse models that are based on experimental placental 
infection by P. berghei. These PAM mouse models were scrutinized for pathological and 
immunological criteria that are relevant for human PAM. We conclude that experimental PAM 
constitutes a lever for new approaches in studying PAM pathogenesis and identifying PAM 
protection mechanisms. 
The experimental model established in non-immune mice showed enhanced disease severity 
and magnified pathology phenotypes as compared to the human disease. The prominent 
histological alterations in mouse placenta heavily infected with P. berghei resemble those 
described for acute P. falciparum malaria in humans. Such phenotypic exacerbation allowed us 
to identify trophoblast thickening and vascular space reduction as hallmarks of placenta 
malaria induced by the P.berghei and to hypothesize that placenta immunopathology results 
from an exacerbated inflammatory response to the presence of adherent P. berghei. In the 
pre-exposure (pregnancy-induced malaria recrudescence) mouse model the intensity of 
parasite recrudescence showed to be quantitatively correlated with the placenta pathology 
while the recrudescence incidence and adverse pregnancy outcomes decreased with parity.  
P. berghei-GFP adhesion experiments indicate that iRBC express ligands for different receptors 
in the mouse placenta. iRBC from recrudescent females displayed enhanced adhesion to the 
placenta suggesting that P. berghei parasites mediating PAM have increased specificity for 
placenta receptors. 
We observed that pre-exposed females showed residual but persistent P. berghei infection 
that could explain the long-lasting anti-parasite humoral response that would contribute to a 
long-term malaria protection state. Pregnancy abrogates this malaria protection status 
strongly indicating that the host mechanisms that confer protection to pregnancy–associated 
P. berghei appear not to protect from non-placental P. berghei. This observation compelled us 
to hypothesize that the immunogenicity of P. berghei involved in PAM differs from regular 
P. berghei in an analogy with the P. falciparum variants involved in human PAM. 
The data provided in this thesis demonstrate that the experimental systems based on 
P. berghei-BALB/c mouse are valid models to study the pathogenesis of placenta malaria, the 
adhesion of placenta parasites and the parasite-placenta interaction and the mechanisms of 
PAM protection elicited during pregnancy. 
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FUTURE PERSPECTIVES AND DIRECTIONS 
 
The experimental systems presented in this thesis could prove useful in drawing hypothesis 
and testing analogies on the factors and mechanisms that are considered relevant for human 
PAM. The data presented in this work suggests a number of research avenues that could be 
followed for the detailed characterization of the parasite-placenta interaction in the mouse, 
the dissection of the inflammatory components of placenta malaria and the analysis of the 
antigenic specificities that are involved in PAM acquired protection (see Table 6). Many of 
these questions remained unsolved in human PAM and these investigations in experimental 
systems could provide new hypothesis and solutions to be tested in human PAM. 
Table 6. Exploring PAM mouse models 
Parasite-Host Interaction Characteristic  Approach 
Antigenic specificity of placental P. berghei  
• Immunologic and molecular studies and gene 
expression analysis of antigens of 
recrudescent parasites  
P. berghei ligands mediating placental 
sequestration  
• Ligand-specific binding assays and analyze 
knockout parasites for candidate ligands 
Placenta receptors for iRBC  
• Purify and test individual mouse placental 
potential receptors for iRBC (GAGs), setting 
up in vitro cell culture systems 
Dynamics of placenta sequestration 
• In vivo imaging of recrudescent and non-
recrudescent parasite in pregnant females 
Host inflammatory components in 
pregnancy-induced recrudescence 
• Make use of knockout mice to identify 
several factors involved in PAM 
immunopathology 
• Investigate the existence of soluble 
peripheral markers that quantitatively reflect 
placental disease 
Protective immunity in multiparity 
• Identify antibodies and T cell responses 
specific for the placental P. berghei 
• Assess the role of asymmetric antibodies in 
PAM 
Vertical transmission of malaria and 
protection 
• Analyze the cellular response of newborns to 
malaria antigens 
• Evaluate the transmission of protection by 
anti-parasite antibodies 
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There are a plethora of other unknown mechanisms worthy of further investigation using PAM 
models. Mouse models of PAM can even be used in more generic studies concerning malaria in 
pregnancy, namely:  
• Perform drug trials in pregnancy. The identification of safety/toxicity and effectiveness 
of novel anti-malarials for pregnancy is urgent (WHO, 2006) and it would be 
appropriate to evaluate the mouse models contribution in this respect. Anti-malarial 
drugs have been facing problems of parasite resistance and recrudescence after drug 
treatment is more common during pregnancy. The spread of drug-resistant parasites 
has eroded the value of the few drugs considered safe in pregnancy.  
• Contribute to PAM vaccine studies to prevent pregnancy malaria by identifying in 
P. berghei proteins targeted by the PAM protective immune responses. This would 
provide additional vaccine targets to be tested in P. falciparum to complement current 
efforts to produce a VAR2CSA-based vaccine. 
• Analyze how placental malaria and pre-eclampsia interplay. Pre-eclampsia, the disease 
with the highest pregnancy related maternal lethality in western countries, it is caused 
by impaired trophoblast invasion and placental vascularization alterations, which can 
be caused by inflammation. Recent research interests are focusing in studying the 
interaction and overlap of malaria and pre-eclampsia and the experimental systems 
presented in this thesis provide a useful tool for this research. 
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